2012-2017 NPPA decisions

1 March 2012 to 31 August 2017

This is a list of decisions on NPPA applications – both approvals and declines. We’ve withheld some decisions to maintain patient confidentiality.

Approximately 1/3 of all submitted applications didn’t met the underlying principles of NPPA (or the pre-requisites under the previous NPPA Policy). Applications that don’t meet the principles (or pre-requisites) aren’t assessed any further. They therefore don’t reach the point where we’d make funding decisions about them. Those applications don’t appear in this list, because no funding decision was made.

Drug Indication Outcome
0.45% saline fluid replacement, Chronic Idiopathic Intestinal Pseudo-obstruction Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome Approved renewal
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome Approved renewal
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome Approved renewal
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome Approved renewal
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, hypertension Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, Malnutrition Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, Malnutrition Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, Malnutrition Approved renewal
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, Malnutrition Approved renewal
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, metastatic adenocarcinoma prostate, Metastatic Bone Disease Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, metastatic adenocarcinoma prostate, Metastatic Bone Disease Approved renewal
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, Small Cell lung Cancer Approved
3,4 diaminopyridine Lambert-Eaton myasthenic syndrome, Small Cell lung Cancer Approved
4 - aminosalicylic acid MDR tuberculosis Approved
4-aminopyridine downbeat nystagmus, opsoclonus myoclonus ataxia, Upbeat nystagmus Approved
4-aminopyridine episodic ataxia, migraine, CACNA 1 (calcium channel) gene abnormality Approved
4-aminopyridine relapsing remitting Multiple Sclerosis, hyperlipidaemia, hypertension Declined
8-methoxypsoralen cutaneous t cell lymphoma, mycosis fungoides, Early CD 30 transformation, Post transplant lymphoproliferative disorder (PTLD), Renal transplant 1987 for reflux nephropathy Approved
abatacept polyarticular juvenile idiopathic arthritis, refractory to other treatments Approved
abatacept polyarticular juvenile idiopathic arthritis, refractory to other treatments Approved renewal
abiraterone castrate resistant, metastatic cancer of prostate, bronchiectasis, GI bleed, leg oedema, ongoing DVT, previous CVA, tophaceous gout Declined
aciclovir viral encephalitis Approved
acitretin oral suspension pustular psoriasis Approved
adalimumab Behcet's disease, allergy to infliximab Approved
adalimumab Behcet's disease, allergy to infliximab Approved renewal
adalimumab Behcet's disease, allergy to infliximab Approved renewal
adalimumab Behcet's disease, allergy to infliximab Approved renewal
adalimumab Behcet's disease, autonomic neuropathy, GORD, hypertension, multiple pulmonary nodules, optic neuritis, Vertigo Approved
adalimumab Behcet's disease, autonomic neuropathy, GORD, hypertension, multiple pulmonary nodules, optic neuritis, Vertigo Approved renewal
adalimumab Behcet's disease, infusion reaction to infliximab, occlusive retinal vasculitis Approved
adalimumab Behcet's disease, occlusive retinal vasculitis, allergy to infliximab Approved
adalimumab Behcet's disease, occlusive retinal vasculitis, allergy to infliximab Approved renewal
adalimumab Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab Approved
adalimumab Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab Approved renewal
adalimumab Behcet's disease, occlusive retinal vasculitis, retinitis, allergy to infliximab Approved renewal
adalimumab Behcet's disease, uveitis, Mouth ulcers, oesophageal ulcers, polyarthralgia, vasculitis Approved
adalimumab Behcet's disease, uveitis, Mouth ulcers, oesophageal ulcers, polyarthralgia, vasculitis Approved renewal
adalimumab bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness Approved
adalimumab bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness Approved renewal
adalimumab bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness Approved renewal
adalimumab bilateral chronic uveitis, cataract, keratopathy, learning difficulties, progressive blindness, splenomegaly, unilateral blindness Approved renewal
adalimumab bilateral chronic uveitis, panuveitis Approved
adalimumab chronic pityriasis rubra pilaris Approved
adalimumab cutaneous Crohns disease Approved
adalimumab cutaneous Crohns disease Approved renewal
adalimumab cystoid macular oedema, severe uveitis, cataract, uveitic sarcoidosis Approved
adalimumab cystoid macular oedema, severe uveitis, cataract, uveitic sarcoidosis Approved renewal
adalimumab funded alternative unsuitable, rheumatoid arthritis, liver fibrosis Approved
adalimumab hidradenitis suppurativa, unresponsive to alternatives Approved
adalimumab HLA B27 associated spondyloarthropathy, iritis, oligoarthritis Approved
adalimumab HLA B27 associated spondyloarthropathy, iritis, oligoarthritis Approved renewal
adalimumab infusion reaction to infliximab, severe uveitis, bilateral Approved
adalimumab juvenile idiopathic arthritis, uveitis Approved renewal
adalimumab juvenile idiopathic uveitis, cataract, cystoid macular oedema, keratopathy Approved
adalimumab occlusive retinal vasculitis, intolerance of infliximab Approved
adalimumab occlusive retinal vasculitis, intolerance of infliximab Approved renewal
adalimumab paradoxical inflammatory reaction to cerebral tuberculosis, allergy to infliximab, cerebral tuberculosis Approved
adalimumab paradoxical inflammatory reaction to cerebral tuberculosis, allergy to infliximab, cerebral tuberculosis Approved renewal
adalimumab punctate inner choroidopathy, uveitis, allergy to infliximab Approved
adalimumab severe idiopathic uveitis, obesity, social issues Approved
adalimumab severe idiopathic uveitis, obesity, social issues Approved renewal
adalimumab severe idiopathic uveitis, obesity, social issues Approved renewal
aflibercept age related macular degeneration, choroidal neovascularisation Declined
aflibercept choroidal neovascularisation Approved
aflibercept diabetic macular oedema, Addison's disease, refractory to other treatments, small cell lymphoma Declined
aflibercept diabetic macular oedema, diabetes type 2 Declined
aflibercept diabetic macular oedema, macular oedema, diabetes Approved renewal
aflibercept macular oedema, choroidal neovascularisation Approved renewal
aflibercept macular oedema, choroidal neovascularisation Approved renewal
aflibercept macular oedema, retinal vein occlusion, diabetes type 2, open angle glaucoma Declined
aflibercept neovascular membranes Approved renewal
albendazole hydatid disease Approved
albendazole microsporidia keratosis Approved
albendazole Ruptured hydatid cyst of the liver Approved
alemtuzumab chronic lymphocytic leukaemia, fludarabine refractory Approved
alemtuzumab relapsing remitting Multiple Sclerosis Declined
alpha tocopheryl acetate Alagille's syndrome Approved
alpha tocopheryl acetate Alagille's syndrome, cholestasis, Liver disease Approved
alpha tocopheryl acetate alpha-1 antitrypsin deficiency, cholestatic jaundice Approved
alpha tocopheryl acetate anaemia, iron deficiency, seizures, Vitamin E deficiency Approved
alpha tocopheryl acetate autism, Cystic fibrosis Approved
alpha tocopheryl acetate biliary atresia Approved
alpha tocopheryl acetate biliary atresia Approved
alpha tocopheryl acetate biliary atresia Approved
alpha tocopheryl acetate biliary atresia Approved
alpha tocopheryl acetate biliary atresia Approved
alpha tocopheryl acetate biliary atresia Approved
alpha tocopheryl acetate biliary atresia, choledhocal cyst Approved
alpha tocopheryl acetate biliary atresia, cholestasis Approved
alpha tocopheryl acetate biliary atresia, cholestasis, malabsorption Approved
alpha tocopheryl acetate biliary atresia, cholestatic liver disease Approved
alpha tocopheryl acetate biliary atresia, neonate Approved
alpha tocopheryl acetate biliary atresia, Short Gut Syndrome Approved
alpha tocopheryl acetate biliary cirrhosis Approved
alpha tocopheryl acetate carnitine palmitoyl transferase II deficiency, Vitamin E deficiency Approved
alpha tocopheryl acetate cholestasis Approved
alpha tocopheryl acetate cholestasis Approved
alpha tocopheryl acetate cholestasis Approved
alpha tocopheryl acetate cholestasis, Cystic fibrosis, Liver disease Approved
alpha tocopheryl acetate cholestatic jaundice Approved
alpha tocopheryl acetate cholestatic jaundice Approved
alpha tocopheryl acetate cholestatic jaundice, Chronic lung disease, decreased gastrointestinal function, fat soluable vitamins deficiency, Liver disease, Premature birth, previous metabolic bone disease, pulmonary hypertension Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease Approved
alpha tocopheryl acetate cholestatic liver disease, biliary atresia Approved
alpha tocopheryl acetate cholestatic liver disease, biliary atresia Approved renewal
alpha tocopheryl acetate cirrhosis, Juvenile Xanthogranulomatosis, Liver disease Approved
alpha tocopheryl acetate cmt 1 disease Approved
alpha tocopheryl acetate congenital nephrotic syndrome Approved
alpha tocopheryl acetate conjugated hyperbilirubinemia Approved
alpha tocopheryl acetate conjugated hyperbilirubinemia Approved
alpha tocopheryl acetate conjugated hyperbilirubinemia Approved
alpha tocopheryl acetate conjugated hyperbilirubinemia Approved
alpha tocopheryl acetate conjugated hyperbilirubinemia Approved
alpha tocopheryl acetate conjugated hyperbilirubinemia Approved
alpha tocopheryl acetate conjugated hyperbilirubinemia Approved
alpha tocopheryl acetate conjugated hyperbilirubinemia Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic Fibrosis Approved
alpha tocopheryl acetate Cystic Fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis Approved renewal
alpha tocopheryl acetate Cystic fibrosis, liver disease or short gut syndrome Approved
alpha tocopheryl acetate Cystic fibrosis, pancreatic insufficiency Approved
alpha tocopheryl acetate Cystic fibrosis, Vitamin E deficiency Approved
alpha tocopheryl acetate Cystic fibrosis, Vitamin E deficiency Approved renewal
alpha tocopheryl acetate deranged liver enzymes, jaundice, myocarditis Approved
alpha tocopheryl acetate fat intolerance, low vit E, malabsorbtion syndrome, cervical cancer, Hepatitis C, hysterectomy, post irradiation bowel disease, recent bacterial endocarditis, recto-vaginal fistulae, urinary incontinence Approved
alpha tocopheryl acetate fat soluable vitamins deficiency, cholestatic jaundice Approved
alpha tocopheryl acetate infantile Refsum phenotype Approved
alpha tocopheryl acetate infantile Refsum phenotype Approved renewal
alpha tocopheryl acetate infantile Refsum phenotype, intellectual disability Approved renewal
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate Liver disease Approved
alpha tocopheryl acetate liver disease or short gut syndrome Approved
alpha tocopheryl acetate liver disease or short gut syndrome Approved
alpha tocopheryl acetate liver disease or short gut syndrome Approved
alpha tocopheryl acetate liver disease or short gut syndrome, Alagille's syndrome, cholestasis Approved
alpha tocopheryl acetate liver disease or short gut syndrome, Vitamin E deficiency Approved renewal
alpha tocopheryl acetate Liver disease, Short Gut Syndrome Approved
alpha tocopheryl acetate Liver disease, Short Gut Syndrome Approved
alpha tocopheryl acetate liver dysfunction Approved
alpha tocopheryl acetate multiple vitamin deficiency Approved
alpha tocopheryl acetate multisystem langerhans cell histiocytosis, cholestasis, cirrhosis, Portal Hypertension Approved
alpha tocopheryl acetate neonatal cholestasis Approved
alpha tocopheryl acetate neonatal hepatitis Approved
alpha tocopheryl acetate neutropaenia Approved
alpha tocopheryl acetate progressive familial intrahepatic cholestasis Approved
alpha tocopheryl acetate severe cholestasis Approved
alpha tocopheryl acetate severe necrotising entercolitis, cholestatic, IVN related Liver disease, jaundice Approved
alpha tocopheryl acetate short gut syndrome Approved
alpha tocopheryl acetate short gut syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate short gut syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved
alpha tocopheryl acetate Short Gut Syndrome Approved renewal
alpha tocopheryl acetate Short Gut Syndrome Approved renewal
alpha tocopheryl acetate short gut syndrome, biliary atresia Approved
alpha tocopheryl acetate TPN cholestasis Approved
alpha tocopheryl acetate Vitamin E deficiency Approved
alpha tocopheryl acetate Vitamin E deficiency Approved
alpha tocopheryl acetate Vitamin E deficiency Approved
alpha tocopheryl acetate Vitamin E deficiency, Cystic fibrosis Approved
alpha tocopheryl acetate Vitamin E deficiency, Cystic fibrosis Approved
alpha tocopheryl acetate Vitamin E deficiency, Cystic fibrosis Approved renewal
alpha tocopheryl acetate Vitamin E deficiency, Cystic fibrosis Approved renewal
alpha tocopheryl acetate Vitamin E deficiency, Cystic fibrosis Approved renewal
alpha tocopheryl acetate Vitamin E deficiency, liver disease or short gut syndrome Approved
alpha tocopheryl acetate Vitamin E deficiency, liver disease or short gut syndrome Approved
alpha tocopheryl acetate Vitamin E deficiency, liver disease or short gut syndrome Approved
alpha tocopheryl acetate Vitamin E deficiency, Liver disease, Short Gut Syndrome Approved
alpha tocopheryl acetate   Approved
amikacin MAIC infection, mycobacterium abscessus pulmonary infection, chronic renal impairment Approved
amikacin MDR tuberculosis Approved
amikacin multidrug-resistant TB Approved
amikacin multidrug-resistant tuberculosis Approved
amiloride chronic kidney disease, multiple drug intolerances, Renal Artery Stenosis, resistant hypertension Approved
amiloride hypercalciuria, recurrent nephrolithiasis Approved
amiloride hypertension Approved
amiloride hypertension, primary hyperaldosteronism Approved
amiloride primary hyperaldosteronism, intolerance to spironolactone Approved
amiloride refractory to treatment hypertension, diabetes type 2, intolerance to alternatives, Renal Artery Stenosis Approved
amino acid formula aminoadipic semialdehyde (AASA) dehydrogenase deficiency, pyridoxine dependant epilepsy, developmental delay Approved
amino acid formula glutaric aciduria type 1 Approved
amino acid formula Maple syrup urine disease Approved
amino acid formula tyrosinaemia type I Approved
amiodarone hydrochloride Shone's syndrome, atrial ectopic beats, norwood procedure performed Approved
amiodarone hydrochloride supraventricular tachycardia Approved
amphotericin Allergic bronchopulmonary aspergillosis, Cystic fibrosis Approved
amphotericin persitent candida vulvovaginitis Approved
anakinra autoinflammatory syndrome Approved renewal
anakinra Bilateral chronic bronchiectasis, Hypertension, Reaction to tocilizumab, systemic onset juvenile idiopathic arthritis Approved
anakinra cryopyrin-associated periodic syndrome (CAPS) Approved
anakinra cryopyrin-associated periodic syndrome (CAPS) Approved renewal
anakinra PAPA syndrome Approved
anakinra periodic fever syndrome Approved
anakinra periodic fever syndrome, failure to thrive Approved
anakinra persistent idiopathic pericarditis Approved
anakinra Schnitzler syndrome Approved
anamix methylmalonic acidemia Approved renewal
androstanolone microphallus, Partial Androgen Insensitivity Syndrome Approved
androstanolone microphallus, Partial Androgen Insensitivity Syndrome Approved
androstanolone microphallus, Partial Androgen Insensitivity Syndrome Approved renewal
arginine Citrullinaemia type 1 Approved renewal
arginine MELAS, epilepsy, fatigue, muscular weakness, Weight Loss Approved
arginine OTC Deficiency, learing impairment, recurrent encephalopathy Approved
arginine OTC Deficiency, urea cycle disorder Approved
aripiprazole aggression, agitation, Autistic Spectrum Disorder, intellectual disability, obesity Approved
aripiprazole Autistic Spectrum Disorder, intellectual disability, anxiety, severe obesity Approved
aripiprazole PTSD, eating disorder, multiple suicide attempts, severe affect dysregulation Approved
atenolol  supraventricular tachycardia Approved
atenolol ectopic atrial tachycardia Approved
atenolol junctional tachycardia, hypoplastic right ventricle, tricuspid atresia Approved
atenolol supraventricular tachycardia Approved
atenolol SVT, flecainide toxicity, Wolff-Parkinson-White syndrome Approved
atenolol Wolff-Parkinson-White syndrome Approved
atomoxetine severe postural hypotension, severe vasovagal syncope Approved
atomoxetine severe postural hypotension, severe vasovagal syncope Approved renewal
atropine excessive salivation, cognitive impairment, distal arthrogryposis syndrome, epilepsy, Excessive drooling Approved renewal
azacitidine acute myeloblastic leukaemia, myelodysplasia, scheduled MUD transplant delayed Approved
azacitidine myelodysplastic syndrome, Refractory Cytopenai with Multilineage Dysplasia (RCMD), multiple skin tumours, xeroderma pigmentosum Approved
azithromycin bronchiolitis obliterans syndrome, Graft Versus Host Disease Approved
azithromycin bronchiolitis obliterans, domiciliary oxygen, possibly secondary to adenovirus, Premature birth Declined
azithromycin bronchiolitis obliterans, Hodgkin's lymphoma, post bone marrow transplant Approved
azithromycin cryptosporidium, bronchiectasis, Cholecystitis, cirrhosis, Congenital Immune Deficiency, malabsorption, Malnutrition, osteoporosis Approved
azithromycin diffuse panbronchiolitis Approved
azithromycin Graft versus host disease of lungs, history of acute lymphoblastic leukemia, history of allogeneic bone marrow transplant Approved
azithromycin MAIC infection, diverticular disease, hypertension Approved
azithromycin Mycobacterium Avium Intracellulare infection Approved
azithromycin mycobacterium chelonae osteomyelitis Approved
azithromycin mycobacterium xenopi infection Approved
azithromycin prophylaxis to prevent infection, acquired gamma-interferon autoantibodies, recurrent atypical mycobacterial infections Approved
azithromycin Radiation Pneumonitis, High Risk Neuroblastoma Approved
azithromycin Severe bronchiectasis, asthma Approved
azithromycin Severe bronchiectasis, asthma Approved renewal
baclofen dystonia, Dopamine-2-receptor antibody encephalitis, spasticity Approved
bedaquiline MDR tuberculosis, pulmonary tuberculosis Approved
bendamustine mantle cell lymphoma Approved
benzathine penicillin prophylaxis, Rheumatic Heart Disease, anaphylaxis to funded alternatives Approved
benzathine penicillin secondary prevention of rheumatic fever Approved
benzathine penicillin secondary prevention of rheumatic fever Approved renewal
benzbromarone allopurinol hypersensitivity, chronic kidney disease, severe tophaceous gout Approved
benzbromarone Chronic Severe Tophaceous Gout, Chronic Renal Failure, heart failure Approved
benzbromarone chronic tophaceous gout Approved
benzbromarone chronic tophaceous gout Approved
benzbromarone chronic tophaceous gout, chronic renal impairment, hypertension, ischaemic heart disease Approved
benzbromarone chronic tophaceous gout, Giant Cell Myocarditis, impaired left ventricle dysfunction, ventricular tachycardia Approved
benzbromarone gout, heart transplant Approved
benzbromarone severe tophaceous gout, CCF, chronic kidney disease, polycythaemia rubra vera Approved
benzbromarone severe tophaceous gout, renal transplant Approved
betaine Homocysteinuria, ataxia, dizziness, Ulcerative Colitis, vitamin B6 responsiveness, vitamin D deficiency Approved
betamethasone encephalopathy, severe intellectual disability, spasticity, status epilepticus Approved
betamethasone sodium phosphate oral graft vs host disease post stem cell transplant, Chronic Myeloid Leukaemia Approved
bevacizumab cerebral radionecrosis Approved
bevacizumab Colorectal Cancer, kras wild type Approved
bevacizumab Hereditary hemorrhagic telangiectasia Approved renewal
bevacizumab Laryngeal and Subglottic Papillomatosis, Scleroderma Approved
bevacizumab Laryngeal and Subglottic Papillomatosis, Scleroderma Approved renewal
bevacizumab Laryngeal and Subglottic Papillomatosis, Scleroderma Approved renewal
bevacizumab neurofibromatosis type 2 Approved
bevacizumab recurrent glioblastoma multiforme Declined
bevacizumab recurrent gondal stromal mixed ovarian tumour Declined
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved
bevacizumab recurrent respiratory papillomatosis Approved renewal
bevacizumab recurrent respiratory papillomatosis Approved renewal
bevacizumab recurrent respiratory papillomatosis, atrial fibrillation, Right Heart Failure Approved
bevacizumab recurrent respiratory papillomatosis, severe dysphonia Approved
bicalutamide testotoxicosis (Male limited gonadotropin-independent precocious puberty), growth advancement, high testosterone levels, severe virilisation Approved
bimatoprost glaucoma, Unable to tolerate funded medicaton Approved
biotin basal ganglia disease, Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding Approved renewal
biotin basal ganglia disease, Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding Approved renewal
biotin Biotin Deficiency, Metabolic disorder, autism, brain damage, global development delay, NG Feeding Approved
biotin biotinidase deficiency Approved
biotin epileptic encephalopathy, infantile spasms Approved
biotin holocarboxylase synthetase deficiency Approved
biotin holocarboxylase synthetase deficiency Approved
biotin holocarboxylase synthetase deficiency Approved
biotin holocarboxylase synthetase deficiency Approved
biotin holocarboxylase synthetase deficiency Approved renewal
biotin holocarboxylase synthetase deficiency Approved renewal
biotin holocarboxylase synthetase deficiency Approved renewal
biotin holocarboxylase synthetase deficiency Approved renewal
biotin holocarboxylase synthetase deficiency, antenatal therapy Approved
biotin multiple carboxylase deficiency, Hypertrophic cardiomyopathy, possible mitochondrial disorder Approved
boric acid metronidazole resistant trichomoniasis Approved
bosentan pulmonary arterial hypertension Approved
bosentan pulmonary arterial hypertension Approved renewal
bosentan raynaud's syndrome, recurrent ulceration, ulceration of digits, risk of amputation Approved
bosutinib Chronic Myeloid Leukaemia, paroxysmal af, Peripheral Vascular disease, Pleural Effusion Declined
brentuximab bridge to transplant, relapsed Hodgkin's lymphoma Approved
brentuximab vedotin anaplastic large cell lymphoma relapse, bridge to transplant Approved
brentuximab vedotin bridge to transplant, relapsed Hodgkin's lymphoma Approved
brentuximab vedotin Hodgkin's lymphoma, post autologous bone marrow transplant Approved
brentuximab vedotin Hodgkin's lymphoma, relapsed/refractory Approved
brentuximab vedotin mycosis fungoides, nodular phase, multiple relapses, refractory to chemotherapy Declined
brentuximab vedotin primary refractory Hodgkin lymphoma, bridge to transplant, planned allogeneic SCT post autograft Approved
brentuximab vedotin relapsed Hodgkin's lymphoma Approved
brentuximab vedotin relapsed Hodgkin's lymphoma, conditioning for stem cell transplant Approved
brimonidine allergy to preservative, glaucoma Approved
brimonidine glaucoma, intolerance to funded alternative Approved
brimonidine glaucoma, intolerance to funded alternative Approved renewal
budesonide autoimmune hepatitis, Dermatitis herpetiformis, obesity Approved
budesonide autoimmune hepatitis, diabetes type 2, Necrotic Lesions Approved
budesonide autoimmune hepatitis, diabetes, severe osteoporosis Approved
budesonide autoimmune hepatitis, sclerosing cholangitis, unacceptable side effects of prednisone Approved
budesonide autoimmune hepatitis, sclerosing cholangitis, unacceptable side effects of prednisone Approved renewal
budesonide common variable immunodeficiency Approved
budesonide common variable immunodeficiency Approved renewal
budesonide common variable immunodeficiency Approved renewal
budesonide common variable immunodeficiency, protein losing enteropathy Approved renewal
budesonide Immunosuppressive Therapy, unacceptable side effects of prednisone, Chronic Idiopathic Intestinal Pseudo-obstruction, Intestinal transplant Approved
budesonide Immunosuppressive Therapy, unacceptable side effects of prednisone, Chronic Idiopathic Intestinal Pseudo-obstruction, Intestinal transplant Approved renewal
budesonide protein losing enteropathy Approved
budesonide protein losing enteropathy Approved
budesonide protein losing enteropathy, complex congenital heart disease, hypoalbuminaemia, oedema, Post Fontan procedure Approved
budesonide protein losing enteropathy, Post Fontan procedure Approved
budesonide cr protein losing enteropathy, hypoalbuminaemia, Post Fontan procedure Approved
bumetanide complex congenital cardiac disease, Post Fontan procedure Approved
bumetanide complex congenital heart disease, Post Fontan procedure Approved
bumetanide complex congenital heart disease, post surgical chylothorax Approved
bumetanide Post Fontan procedure, complex congenital cardiac disease Approved
bumetanide oral suspension post surgical chylothorax, congenital cardiac condition, Post Fontan procedure Approved
bupivacaine hydrochloride uncontrolled cancer pain, metastatic lung cancer Approved
bupivacaine/fentanyl severe pain, metastatic carcinoma, parietal subdural haemorrhage Approved
bupivacaine/morphine/clonidine pain, Myeloma, pathological fracture Approved
buprenorphine progressive familial myopathy, gastrointestinal failure, Growth Failure, severe pain, TPN dependent pseudo-obstruction, vitamin D deficiency Approved
buprenorphine (Subutex) opioid dependence, opiod substitution programme, pregnant Approved
cabergoline Cushing's Disease, hypercorticolism Approved
cabergoline non-functioning pituitary adenoma, not surgically resectable, visual impairment Approved
calcitriol autosomal recessive polycystic kidney disease, End stage renal failure, gastrointestinal malabsorbtion, osteitis fibrosa cystica Approved
calcium hydroxyapatite dysphonia, hypophonia, vascular disease Approved
calcium hydroxyapatite Glottal insufficiency Approved
calcium hydroxyapatite Glottal insufficiency Approved
calcium hydroxyapatite Glottal insufficiency Approved
calcium hydroxyapatite Glottal insufficiency Approved
calcium phosphate diabetes type 2, mucositus, supraglottic tumour Approved
calcium phosphate infection, carcinoma of the tonsil Approved
calcium phosphate mucositis Approved
calcium phosphate mucositis Approved
calcium phosphate mucositis Approved
calcium phosphate mucositis Approved
calcium phosphate mucositis, squamous cell carcinoma Approved
calcium phosphate oral mucositis Approved
calcium phosphate oral mucositis Approved
calcium phosphate oral mucositis Approved
calcium phosphate oral mucositis Approved
calcium phosphate oral mucositis Approved
calcium phosphate oral mucositis Approved
calcium phosphate oral mucositis, carcinoma of the tonsil Approved
calcium phosphate oral mucositis, carcinoma of tongue, radiation treatment Approved
calcium phosphate oral mucositis, chemotherapy, Radiotherapy Approved
calcium phosphate oral mucositis, Radiotherapy Approved
calcium phosphate oral mucositis, radiotherapy, squamous cell carcinoma of subglottic space Approved
calcium phosphate oral mucositis, squamous cell carcinoma left tonsil, undergoing chemotherapy and radiotherapy Approved
calcium phosphate oral mucositis, squamous cell carcinoma of subglottic space Approved
calcium phosphate oral mucositis, squamous cell carcinoma of subglottic space Approved
calcium phosphate radiation induced oral mucositis Approved
calcium phosphate radiation induced oral mucositis Approved
calcium phosphate radiation induced oral mucositis, squamous cell carcinoma Approved
calcium phosphate squamous cell carcinoma, Mucosal radiation toxicity, Oral Chemotherapy, oral mucositis Approved
captopril cystine stones, nephrolithiasis Approved
captopril mitral regurgitation, mitral stenosis, Autistic Spectrum Disorder, elevated pulmonary arterial pressures, pulmonary hypertension Approved renewal
carbohydrate free mixture congenital glucose galactose malabsorption Approved
carbohydrate free mixture congenital glucose galactose malabsorption Approved renewal
carbohydrate free mixture enteropathy, intestinal failure, carbohydrate intolerance, failure to thrive, fructose intolerance, glucose intolerance, secretory diarrhoea, TPN dependent Approved
carbomer sicca syndrome, rheumatoid arthritis Approved
carmellose sodium dry eyes, graft vs host disease Approved
carmellose sodium eye drops bilateral corneal transplant, atopy, keratoconus, stem cell deficiency Approved
carmustine wafer astrocytoma Approved
carmustine wafer relapsed oligodendroglioma Approved
carnitine carnitine deficiency Approved
carnitine carnitine deficiency Approved
carnitine carnitine deficiency Approved renewal
carnitine carnitine deficiency Approved renewal
carnitine carnitine deficiency, low L-carnitine levels post sodium valproate, Congenital Ponto-Cerebellar Hypolasia, nasogastric tube Approved
carnitine carnitine deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency Approved
carnitine carnitine palmitoyl transferase II deficiency Approved
carnitine holocarboxylase synthetase deficiency Approved
caspofungin candida lusitaniae infection, Glycogen Storage Disease type 1b, immunosuppressed, infected portacath, neutropaenia Approved
caspofungin disseminated aspergillosis, Acute Lymphoblastic Leukaemia Approved
cefuroxime microbial keratitis Approved
celecoxib previous resection, pulmonary inflammatory myofibroblastic tumour, nasogastric tube Approved renewal
celecoxib Rheumatoid Arthritis Declined
cetuximab liver metastases, lung metastases, lymph node spread, metastatic squamous cell carcinoma, primary skin cancer, diabetes type 2, hyperlipidaemia, hypertension Declined
chloral hydrate lissencephaly, cerebal palsy, epilepsy, severe sleep disorder, spastic quadriplegia Approved
chloral hydrate seizure disorder, cerebral palsy, Incontinence, intellectual handicap, scoliosis, spastic quadriplegia Approved
chloral hydrate severe sleep disorder, Complex Mitochondrial Disorder, gastrotomy fed, global development delay Approved
chloral hydrate severe sleep disorder, FOX G1 Syndrome, gastrotomy fed, global development delay Approved renewal
chloral hydrate severe sleep disorder, FOX G1 Syndrome, gastrotomy fed, global development delay Approved renewal
chloramphenicol allergic eye disease, corneal ulcers, Herpes Simplex Keratitis Approved
cholic acid infantile Refsum phenotype, peroxisomal biogenesis defect, Zellweger spectrum disorder Approved
cinacalcet autonomous hyperparathyroidism, Cardiomyopathy, diabetes type 2, haemodialysis Approved
cinacalcet autonomous hyperparathyroidism, end stage renal disease Approved
cinacalcet autonomous hyperparathyroidism, end-stage renal failure on dialysis, Peripheral Vascular disease Approved
cinacalcet autosomal recessive polycystic kidney disease, bone marrow fibrosis, congenital hepatic fibrosis, End stage renal failure, failure to thrive, hypersplenism, oesophageal varicies, Portal Hypertension, Severe hyperthyroidism Approved
cinacalcet Calciphylaxis, Coronary Artery Disease, diabetes type 2, diabetic nephropathy, end stage renal disease, hyperparathyroidism, Peripheral Vascular disease Approved
cinacalcet Calciphylaxis, dialysis, end stage renal failure, hyperparathyroidism Approved
cinacalcet Calciphylaxis, hypercalcaemia, hyperphosphataemia, Severe ulceration of both legs, Atrial fibrillation, end stage kidney disease, gout, Insulin-Dependent Diabetes Mellitus, necrotic skin ulceration, non ST elevation myocardial infarction, secondary hyperparathyroidism, smoker, VF cardiac arrest Approved
cinacalcet Calciphylaxis, tertiary hyperparathyroidism, diabetic nephropathy, haemodialysis, severe peripheral vascular disease Approved
cinacalcet Calciphylaxis, tertiary hyperparathyroidism, parathyroidectomy Approved
cinacalcet Calciphylaxis, tertiary hyperparathyroidism, parathyroidectomy Approved renewal
cinacalcet Dialysis, hyperparathyroidism, renal failure Approved
cinacalcet Dialysis, hyperparathyroidism, renal failure Approved renewal
cinacalcet Dialysis, hyperparathyroidism, renal failure Approved renewal
cinacalcet ESRF, IgA nephropathy, parathyromatosis, transplant planned, hypertension, limited vascular access Approved
cinacalcet hypercalcaemia Approved
cinacalcet hypercalcaemia, metastatic pancreatic neuroendocrine tumour Approved
cinacalcet hypercalcaemia, primary hyperparathyroidism Approved
cinacalcet hypercalcaemia, primary hyperparathyroidism Approved
cinacalcet hypercalcaemia, primary hyperparathyroidism Approved
cinacalcet hypercalcaemia, primary hyperparathyroidism, atrial fibrillation, B cell lymphoma, cognitive impairment, gout, parkinson's disease, previous PE, Prostate cancer Approved
cinacalcet hyperparathyroidism Approved
cinacalcet hyperparathyroidism Approved
cinacalcet hyperparathyroidism Approved renewal
cinacalcet hyperparathyroidism Approved renewal
cinacalcet hyperparathyroidism, autonomous hyperparathyroidism, end stage renal failure, surgery contraindicated Approved
cinacalcet hyperparathyroidism, autonomous hyperparathyroidism, end stage renal failure, surgery contraindicated Approved renewal
cinacalcet hyperparathyroidism, autonomous hyperparathyroidism, previous surgery, surgery contraindicated, unsuccessful parathyroid surgery Approved
cinacalcet hyperparathyroidism, diabetes type 2, end stage renal failure, hypertension, pulmonary tuberculosis Approved
cinacalcet hyperparathyroidism, diabetes type 2, end stage renal failure, hypertension, pulmonary tuberculosis Approved renewal
cinacalcet hyperparathyroidism, ectopic tissue Approved
cinacalcet hyperparathyroidism, ectopic tissue Approved renewal
cinacalcet hyperparathyroidism, failed surgery, post renal transplant Approved renewal
cinacalcet hyperparathyroidism, IgA nephropathy, post kidney transplant Approved
cinacalcet hyperparathyroidism, infected SVC clot, SVC stenosis Approved
cinacalcet Pancreatic neuroendocrine tumor Approved
cinacalcet Pancreatic neuroendocrine tumor Approved renewal
cinacalcet Pancreatic neuroendocrine tumor Approved renewal
cinacalcet Pancreatic neuroendocrine tumor Approved renewal
cinacalcet pancreatic neuroendocrine tumour, severe treatment resistant hypercalcaemia Approved renewal
cinacalcet parathyroid adenoma, primary hyperparathyroidism, severe treatment resistant hypercalcaemia, bridge to surgery, chronic renal impairment, heart failure Approved
cinacalcet Parathyroid carcinoma with recurrence Approved
cinacalcet primary hypercalcaemia, unfit for surgery Approved
cinacalcet primary hyperparathyroidism Approved renewal
cinacalcet primary hyperparathyroidism, atrial fibrillation, hypercalcaemia, previous CVAs, renal impairment Approved
cinacalcet primary hyperparathyroidism, awaiting surgery, hypercalcaemia, metastatic melanoma Approved
cinacalcet primary hyperparathyroidism, congestive heart failure, gout, hypercalcaemia, hypercholesterolaemia, hypertension, osteoporosis, renal failure Approved
cinacalcet primary hyperparathyroidism, congestive heart failure, gout, hypercalcaemia, hypercholesterolaemia, hypertension, osteoporosis, renal failure Approved renewal
cinacalcet primary hyperparathyroidism, dementia, surgery contraindicated Approved
cinacalcet primary hyperparathyroidism, dementia, surgery contraindicated Approved renewal
cinacalcet primary hyperparathyroidism, dementia, surgery contraindicated Approved renewal
cinacalcet primary hyperparathyroidism, failed surgery Approved
cinacalcet primary hyperparathyroidism, failed surgery Approved renewal
cinacalcet primary hyperparathyroidism, heart disease, lung disease, parathyroid adenoma Approved
cinacalcet primary hyperparathyroidism, heart disease, lung disease, parathyroid adenoma Approved renewal
cinacalcet primary hyperparathyroidism, hypercalcaemia Approved
cinacalcet primary hyperparathyroidism, hypercalcaemia Approved
cinacalcet primary hyperparathyroidism, hypercalcaemia Approved renewal
cinacalcet primary hyperparathyroidism, hypercalcaemia Approved renewal
cinacalcet primary hyperparathyroidism, hyperlipidaemia, hypertension, impaired glucose tolerance, ischaemic heart disease Approved
cinacalcet primary hyperparathyroidism, hyperlipidaemia, hypertension, impaired glucose tolerance, ischaemic heart disease Approved renewal
cinacalcet primary hyperparathyroidism, IHD, Pancreatic neuroendocrine tumor, renal impairment Approved
cinacalcet primary hyperparathyroidism, tertiary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, hypertension, obesity, Renal Impairment Approved
cinacalcet primary hyperparathyroidism, unfit for surgery, bipolar disease, Diabetes Insipidus, diabetes type 2, ischaemic bowel Approved
cinacalcet primary hyperparathyroidism, unsuccessful parathyroid surgery Approved
cinacalcet secondary hyperparathyroidism, bone pain, ESRF on Dialysis, unfit for surgery Approved
cinacalcet secondary hyperparathyroidism, bone pain, ESRF on Dialysis, unfit for surgery Approved renewal
cinacalcet secondary hyperparathyroidism, bronchiectasis, CF related diabetes, Cystic fibrosis, end stage kidney disease, liver transplant, severe chronic lung disease, surgery contraindicated, tertiary hyperparathyroidism Approved
cinacalcet secondary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, end stage renal failure, haemodialysis, long QT syndrome, obesity, Osteoarthritis Approved
cinacalcet secondary hyperparathyroidism, diabetes type 2, dilated cardiomyopathy, end stage renal failure, haemodialysis, long QT syndrome, obesity, Osteoarthritis Approved renewal
cinacalcet secondary hyperparathyroidism, dialysis dependent, ischaemic heart disease, kidney failure, Myasthenia gravis Approved
cinacalcet secondary hyperparathyroidism, end stage renal failure, haemodialysis, tertiary hyperparathyroidism Approved
cinacalcet secondary hyperparathyroidism, post renal transplant, unfit for surgery Approved
cinacalcet secondary hyperparathyroidism, post renal transplant, unfit for surgery Approved renewal
cinacalcet secondary hyperparathyroidism, unfit for surgery Approved
cinacalcet secondary hyperparathyroidism, unfit for surgery Approved renewal
cinacalcet severe hyperparathyroidism, aortic valve disease, cardiac disease, end stage renal failure, Endocarditis, ineligible for transplant, on warfarin, previous stroke, unfit for surgery Approved
cinacalcet severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE Approved
cinacalcet severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE Approved renewal
cinacalcet severe hyperparathyroidism, back pain, occlusion subclavian vein, renal failure, SLE Approved renewal
cinacalcet severe hyperparathyroidism, diabetes type 2, end stage renal failure, haemodialysis, ischaemic heart disease, obesity Approved
cinacalcet severe hyperparathyroidism, diabetes type 2, end stage renal failure, haemodialysis, ischaemic heart disease, obesity Approved renewal
cinacalcet severe hyperparathyroidism, end stage renal failure, ESRD, gout, obesity Approved
cinacalcet severe hyperparathyroidism, end stage renal failure, haemodialysis, unfit for surgery Approved
cinacalcet severe hyperparathyroidism, ESRD, haemodialysis, Peripheral Vascular disease, severe ischaemic heart disease Approved
cinacalcet severe hyperparathyroidism, ESRD, haemodialysis, Peripheral Vascular disease, severe ischaemic heart disease Approved renewal
cinacalcet severe hyperparathyroidism, surgery contraindicated Approved
cinacalcet severe hyperparathyroidism, surgery contraindicated Approved renewal
cinacalcet severe hyperparathyroidism, surgery contraindicated Approved renewal
cinacalcet Severe hyperthyroidism, Calciphylaxis, diabetes type 2, ESRF on Dialysis, gout, IHD, no venous access, obesity, Peripheral Vascular disease, probable uterine fibroid mass, renal calculus Approved
cinacalcet Severe hyperthyroidism, Calciphylaxis, diabetes type 2, ESRF on Dialysis, gout, IHD, no venous access, obesity, Peripheral Vascular disease, probable uterine fibroid mass, renal calculus Approved renewal
cinacalcet Severe hyperthyroidism, Coronary Artery Disease, end stage renal failure, polycystic kidney disease Approved
cinacalcet severe secondary hyperparathyroidism, aortic stenosis, end stage renal failure Approved
cinacalcet severe secondary hyperparathyroidism, aortic stenosis, end stage renal failure Approved renewal
cinacalcet severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease Approved
cinacalcet severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease Approved renewal
cinacalcet severe secondary hyperparathyroidism, diabetes mellitus, end stage renal failure, ischaemic cardiomyopathy, Peripheral Vascular disease Approved renewal
cinacalcet severe secondary hyperparathyroidism, diabetes, end stage renal failure, Severe Ischaemic Heart Disease Approved
cinacalcet severe secondary hyperparathyroidism, diabetes, end stage renal failure, Severe Ischaemic Heart Disease Approved renewal
cinacalcet severe secondary hyperparathyroidism, diabetes, end stage renal failure, severe ischaemic heart disease Approved renewal
cinacalcet severe secondary hyperparathyroidism, end stage renal disease, surgery contraindicated Approved
cinacalcet severe secondary hyperparathyroidism, end stage renal failure, unfit for surgery Approved
cinacalcet severe secondary hyperparathyroidism, end stage renal failure, unfit for surgery Approved renewal
cinacalcet severe secondary hyperparathyroidism, severe treatment resistant hypercalcaemia, end stage renal failure, Right Heart Failure Approved
cinacalcet severe secondary hyperparathyroidism, surgery contraindicated, coronary disease, dialysis dependent, ESRF secondary to focal glomerulosclerosis, previous CABG, severe peripheral vascular disease Approved
cinacalcet severe secondary hyperparathyroidism, surgery contraindicated, coronary disease, dialysis dependent, ESRF secondary to focal glomerulosclerosis, previous CABG, severe peripheral vascular disease Approved renewal
cinacalcet severe treatment resistant hypercalcaemia, end stage renal failure due to hypertension, ischaemic heart disease, post renal transplant, recurrent bacteraemia, recurrent urinary tract infections, tertiary hyperparathyroidism Approved
cinacalcet severe treatment resistant hypercalcaemia, pre-operative treatment, primary hyperparathyroidism Approved
cinacalcet tertiary hyperparathyroidism Approved
cinacalcet tertiary hyperparathyroidism Approved
cinacalcet tertiary hyperparathyroidism Approved renewal
cinacalcet tertiary hyperparathyroidism Approved renewal
cinacalcet tertiary hyperparathyroidism Approved renewal
cinacalcet tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease Approved
cinacalcet tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease Approved renewal
cinacalcet tertiary hyperparathyroidism, atrial fibrillation, diabetic nephropathy, dialysis, ESRD, severe peripheral vascular disease Approved renewal
cinacalcet tertiary hyperparathyroidism, cardiac disease, ESRD, Peripheral Vascular disease Approved
cinacalcet tertiary hyperparathyroidism, Cardiomyopathy, ESRF, hypertension, musculoskeletal pain, severe emphysema, surgery contraindicated Approved
cinacalcet tertiary hyperparathyroidism, Cardiomyopathy, ESRF, hypertension, musculoskeletal pain, severe emphysema, surgery contraindicated Approved renewal
cinacalcet tertiary hyperparathyroidism, Coronary Artery Disease, diabetic nephropathy, ESRF, surgery contraindicated Approved
cinacalcet tertiary hyperparathyroidism, coronary disease, diabetes type 2, ESRF secondary to FSGS, hypertension, myopathy Approved
cinacalcet tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA Approved
cinacalcet tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA Approved renewal
cinacalcet tertiary hyperparathyroidism, diabetes type 2, IHD, previous CVA Approved renewal
cinacalcet tertiary hyperparathyroidism, diabetes, ESRD Approved
cinacalcet tertiary hyperparathyroidism, diabetic nephropathy, end stage renal failure, ischaemic heart disease Approved
cinacalcet tertiary hyperparathyroidism, diabetic nephropathy, end stage renal failure, ischaemic heart disease Approved renewal
cinacalcet tertiary hyperparathyroidism, end stage kidney failure, hypercalcaemia Approved
cinacalcet tertiary hyperparathyroidism, end stage renal disease Approved
cinacalcet tertiary hyperparathyroidism, ESRF on Dialysis, ischaemic heart disease, painful extra-skeletal calcium deposits Approved
cinacalcet tertiary hyperparathyroidism, ESRF on Dialysis, ischaemic heart disease, painful extra-skeletal calcium deposits Approved renewal
cinacalcet tertiary hyperparathyroidism, ESRF, surgery contraindicated Approved
cinacalcet tertiary hyperparathyroidism, heart failure Approved
cinacalcet tertiary hyperparathyroidism, heart failure Approved renewal
cinacalcet tertiary hyperparathyroidism, hypercalcaemia, severe renal osteodystrophy Approved
cinacalcet tertiary hyperparathyroidism, hypercalcaemia, severe renal osteodystrophy Approved renewal
cinacalcet tertiary hyperparathyroidism, hypertension, polyarticular gout Approved
cinacalcet tertiary hyperparathyroidism, hypertension, polyarticular gout Approved renewal
cinacalcet tertiary hyperparathyroidism, infected SVC clot, SVC stenosis Approved renewal
cinacalcet tertiary hyperparathyroidism, infected SVC clot, SVC stenosis Approved renewal
cincalcet tertiary hyperparathyroidism, diabetes, ESRD, renal arterial disease Approved
cincalcet tertiary hyperparathyroidism, diabetes, ESRD, renal arterial disease Approved renewal
ciprofloxacin recurrent UTI, unable to swallow these pills Approved
cisapride cerebral palsy, constipation, enteral feeds, pain Approved
cisapride obstruction PU5, gut dysmotility, intolerance to feed, Renal Impairment, single dysplastic kidney, Vomiting Approved
cisapride oesophageal dysmotility, dysphagia, GORD Approved
cisapride oesophageal dysmotility, dysphagia, GORD Approved renewal
cisapride poor antroduodenal motility, Hirschsprung's disease, intolerance to feed, jejunal obstruction Approved
citric acid 12 g + magnesium oxide 3.5 g + picosulfate sodium 10 mg oral liquid Chronic severe constipation, constipation secondary to clozapine, Schizoaffective disorder Approved
citric acid with magnesium oxide and sodium picosulfate abdominal pain, Encopresis, slow transit constipation Approved
citric acid with magnesium oxide and sodium picosulfate Chronic severe constipation Approved
clarithromycin Nocardiosis, prophylaxis, immunocompromised Approved
clindamycin desquamative inflammatory vaginitis Approved
clindamycin clotrimazole desquamative inflammatory vaginitis Approved
clindamycin clotrimazole desquamative inflammatory vaginitis Approved
clindamycin clotrimazole desquamative inflammatory vaginitis Approved
clindamycin clotrimazole desquamative inflammatory vaginitis Approved renewal
clinigel lubricating jelly persitent candida vulvovaginitis Approved
clofarabine Langerhans cell histiocytosis Approved
clofazimine Cystic fibrosis, mycobacterium abscessus pulmonary infection Approved
clofazimine leprosy Approved
clofazimine MDR tuberculosis Approved
clofazimine multibacillary leprosy, peripheral neuropathy Approved
coagucheck testing strips on warfarin, cerebral palsy, epilepsy, pericardial effusion, Pleural Effusion, Rheumatic Heart Disease, valve replacement Approved
co-enzyme q autosomal recessive cerebellar atrophy Approved
co-enzyme q autosomal recessive cerebellar atrophy Approved renewal
coenzyme q 10 alpers' disease, mitochondrial disorder, gastrostomy feeding, Neuropathic pain, partial epilepsy Approved renewal
co-enzyme q10 autosomal recessive cerebellar atrophy Approved
co-enzyme q10 autosomal recessive cerebellar atrophy Approved renewal
co-enzyme q10 heart failure, hyperkalaemia, MELAS, Pleural Effusion Approved
co-enzyme q10 heart failure, hyperkalaemia, MELAS, Pleural Effusion Approved renewal
colesevelam bile salt diarrhoea Approved
colesevelam bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances Approved
colesevelam bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances Approved renewal
colesevelam bile salt diarrhoea post cholecystectomy, Coeliac disease, multiple food intolerances Approved renewal
colistin Resistant Pseudomonas infection, Pseudomonas Chest Infection Approved
condoms contraception, funded alternative unsuitable Approved
crisantaspase NK/T cell lymphoma Approved
crizotinib metastatic lung adenocarcinoma, ALK positive Declined
custodiol htk aortic valve replacement Approved
custodiol htk aortic valve replacement, cardiac surgery, coronary artery bypass grafting, mitral valve replacement Approved
custodiol htk AVR, CABG Approved
custodiol htk cardiac surgery Approved
custodiol htk cardiac surgery Approved
custodiol htk cardiac surgery Approved
custodiol htk cardiac surgery Approved
custodiol htk cardiac surgery Approved
custodiol htk cardiac surgery Approved
custodiol htk cardiac surgery Approved
custodiol htk cardiac surgery, aortic arch repair, transluminal repair of aorta Approved
custodiol htk cardiac surgery, aortic regurgitation, mitral regurgitation, Valve Replacement Approved
custodiol htk cardiac surgery, aortic valve replacement, Congestive Heart Failure, mitral stenosis, Rheumatic Heart Disease Approved
custodiol htk cardiac surgery, aortic valve replacement, mitral valve replacement, tricuspid valve replacement Approved
custodiol htk cardiac surgery, Bentall's procedure Approved
custodiol htk cardiac surgery, Congestive Heart Failure Approved
custodiol htk cardiac surgery, coronary artery bypass grafting Approved
custodiol htk cardiac surgery, PAH Approved
custodiol htk coronary artery bypass graft, mitral valve replacement Approved
custodiol htk triple valve replacement Approved
custodiol htk triple valve replacement Approved
custodiol htk upcoming aortic valve replacement surgery Approved
cyanocobalamin transcobalamin deficiency Approved
cyanocobalamin transcobalamin deficiency Approved
cyanocobalamin vitamin B 12 deficiency, on warfarin, Post Fontan procedure, protein losing enteropathy Approved
cycloserine MDR tuberculosis Approved
cycloserine MDR tuberculosis Approved
cycloserine multidrug-resistant TB Approved
cycloserine multidrug-resistant tuberculosis Approved
cycloserine suspected MDR tuberculosis Approved
cyclosporin atopic conjunctivitis, dry eye Approved
cyclosporin atopic keratoconjunctivitis Approved
cyclosporin atopic keratoconjunctivitis Approved
cyclosporin atopic keratoconjunctivitis Approved
cyclosporin bilateral corneal ulcers, severe acute graft versus host disease, bone marrow transplant Approved
cyclosporin Blepharitis, terrien's marginal deterioration, corneal neovascularisation Approved
cyclosporin breakdown of corneal transplant, keratoconus, peripheral corneal vascularisation Approved
cyclosporin Chronic hyposecretory dry eyes, juvenile rheumatoid arthritis Approved
cyclosporin Chronic hyposecretory dry eyes, juvenile rheumatoid arthritis Approved renewal
cyclosporin conjunctivitis sicca, severe dry eye syndrome Approved renewal
cyclosporin conjunctivitis sicca, severe dry eye syndrome Approved renewal
cyclosporin corneal graft rejection Approved
cyclosporin corneal graft rejection, keratoconus Approved
cyclosporin corneal graft rejection, keratoconus Approved renewal
cyclosporin dry eyes Approved
cyclosporin dry eyes Approved
cyclosporin dry eyes Approved renewal
cyclosporin dry eyes Approved renewal
cyclosporin graft versus host disease, severe dry eyes, corneal transplant, intolerance to ocular steroids Approved
cyclosporin Graft vs Host Disease, Blepharitis Approved
cyclosporin Graft vs Host Disease, bone marrow transplant, conjunctivitis, leukaemia Approved
cyclosporin keratoconjunctivitis Approved
cyclosporin keratoconjunctivitis sicca Approved
cyclosporin keratoconjunctivitis sicca Approved
cyclosporin keratoconjunctivitis sicca Approved
cyclosporin keratoconjunctivitis sicca Approved
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca Approved renewal
cyclosporin keratoconjunctivitis sicca, glaucoma Approved
cyclosporin keratoconjunctivitis sicca, glaucoma Approved renewal
cyclosporin keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis Approved
cyclosporin keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis Approved renewal
cyclosporin keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis Approved renewal
cyclosporin keratoconjunctivitis sicca, meibomian gland dysfunction, rheumatoid arthritis Approved renewal
cyclosporin keratoconjunctivitis sicca, severe dry eye syndrome Approved
cyclosporin keratoconjunctivitis sicca, severe dry eyes Approved
cyclosporin keratoconjunctivitis sicca, severe dry eyes Approved renewal
cyclosporin keratoconus, corneal graft rejection, prophylaxis, recurrent corneal graft Approved renewal
cyclosporin keratoconus, corneal graft rejection, prophylaxis, recurrent corneal graft Approved renewal
cyclosporin keratoconus, recurrent corneal graft Approved renewal
cyclosporin ocular inflammation, photophobia, thyroid eye disease Approved
cyclosporin ocular rosacea, corneal neovascularisation, limbal stem cell deficiency Approved
cyclosporin recurrent corneal graft, hsv recurrence, keratitis Approved
cyclosporin severe allergic conjunctivitis, Vernal Keratoconjunctivitis Approved
cyclosporin severe allergic eye disease, vernal catarrh, vernal conjunctivitis Approved
cyclosporin severe atopic keratoconjunctivitis Approved
cyclosporin severe atopic keratoconjunctivitis, glaucoma Approved
cyclosporin severe dry eye syndrome Approved
cyclosporin severe dry eye syndrome Approved
cyclosporin severe dry eye syndrome, Blepharitis, meibomian gland dysfunction Approved
cyclosporin severe dry eye syndrome, sjogrens syndrome Approved
cyclosporin severe dry eye syndrome, sjogrens syndrome Approved renewal
cyclosporin severe dry eye syndrome, sjogrens syndrome, Blepharitis, meibomian gland dysfunction Approved
cyclosporin severe dry eye syndrome, Trichiasis Approved
cyclosporin severe dry eyes, sjogrens syndrome Approved
cyclosporin severe dry eyes, sjogrens syndrome Approved renewal
cyclosporin severe dry eyes, sjogrens syndrome Approved renewal
cyclosporin severe steroid dependant allergic eye disease Approved
cyclosporin severe steroid dependant allergic eye disease Approved renewal
cyclosporin severe vernal keratoconjunctivitis Approved
cyclosporin severe vernal keratoconjunctivitis Approved
cyclosporin sjogrens syndrome Approved
cyclosporin sjogrens syndrome Approved
cyclosporin sjogrens syndrome Approved renewal
cyclosporin sjogrens syndrome Approved renewal
cyclosporin sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca Approved
cyclosporin sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca Approved renewal
cyclosporin sjogrens syndrome, corneal epithelial defect, keratoconjunctivitis sicca Approved renewal
cyclosporin sjogrens syndrome, Fibromyalgia, systemic lu Approved renewal
cyclosporin Unable to produce tears, Blepharitis Approved
cyclosporin vernal allergic eye disease Approved
cyclosporin Vernal Keratoconjunctivitis Approved
cyclosporin Vernal Keratoconjunctivitis Approved
cyclosporin Vernal Keratoconjunctivitis Approved
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis Approved renewal
cyclosporin Vernal Keratoconjunctivitis, asthma, eczema, hayfever, ocular hypertension Approved
cyclosporin Vernal Keratoconjunctivitis, asthma, eczema, hayfever, ocular hypertension Approved renewal
cyclosporin Vernal Keratoconjunctivitis, corneal ectasia Approved
cyclosporin 0.2% Vernal Keratoconjunctivitis Approved renewal
cyclosporin eye chronic dry eye, thyroid-related orbitopathy Approved
cyclosporin eye severe dry eye syndrome Approved
cyclosporin eye sjogrens syndrome, Fibromyalgia, systemic lu Approved
cyclosporin eye sjogrens syndrome, Fibromyalgia, systemic lu Approved renewal
cyclosporin eye Vernal Keratoconjunctivitis Approved
cyclosporin eye Vernal Keratoconjunctivitis Approved
cyclosporin eye Vernal Keratoconjunctivitis, allergic eye disease Approved renewal
cyclosporin eye drops keratoconjunctivitis sicca Approved
cyclosporin eye drops keratoconjunctivitis sicca Approved
cyclosporin eye drops keratoconjunctivitis sicca Approved renewal
cyclosporin eye drops keratoconjunctivitis sicca, meibomian gland dysfunction Approved
cyclosporin eye drops keratoconus, corneal graft rejection Approved
cyclosporin eye drops keratoconus, recurrent corneal graft Approved
cyclosporin eye drops severe vernal keratoconjunctivitis Approved
cyclosporin eye drops severe vernal keratoconjunctivitis Approved
cyclosporin eye drops severe vernal keratoconjunctivitis Approved renewal
cyclosporin eye drops severe vernal keratoconjunctivitis Approved renewal
cyclosporin eye drops Stevens-Johnson Syndrome, bilateral forniceal scarring, chronic ocular discomfort, cicatricial conjunctivitis, corneal grafting, Trichiasis Approved
cyclosporin eye drops Vernal Keratoconjunctivitis Approved
cyclosporin eye drops Vernal Keratoconjunctivitis Approved
cyclosporin eye drops Vernal Keratoconjunctivitis Approved
cyclosporin eye ointment atopic keratoconjunctivitis, meibomian gland dysfunction Approved
cyclosporin eye ointment corneal epithelial defect, ocular inflammation, allergies, keratitis, photophobia Approved
cyclosporin eye ointment filamentary keratitis, ocular dry eyes Approved
cyclosporin eye ointment filamentary keratitis, ocular dry eyes Approved renewal
cyclosporin eye ointment keratoconjunctivitis sicca, glaucoma, melbomium gland dysfunction Approved
cyclosporin eye ointment ocular rosacea, corneal neovascularisation, limbal stem cell deficiency Approved renewal
cyclosporin eye ointment refractory dry eye Approved
cyclosporin eye ointment severe dry eye syndrome Approved
cyclosporin eye ointment severe dry eye syndrome Approved renewal
cyclosporin eye ointment severe dry eye syndrome Approved renewal
cyclosporin eye ointment severe dry eyes, facial nerve palsy, neurotrophic cornea secondary to herpes zoster opthalmicus, Rheumatoid Arthritis, sjogrens syndrome Approved
cyclosporin eye ointment severe steroid dependant vernal keratoconjunctivitis Approved
cyclosporin eye ointment sjogrens syndrome, severe dry eyes Approved
cyclosporin eye ointment Vernal Keratoconjunctivitis, asthma, eczema Approved
cyclosporin eye ointment Vernal Keratoconjunctivitis, asthma, eczema Approved renewal
cyclosporin eye ointment Vernal Keratoconjunctivitis, limbitis, shield ulcer Approved
cyclosporin ointment conjunctivitis Approved
cyclosporin ointment conjunctivitis sicca, severe dry eye syndrome Approved
cyclosporin ointment dry eyes Approved
cyclosporin ointment herpes zoster, keratouveitis, severe dry eye syndrome Approved
cyclosporin ointment keratoconjunctivitis sicca Approved
cyclosporin ointment severe allergic conjunctivitis Approved
cyclosporin ointment sjogrens syndrome, keratoconjunctivitis sicca Approved
cyclosporin ointment Vernal Keratoconjunctivitis, allergic eye disease Approved
cyclosporin ointment Vernal Keratoconjunctivitis, limbitis, shield ulcer Approved renewal
cyclosporin ointment, 0.2% atopic keratoconjunctivitis Approved
cyclosporin ointment, 0.2% Vernal Keratoconjunctivitis Approved
cyclosporin ointment, 0.2% Vernal Keratoconjunctivitis, steroid side effects Approved
cyclosporin ointment, 0.2% Vernal Keratoconjunctivitis, steroid side effects Approved renewal
cyclosporin ointment, 0.2% Vernal Keratoconjunctivitis, steroid side effects Approved renewal
cyclosporin ophthalmic emulsion sjogrens syndrome, keratitis Approved renewal
cyclosporine ophthalmic emulsion sjogrens syndrome, keratitis Approved
cyproheptadine cyclical vomiting, Alagille's syndrome, complex congenital heart disease, tetralogy of fallot repair Approved
cyproheptadine Cyclical vomiting, Hydrocephalus, VP shunt Approved
cysteamine Cystinosis Approved
cysteamine Cystinosis Approved renewal
cysteamine Cystinosis, Chronic Renal Failure Approved renewal
cysteamine eye drops Cystinosis, Chronic Renal Failure Approved
cysteamine hcl Cystinosis, cystine corneal deposits, failure to thrive, renal fanconi syndrome Approved
dabigatran deep vein thrombosis, pulmonary embolism, Immobile, Motor Neurone disease Approved
d-alpha tocopheryl acetate cholestasis Approved
dantrolene Motor Neurone disease, spasm, spasticity, spinal myelopathy Approved
dantrolene spasticity Approved
dantrolene spasticity, cerebral palsy Approved
dantrolene spasticity, stroke Approved
daptomycin allergy to antibiotics, septic arthritis right hip Approved
daptomycin infected prosthetic knee joint, vancomycin resistant staphylococcus aureus Approved
daptomycin infected thrombus, MRSA, Septicaemia Approved
dasatinib Philadelphia positive acute lymphoblastic leukemia Approved
dasatinib Philidelphia positive acute lymphoblastic leukemia, Hodgkin's B cell lymphoma in remission, ischaemic heart disease Approved
deferasirox Blackfan-Diamond Syndrome, transfusion dependent iron overload Approved
deferasirox Blackfan-Diamond Syndrome, transfusion dependent iron overload Approved renewal
deferasirox Fanconi Anaemia, bone marrow aplasia Approved
deferasirox transfusion iron overload, t cell LGL Approved
deferiprone iron overload Approved
deferiprone superficial siderosis Approved
deferiprone superficial siderosis Approved
deferiprone superficial siderosis of CNS, cerebellar ataxia, deafness, erectile dysfunction, myelopathy Approved
deferiprone transfusion dependent iron overload, Severe Aplastic Anaemia Approved
deflazacort Duchenne Muscular Dystrophy Approved
deflazacort Duchenne Muscular Dystrophy Approved renewal
delta-9-tetrahydrocannabinol and cannabidiol Intractable epilepsy, myoclonic seizures, tonic clonic seizures, Behaviour disorder, Chromosomal abnormality, intellectual disability Declined
delta-9-tetrahydrocannabinol and cannabidiol Intractable epilepsy, myoclonic seizures, tonic clonic seizures, Behaviour disorder, Chromosomal abnormality, intellectual disability Declined
delta-9-tetrahydrocannabinol and cannabidiol muscle spasm and pain Declined
delta-9-tetrahydrocannabinol and cannabidiol Severe epilepsy Declined
demeclocycline hyponatraemia secondary to SIADH Approved
demeclocycline hyponatraemia, SIADH, Small Cell lung Cancer Approved
demeclocycline hyponatraemmia, Small Cell lung Cancer Approved
denosumab giant cell tumour of the bone Approved
denosumab giant cell tumour of the bone Approved
denosumab giant cell tumour of the bone Approved
denosumab giant cell tumour of the bone Approved
denosumab giant cell tumour of the bone Approved renewal
denosumab giant cell tumour of the bone Approved renewal
denosumab giant cell tumour of the bone Approved renewal
denosumab multicentric carpotarsal osteolysis Approved
desmopressin addictive behaviour, diabetes insipidus, Langerhans cell histiocytosis Approved
desmopressin central diabetes insipidus Approved
desmopressin central diabetes insipidus, central adrenal insufficiency, central hypothyroidism, Septo-optic dysplasia Approved
desmopressin diabetes insipidus Approved
desmopressin diabetes insipidus secondary to brain tumour Approved
desmopressin diabetes insipidus, Hypopituitarism, Nasal obstruction, somnolence Approved
desmopressin diabetes insipidus, nasal surgery, requires lower dose Approved
desmopressin severe epistaxis, Hereditary hemorrhagic telangiectasia Approved
desmopressin tablet addictive behaviour, diabetes insipidus, Langerhans cell histiocytosis Approved
desmopressin tablet central diabetes insipidus, Langerhans cell histiocytosis Approved
desmopressin tablet central diabetes insipidus, Wegener's Granulomatosis Approved
desmopressin tablet diabetes insipidus, blindness, suprasellar tumour Approved
dexamethasone bilateral multifocal choroiditis, panuveitis, cystoid macular oedema, secondary glaucoma, vasoproliferative tumors Approved
dexamethasone cystoid macular oedema Approved
dexamethasone cystoid macular oedema, uveitis, Psoriatic Arthritis Approved
dexamethasone ocular inflammation, steroid resistance Approved
dexamethasone ocular inflammation, steroid resistance Approved renewal
dexamethasone retinal vein occlusion Approved
dexamethasone retinal vein occlusion Approved renewal
dexrazoxane cardioprotective agent, metastatic osteosarcoma Approved
dextromethorphan non-ketotic hyperglycinaemia Approved
diazoxide generalised seizures, cognitive impairment, convulsions, glucose transporter abnormality Approved
diazoxide generalised seizures, cognitive impairment, convulsions, glucose transporter abnormality Approved
diazoxide Genetic testing re undiagnosed syndrome, Recurrent hypoglycaemia secondary to hyperinsulinism Approved
diazoxide hypoglycaemia due to insulinoma Approved
diazoxide Hypoglycaemia in infant, impaired LV function Approved
diazoxide hypoglycaemia, gastric bypass, Hyperinsulinaemia Approved
diazoxide hypoglycaemia, Insulinoma Approved
diazoxide Insulinoma Approved
diazoxide Insulinoma Approved
diazoxide Insulinoma, spontaneous hypoglycaemia Approved
diazoxide metastatic insulinoma Approved
diazoxide (ECP) hyperinsulinism, hypoglycaemia Approved
dienogest invasive endometriosis, refractory to surgery Approved
diethylcarbamazine Filariasis Approved
dihydrotestosterone androgen insensitivity syndrome Approved
diloxanide amoebic liver abscess Approved
diloxanide intestinal amebiasis Approved
diloxanide invasive amoebiasis, cellulitis, entamoeba histolytica intestinal colonisation Approved
diloxanide fuorate amoebic liver abscess, entamoeba histolytica liver abscess Approved
dimercaptosuccinic acid lead toxicity Approved
diphtheria, tetanus and pertussis vaccine post allogeneic stem cell transplant Approved
diptheria, tetanus and pertussis acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient Approved
diptheria, tetanus and pertussis pertussis infections, Dee pertussis transmission to infant Approved
dipyridamole congenital nephrotic syndrome, VTE prophylaxis Approved
dornase alfa chronic infection with burkholderia cepecia, Cystic fibrosis Approved
dornase alfa chronic obstructive asthma, bronchiolitis Approved
dornase alfa Cystic fibrosis Approved
dornase alfa Cystic fibrosis Approved
dornase alfa Cystic fibrosis, chronic pseudomonas Approved
dornase alfa Cystic fibrosis, lung disease Approved
dornase alfa Cystic fibrosis, pancreatic insufficiency Approved
dornase alfa Cystic fibrosis, pancreatic insufficiency Approved renewal
droperidol anxiety, G tube, J tube, progressive gut failure, severe abdominal pain, TPN dependent Approved
droxidopa intractable postural hypotension, autonomic neuropathy, Familial Amyloid Polyneuropathy due to a mutation in TTR Approved
duloxetine Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction Approved
duloxetine Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction Approved renewal
duloxetine Major Depressive disorder, psychotic symptoms, long QT syndrome Approved renewal
duloxetine pain, erythromelalgia Approved
eculizumab atypical haemolytic uraemic syndrome Declined
eculizumab atypical haemolytic uraemic syndrome, chronic anaemia, intravascular haemolysis Declined
eltrombopag amegakaryocytic thrombocytopaenia Approved
eltrombopag angio immunoblastic T cell lymphoma, aplastic anaemia Approved
eltrombopag angio immunoblastic T cell lymphoma, aplastic anaemia Approved renewal
eltrombopag angio immunoblastic T cell lymphoma, aplastic anaemia Approved renewal
eltrombopag aplastic anaemia Approved
eltrombopag aplastic anaemia Approved
eltrombopag Aplastic Anaemia Declined
eltrombopag aplastic anaemia, Thrombocytopaenia Approved
eltrombopag aplastic anaemia, Thrombocytopaenia Declined renewal
eltrombopag aplastic anaemia, transfusion dependent, high dose cyclophosphamide, severe neutropaenia Approved
eltrombopag bone marrow failure, Severe Aplastic Anaemia, refractory pseudomonal sepsis Approved
eltrombopag chronic immune mediated thrombocytopaenia Approved
eltrombopag chronic immune thrombocytopenia Approved
eltrombopag chronic immune thrombocytopenia Approved renewal
eltrombopag idiopathic thrombocytopaenic purpura Approved
eltrombopag idiopathic thrombocytopaenic purpura, low platelet count, aortic valve replacement, B cell non-hodgkin's lymphoma, upcoming major surgery Approved
eltrombopag immune thrombocytopaenia, Hepatitis B, hyptertension, Recurrent bladder tumours Approved
eltrombopag immune thrombocytopaenia, Hepatitis B, hyptertension, Recurrent bladder tumours, surgery contraindicated Approved renewal
eltrombopag immune thrombocytopaenia, severe steroid effect Approved
eltrombopag immune thrombocytopaenia, severe steroid effect Approved renewal
eltrombopag immune thrombocytopaenic purpura Approved
eltrombopag immune thrombocytopaenic purpura Approved
eltrombopag immune thrombocytopaenic purpura, SLE Approved
eltrombopag immune thrombocytopaenic purpura, SLE Approved renewal
eltrombopag leukaemia, immune thrombocytopaenia Approved renewal
eltrombopag Refractory ITP Approved
eltrombopag Refractory ITP Approved
eltrombopag Refractory ITP, chronic renal impairment, ischaemic heart disease Approved
eltrombopag Refractory ITP, nasal mucosal ulceration, SLE, splenectomy, Thrombocytopaenia Approved
eltrombopag Refractory ITP, nasal mucosal ulceration, SLE, splenectomy, Thrombocytopaenia Approved renewal
eltrombopag Refractory ITP, Underlying CLL Approved
eltrombopag refractory thrombocytopaenia, Underlying CLL Approved
eltrombopag Severe Aplastic Anaemia Approved
eltrombopag Severe Aplastic Anaemia Approved
eltrombopag Severe Aplastic Anaemia Approved
eltrombopag Severe Aplastic Anaemia Approved
eltrombopag Severe Aplastic Anaemia, bone marrow failure Approved
eltrombopag Severe Aplastic Anaemia, bronchiectasis, hypogammaglobulinaemia, thymoma Approved
eltrombopag Severe Aplastic Anaemia, rare platelet match, risk of iron overload Approved
emsogen carnitine-acylcarnitine translocase deficiency, eosinophilic oesophagitis, hyperammonaemia, Autistic Spectrum Disorder, epilepsy, intellectual disability, multiple food allergies Approved
energivit Citrullinaemia type 1 Approved renewal
energivit methylmalonic acidemia Approved
energivit methylmalonic acidemia, brain injury, hyperammonaemia Approved
energivit OTC Deficiency, Ornithine transcarbamylase deficiency, urea cycle disorder Approved
energivit Propionic Acidaemia Approved
enfuvirtide resistant HIV Approved
enoxaparin Adenocarcinoma of the stomach, aortic regurgitation, mitral valve replacement, Rheumatic Heart Disease, st jude's aortic valve replacement Approved
enoxaparin antiphospholipid syndrome, Chest Pain, pulmonary hypertension, unstable INR Approved
enoxaparin antiphospholipid syndrome, thromboses on warfarin, venous thrombosis Approved
enoxaparin antiphospholipid syndrome, thromboses on warfarin, venous thrombosis Approved renewal
enoxaparin antiphospholipid syndrome, thromboses on warfarin, venous thrombosis Approved renewal
enoxaparin aortic valve disease, warfarin interaction, latent TB Approved
enoxaparin artery thrombosis, atrial fibrillation, TPN dependent Approved
enoxaparin Atrial fibrillation, hypertension, lower extremety DVT, previous asbestos exposure Approved
enoxaparin basilar artery occlusion, No resolution on warfarin, recurrent stroke syndromes Approved
enoxaparin bilateral dvt Approved
enoxaparin bilateral pulmonary emboli, deep vein thrombosis, thrombus on dabigatran, warfarin resistance Approved
enoxaparin bilateral pulmonary emboli, PEG tube with gastroparesis/malabsorption oral meds Approved
enoxaparin Calciphylaxis, end stage renal failure, long term anticoagulation, mechanical aortic valve replacement Approved
enoxaparin Calciphylaxis, long term anticoagulation, end stage renal disease, mitral valve replacement Approved
enoxaparin cerebral haemorrhages, familial cavernoma syndrome, inferior vena cava filter, large bilateral pulmonary emboli, severe essential hypertension Approved
enoxaparin chronic loculated left sided pleural effusion, Crohn's disease, primary sclerosing cholangitis, pulmonary embolism Approved
enoxaparin Crohn's diease, Chronic Renal Failure, enterocutaneous fistulae, renal vein thrombosis Approved
enoxaparin deep vein thrombosis Approved
enoxaparin deep vein thrombosis, bilateral pulmonary emboli, factor VII deficiency Approved
enoxaparin deep vein thrombosis, diverticulitis, Malnutrition, pneumonia Approved
enoxaparin deep vein thrombosis, hip fracture, impaired mobility Approved
enoxaparin deep vein thrombosis, hip fracture, impaired mobility Approved renewal
enoxaparin deep vein thrombosis, Multiple Sclerosis Approved
enoxaparin DVT prophylaxis, PEG feeding Approved
enoxaparin hepatic vein thrombosis, Budd Chiari Syndrome, thromboses on warfarin Approved
enoxaparin high risk of deep vein thrombosis, risk of PE, R humeral fracture, Right distal radius fracture Approved
enoxaparin increased risk of DVT due to immobilisation, previous DVT and PE Approved
enoxaparin inferior mesenteric artery thrombosis, chronic diarrhoea, short bowel syndome, small bowel infarction Approved
enoxaparin intolerance to warfarin, DVTs, pulmonary embolism Approved
enoxaparin IVC thrombosis, venous thrombus of inferior vena cava, spontaneous VTE extending into the heart Approved
enoxaparin lower limb deep vein thrombosis, chronic abdominal pain, ileal conduit and ACE, poorly functioning poracath in situ, recurrent infection, recurrent rectal bleeding, Spina Bifida, very poor venous access Approved
enoxaparin multiple pulmonary embolisms, risk of bleeding on warfarin, tetraplegia, unstable INR Approved
enoxaparin multiple thrombi, thromboembolic disease, stroke Approved
enoxaparin non compliance on warfarin, pregnant, Rheumatic Heart Disease, upcoming aortic valve replacement surgery Approved
enoxaparin portal vein thrombosis, atrial fibrillation, previous stroke Approved
enoxaparin post-operative PE, IVF Therapy, polycythaemia Approved
enoxaparin post-operative PE, IVF Therapy, polycythaemia Approved renewal
enoxaparin pulmonary embolism Approved
enoxaparin pulmonary embolism Approved
enoxaparin pulmonary embolism, COPD, epistaxis, LLL pneumonia, recurrent haemoptysis Approved
enoxaparin pulmonary embolism, deep vein thrombosis, warfarin contraindicated (risk of overdose) Approved
enoxaparin pulmonary embolism, diabetes type 2, HSV skin lesions, hypertension, tuberculosis Approved
enoxaparin pulmonary embolism, Headache Approved
enoxaparin pulmonary embolism, intolerance to warfarin Approved
enoxaparin pulmonary embolism, Multiple previous haemorraghic CVA, shoulder replacement Approved
enoxaparin pulmonary embolism, previous stroke Approved
enoxaparin pulmonary embolism, pseudoseizures, recurrent DVTs, thalamic bleed Approved
enoxaparin pulmonary embolism, pseudoseizures, recurrent DVTs, thalamic bleed Approved
enoxaparin recurrent DVTs, intolerance to dabigatran, intolerance to warfarin Approved
enoxaparin recurrent DVTs, intolerance to dabigatran, intolerance to warfarin Approved renewal
enoxaparin recurrent PE, antiphospholipid antibody syndrome Approved
enoxaparin recurrent PE, intolerance to warfarin Approved
enoxaparin recurrent pulmonary emboli Approved
enoxaparin recurrent pulmonary emboli Approved renewal
enoxaparin recurrent venous thromboembolism Approved
enoxaparin recurrent VTE, failed on warfarin Approved
enoxaparin recurrent VTE, failed on warfarin Approved renewal
enoxaparin recurrent VTE, failed on warfarin Approved renewal
enoxaparin recurrent VTE, Immobile, Motor Neurone disease, unable to swallow Approved
enoxaparin relapsed multiple myeloma Approved
enoxaparin right basilic vein thrombosis, very poor venous access Approved
enoxaparin risk of bleeding on warfarin, Atrial fibrillation, congestive heart failure, prosthetic heart valve, Rheumatic Heart Disease, unstable INR Approved
enoxaparin risk of bleeding on warfarin, haematoma, Metastatic liver cancer, post aortic valve replacement Approved
enoxaparin risk of thrombosis, chemotherapy, chronic atrial fibrillation, endometrial cancer, rheumatic valvular disease, unstable INR Approved
enoxaparin Short Gut Syndrome, intestinal failure, sepsis, venous thrombosis Approved
enoxaparin st jude's aortic valve replacement, Depression, fatigue Approved
enoxaparin stroke prevention in atrial fibrillation, GI cancer Approved
enoxaparin superior mesenteric artery occlusion, atrial fibrillation, TPN dependent Approved
enoxaparin SVC Obstruction, bilateral lung transplant, Cystic fibrosis Approved
enoxaparin systemic lupus erythematosus, haematoma, lupus nephritis, SLE Approved
enoxaparin thromboembolic CVAs, Atrial fibrillation Approved
enoxaparin thromboembolic disease Approved
enoxaparin thromboembolic disease Approved
enoxaparin thromboembolic disease Approved renewal
enoxaparin thromboembolic disease Approved renewal
enoxaparin Thrombus, infarct Approved
enoxaparin venous thrombosis Approved
enoxaparin venous thrombosis Approved renewal
entecavir HBsAg chronic carriage, cytotoxic chemotherapy Approved
entecavir Hepatitis B Approved
entecavir Hepatitis B, chronic hepatitis B virus cirrhosis, lamivudine resitant hepatitis B, liver fibrosis Approved
eplerenone Cardiac Failure, Left Ventricular Dysfunction Approved
eplerenone Cardiac Failure, Left Ventricular Dysfunction Approved renewal
eplerenone Cardiac Failure, Left Ventricular Dysfunction Approved renewal
eplerenone cardiac resynchronisation therapy not suitable, intolerance to spironolactone, Severe dilated cardiomyopathy Approved
eplerenone central serous chorioretinopathy, intolerance to funded alternative Approved
eplerenone dilated cardiomyopathy, gynaecomastia, intolerance to funded alternative Approved
eplerenone dilated cardiomyopathy, gynaecomastia, intolerance to funded alternative Approved renewal
eplerenone end stage heart failure, intolerance to funded alternative, prior cerebrovascular accidents Approved
eplerenone heart failure, gynaecomastia, intolerance to spironolactone, Left Ventricular Dysfunction, lowered ejection fraction Approved
eplerenone heart failure, gynaecomastia, intolerance to spironolactone, Left Ventricular Dysfunction, lowered ejection fraction Approved renewal
eplerenone severe left ventricular systolic dysfunction Approved
eplerenone severe left ventricular systolic dysfunction Approved renewal
erwinia asparaginase acute lymphoblastic leukaemia, allergic reaction to PegAsparaginase Approved
erwinia asparaginase acute lymphoblastic leukaemia, allergy to alternatives Approved
erwinia asparaginase allergic reaction to PegAsparaginase, Lymphoblastic T-cell lymphoma Approved
erwinia asparaginase (crisantaspase) ALL, allergic reaction to PegAsparaginase Approved
erwinia asparaginase (crisantaspase) NK/T cell lymphoma Approved
erwinia asparaginase (crisantaspase) NK/T cell lymphoma, allergy to alternatives Approved
erwinia asparaginase (crisantaspase) NK/T cell lymphoma, allergy to pegaspargase Approved
erythropoietin anaemia, transfusion dependent, t cell LGL Approved
erythropoietin alfa anaemia, congenital nephrotic syndrome Approved
erythropoietin alfa anaemia, congenital nephrotic syndrome Approved renewal
erythropoietin alfa chronic anaemia, chronic kidney disease, membranous glomerulonephritis Approved
erythropoietin alfa chronic anaemia, chronic kidney disease, membranous glomerulonephritis Approved renewal
erythropoietin alfa chronic anaemia, chronic kidney disease, membranous glomerulonephritis Approved renewal
erythropoietin alfa symptomatic anaemia, metastatic melanoma Approved
erythropoietin beta anaemia, bilateral PE, renal calculus Declined
erythropoietin beta myelodysplasia sideroblastic anaemia, chronic atrial fibrillation, chronic iron deficiency secondary to gastro intestinal bleeding, congestive heart failure, red cell antibodies, red cell crossmatch difficult, transfusion dependent Approved
erythropoietin beta Red cell aplasia, chronic graft versus host disease, hurler's syndrome, post bone marrow transplant Approved
essential amino acid mix arginase deficiency, essential amino acid deficiency, multiple vitamin deficiency, reduced bone density, Zinc Deficiency Approved renewal
essential amino acid mix arginase deficiency, essential amino acid deficiency, multiple vitamin deficiency, reduced bone density, Zinc Deficiency Approved renewal
essential amino acid mix hypoalbuminaemia and hypoproteinaemia, severe atopic dermatitis Approved
essential amino acid mix Ornithine transcarbamylase deficiency, developmental delay Approved
essential amino acid mix urea cycle disorder Approved
etanercept idopathic pneumonia syndrome, deteriorating respiratory function, post allogenic transplant Approved
etanercept juvenile idiopathic arthritis Approved
ethanol recurrent infection, haemophilia A, prophylaxis Approved
etoricoxib Behcet's disease, oral ulceration, painful arthropathy Declined
everolimus hypoglycaemia due to insulinoma, liver metastases, metastatic pancreatic neuroendocrine tumour Approved
everolimus metastatic atypical carcinoid, carcinoid syndrome, metastatic neuroendocrine tumour, neuroendocrine tumour Declined
everolimus metastatic insulinoma, persistant hypoglycaemia Approved
everolimus metastatic neuroendocrine tumour, ACTH secreting tumour, bilateral hip replacement, chronic infection of hip joint replacement, cushing's syndrome, FGF23 secreting tumour, osteomalacia Declined
everolimus tuberous sclerosis, intellectual disability, rash, renal angiomyolipoma, risk of haemorrhage, subependymal giant cell astrocytomas Declined
ex tyr anamix infant powder tyrosinemia type II Approved
febuxostat Chronic gout, allopurinol hypersensitivity, kidney stone, sclerosing cholangitis, Ulcerative Colitis Approved
febuxostat chronic tophaceous gout, amputation of leg, chronic kidney disease, obesity Approved
febuxostat gout, Hepatitis B, hypertension, Unable to tolerate funded medicaton Approved
febuxostat gout, probable renal calculi, renal impairment Approved
febuxostat severe tophaceous gout, allopurinol hypersensitivity, Atrial fibrillation, chronic kidney disease, ischaemic heart disease, previous nephrolithiasis Approved
febuxostat severe tophaceous gout, allopurinol hypersensitivity, congestive heart failure, persistent hyperuricemia Approved
febuxostat severe tophaceous gout, bone destruction, chronic kidney disease, intolerant to allopurinol, nephrectomy Approved
febuxostat severe tophaceous gout, congestive heart failure, intolerant to allopurinol, persistent hyperuricemia Approved renewal
febuxostat tophaceous gout, acute renal failure, bilateral forniceal narrowing, degenerative disc disease, diffuse annular bulging, facet hypertrophy, iatrogenic Cushing’s syndrome, pulmonary embolism Approved
felbamate Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology Approved
felbamate Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology Approved renewal
felbamate Itractable epilepsy and non-convulsive status, Lennox-Gastaut variant, Neurodegenerative disease of unknown aetiology Approved renewal
fenofibrate atypical teratoid rhabdoid tumour (ATRT), constipation, deafness, gastrostomy, recurrent sinusitis, Vomiting Approved
ferric carboxymaltose anaemia, end-stage renal disease, intolerance to alternatives, on transplant list Approved
ferric carboxymaltose iron deficiency, end stage renal failure Approved
ferric carboxymaltose iron deficiency, end stage renal failure Approved renewal
fexofenadine indolent systemic mastocytosis, mast cell activation syndrome Approved
fexofenadine indolent systemic mastocytosis, mast cell activation syndrome Approved renewal
filgrastim colitis, severe neutropaenia Approved
filgrastim Glycogen Storage Disease type 1b, congenital neutropaenia Approved
filgrastim menorrhagia, severe neutropaenia, uterine fibroid Approved
filgrastim systemic lupus erythematosus, neutropaenia, Thrombocytopaenia Approved
flucytosine candida parapsilosis infection, Rheumatoid Arthritis Approved
flucytosine cryptococcal infection Approved
flucytosine Cryptococcal Meningitis, hepatitis C, HIV Approved
flucytosine persitent candida vulvovaginitis Approved
flunarizine ATP1A3 related neurologic disorder, dystonia, hemiplegia Approved
fluoxetine (Prozac) Depression Declined
food thickener (Nutilis 900) chronic dysphagia, spastic quadriplegia Declined
fortijuice allergy to dairy, Oesophageal carcinoma Approved
fortijuice bowel cancer, epilepsy, global cognitive delay Approved
fosfomycin cholangitis, ESBL producer, unfit for surgery Approved
fosfomycin ESBL Klebsiella UTI, prosthetic hip infection Approved
fosfomycin proteus mirabilis UTI, diabetes, end-stage renal failure on CAPD, ESBL producer, HIV, hypertension, infected renal abscess Approved
fosfomycin Recurrent ESBL E.coli UTI Approved
fosfomycin Recurrent ESBL E.coli UTI Approved
fosfomycin Recurrent ESBL E.coli UTI, chronic leg ulcers, ischaemic heart disease, renal failure Approved
fosfomycin Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome Approved
fosfomycin Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome Approved
fosfomycin Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome Approved renewal
fosfomycin Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome Approved renewal
fosfomycin Recurrent ESBL E.coli UTI, diabetes, hypertension, sjogrens syndrome Approved renewal
fosfomycin recurrent urinary tract infections Approved
fosfomycin recurrent UTI, urinary catheter Approved
fructose congenital glucose galactose malabsorption Approved
fumagillin microsporidia keratosis Approved
gabapentin neuropathic pain Approved
gabapentin nodular prurigo, Depression, eczema, obesity Approved
gabapentin nystagmus, severe oscillopsia, Myeloproliferative disorder Approved
gabapentin pubic symphysis diastasis, pregnant Approved
galactomin 19 congenital glucose galactose malabsorption Approved
ganciclovir anterior uveitis, Cytomegalovirus, fluctuating refraction and vision, ocular hypertension Approved
ganciclovir anterior uveitis, Cytomegalovirus, fluctuating refraction and vision, ocular hypertension Approved
ganciclovir bacterial keratitis, herpetic corneal ulcer Approved
ganciclovir Cytomegalovirus Approved
ganciclovir Cytomegalovirus Approved renewal
ganciclovir herpes simplex infection, central corneal melt, graft failure Approved
gefitinib EGFR positive, non-small cell carcinoma of lung Approved
gemcitabine angiosarcoma of breast, breast cancer Approved
gemcitabine cervical cancer, metastatic lung cancer, metastatic mediastinum Approved
gemcitabine metastatic uterine leiomyo-sarcoma Approved
gemcitabine metastatic uterine leiomyo-sarcoma, impaired left ventricle function Approved
gentamicin intestinal failure, small intestinal bacterial overgrowth, failure to thrive, fatigue, gastrojejunostomy tube, muscle pain, severe gastroesophageal reflux Approved
gentamicin intestinal failure, small intestinal bacterial overgrowth, failure to thrive, fatigue, gastrojejunostomy tube, muscle pain, severe gastroesophageal reflux Approved renewal
gentamicin small intestinal bacterial overgrowth Approved
gentamicin small intestinal bacterial overgrowth Approved
glucose recurrent severe hypoglycaemia, Glycogen Storage Disease type 1b, neutropaenia, oral aversion Approved
glucose recurrent severe hypoglycaemia, Glycogen Storage Disease type 1b, neutropaenia, oral aversion Approved renewal
glucose gel hypoglycaemia, fructose 1,6-bisphosphatase deficiency Approved
glucose gel hypoglycaemia, fructose 1,6-bisphosphatase deficiency Approved renewal
glucose gel hypoglycaemia, Glycogen Storage Disease type 1b Approved
glucose gel hypoglycaemia, Glycogen Storage Disease type 1b Approved renewal
glucose gel hypoglycaemia, Glycogen Storage Disease type 1b Approved renewal
glucose test strips diabetes type 1, developmental delay, poorly controlled diabetes Approved
glucose test strips diabetes type 1, developmental delay, poorly controlled diabetes Approved renewal
glucose test strips diabetes type 1, developmental delay, poorly controlled diabetes Approved renewal
glyceryl trinitrate angina, funded alternative unsuitable Approved
glyceryl trinitrate ischaemic heart disease, Atrial fibrillation, Osteoarthritis Approved renewal
glyceryl trinitrate (Nitrolingual Pump Spray) ischaemic heart disease, Atrial fibrillation, Osteoarthritis Approved
glyceryl trinitrate (Nitrolingual Pump Spray) paroxysmal af, aortic stenosis, Osteoarthritis, STEMI Approved
glyceryl trinitrate (Nitrolingual Pumpspray) ischaemic heart disease, Osteoarthritis Approved
glycopyrrolate excessive  pooling oral secretions due to Bulbar palsy, Motor Neurone disease Approved
haemophilus influenzae type b vaccination acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient Approved
haemophilus influenzae type b vaccination post allogeneic stem cell transplant Approved
histidine-tryptophan-ketoglutarate cardiac surgery, Valve Replacement, Liver Failure, renal failure Approved
histidine-tryptophan-ketoglutarate double coronary byoass graft, upcoming aortic valve replacement surgery, possible interposition aortic graft, possible limited hemi-arch replacement Approved
hpv recombinant vaccine recurrent respiratory papillomatosis Approved
hpv recombinant vaccine Severe recurrent respiratory papillomatosis refractory to surgical debulking Approved
hpv recombinant vaccine Severe recurrent respiratory papillomatosis refractory to surgical debulking Approved
hyaluronic acid post enucleation socket syndrome Approved
hyaluronic acid post enucleation socket syndrome Approved
hyaluronic acid 20mg/ml and lidocaine 3 mg/ml post enucleation socket syndrome Approved renewal
hydromorphone chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction Approved
hydromorphone chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction Approved
hydromorphone chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction Approved renewal
hydromorphone chronic pain, Chronic Idiopathic Intestinal Pseudo-obstruction Approved renewal
hydroxybutyrate Alternating hemiplegia of childhood, glucose transporter abnormality Declined
hydroxybutyrate Alternating hemiplegia of childhood, glucose transporter abnormality Declined
hydroxyurea cerebral sickling, sickle cell anaemia Approved
hydroxyurea Myeloproliferative disorder, Budd Chiari Syndrome, liver transplant Approved
hydroxyurea Myeloproliferative disorder, Budd Chiari Syndrome, liver transplant Approved renewal
hydroxyzine hydrochloride adjustment disorder, Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction Approved
hydroxyzine hydrochloride adjustment disorder, Depression, social anxiety, Chronic Idiopathic Intestinal Pseudo-obstruction Approved renewal
hypromellose 0.3%, dextran 70 0.1% conjunctivitis sicca, dry eyes, keratitis Approved
hypromellose 0.3%, dextran 70 0.1% sjogrens syndrome, conjunctivitis sicca, dry eyes, keratitis Approved renewal
ibrutinib AL amyloidosis, waldenstrom's macroglobulinaemia Declined
ibrutinib splenic marginal zone lymphoma, post splenectomy Declined
icatibant hereditary angioedema, congenital absence of thyroid gland Approved
icatibant hereditary angioedema, congenital absence of thyroid gland Approved renewal
idebenone MELAS Approved
imatinib Hypereosinophilic Syndrome, secondary myelofibrosis, unacceptable side effects of steroid Approved
imatinib Myeloproliferative neoplasm, eosinophilia, PDGFRA abnormality Approved
imatinib philadelphia-positive precursor B cell acute lymphoblastic leukaemia Approved
imatinib systemic mastocytosis, breast cancer in remission, diabetes type 2, previous IgA nephropathy Approved
imiquimod extramammary Paget's Disease Approved
imiquimod Genital Herpes, aciclovir resistant, HIV infection Approved
imiquimod recurrent squamous cell carcinoma Approved
indomethacin congenital nephrotic syndrome, oedema Approved
indomethacin congenital nephrotic syndrome, proteinuria Approved
indomethacin hemicrania continua Approved
indomethacin hemicrania continua Approved
indomethacin paroxysmal hemicrania, severe headaches Approved
indomethacin paroxysmal hemicrania, severe headaches Approved renewal
infatrini failure to gain weight, abnormal pulmonary venous drainage, aortic coarctation, dextroposition of the heart, multiple VSDs, transposition of the great arteries Approved
infatrini failure to thrive Approved
infatrini failure to thrive, Cleft palate, faltering growth, nasopharyngeal tube, pierre robin syndrome, stickler syndrome Approved
infatrini failure to thrive, congenital heart disease, Previous heart failure, unrestricted pulmonary blood flow Approved
infatrini failure to thrive, developmental delay, Feeding difficulties, swallowing dysfunction, very premature birth Approved
infatrini failure to thrive, heart failure Approved
infatrini failure to thrive, lower respiratory tract infection, micrognathia, previous nissen fundoplication, retrognathia, upper airway obstruction Approved
infatrini faltering growth, Central hypotonia, Gastrooesophageal reflux, nystagmus Approved
infatrini faltering growth, Central hypotonia, Gastrooesophageal reflux, nystagmus Approved renewal
infatrini faltering growth, global development delay, preterm, very low birth weight Approved
infatrini faltering growth, global development delay, preterm, very low birth weight Approved renewal
infatrini Growth Failure, Congestive Heart Failure, ventricular septal defect Approved
infliximab Behcet's disease, Cutaneous Vasculitis, optic neuritis, oral ulceration, vasculitic skin lesions Approved
infliximab Behcet's disease, severe ulceration of bowel, diabetes type 2, Hypothyroidism, psychotic depression Approved
infliximab Behcet's disease, severe ulceration of bowel, diabetes type 2, Hypothyroidism, psychotic depression Approved renewal
infliximab bilateral chronic uveitis, granulomatous uveitis, cystoid macular oedema, keratopathy, sarcoidosis Approved
infliximab cardiac sarcoidosis, severe heart failure Approved
infliximab Crohn's diease Approved
infliximab Erythema Nodosum Leprosum, multibacillary leprosy Approved renewal
infliximab juvenile idiopathic arthritis, uveitis, cataract, cystoid macular oedema, keratopathy, ocular hypertension Approved
infliximab neuro tuberculosis Approved
infliximab neurosarcoidosis Approved
infliximab neurosarcoidosis Approved renewal
infliximab neurosarcoidosis, dyslipidaemia, IHD Approved
infliximab neurosarcoidosis, dyslipidaemia, IHD Approved renewal
infliximab neurosarcoidosis, Hydrocephalus, Panhypopituitarism Approved
infliximab neurosarcoidosis, Hydrocephalus, Panhypopituitarism Approved renewal
infliximab neurosarcoidosis, Hydrocephalus, Panhypopituitarism Approved renewal
infliximab pyoderma gangrenosum Approved
infliximab pyoderma gangrenosum Approved renewal
infliximab pyoderma gangrenosum, anaemia Approved
infliximab uveitis, juvenile idiopathic arthritis Approved renewal
insulin type 1 diabetes, multiple suicide attempts, psychotic depression Approved
insulin pump Cystic fibrosis, considered for lung transplant, insulin-dependent diabetes mellitus, pancreatic loss Approved
insulin pump consumables Cystic fibrosis, considered for lung transplant, insulin-dependent diabetes mellitus, pancreatic loss Approved
interferon gamma-1b chronic granulomatous disease, lung abscess, splenic abscesses Approved
interferon gamma-1b Mycobacterium Avium Intracellulare infection, lymphopaenia Approved
interferon gamma-1b Mycobacterium Avium Intracellulare infection, lymphopaenia Approved
irinotecan adenocarcinoma Approved
irinotecan and oxaliplatin pancreatic cancer Approved
isoleucine Maple syrup urine disease Approved
isotretinoin mycosis fungoides Approved
isotretinoin mycosis fungoides, sezary syndrome Approved
isradipine hypertension, Chronic Idiopathic Intestinal Pseudo-obstruction Approved
isradipine hypertension, Chronic Idiopathic Intestinal Pseudo-obstruction Approved renewal
itraconazole chronic ear infection aspergillus Approved
itraconazole fungal prophylaxis, chronic granulomatous disease Approved
itraconazole fungal prophylaxis, chronic granulomatous disease Approved
itraconazole microsporum canis infection Approved
ivabradine sinus tachycardia Approved
ketamine acute myeloblastic leukaemia, bone marrow transplant, pain management, palliative care Approved
ketamine chronic neuropathic pain, Multiple Sclerosis Approved
ketamine Fistulating Anus, pain, rectal carcinoma Approved
ketamine metastatic cervical cancer, palliative pain care Approved
ketamine neuropathic pain, metastatic uterine leiomyo-sarcoma Approved
ketamine pain, adenocarcinoma, metastatic disease Approved
ketamine pain, palliative care Approved
ketamine palliative pain care, lung cancer, stage IV Approved
ketamine palliative pain care, lung cancer, stage IV Approved renewal
ketamine Prostate carcinoma, Metastatic Bone Disease, pathological fracture, spinal cord compression Approved
ketamine uncontrolled cancer pain Approved
ketamine uncontrolled cancer pain, metastatic lung cancer Approved
ketocal 3:1 (Nutricia) pyruvate dehydrogenase deficiency, developmental delay, seizures Approved
ketoconazole cushing's syndrome, hypercortisolism, poor tolerance to metyrapone Approved
ketoconazole hypercalcaemia, renal impairment, renal stones Approved
ketotifen mast cell activation syndrome, mastocytosis, Anaphylaxis, asthma, eczema, multiple drug allergies, peripheral neuropathy, rhinitis Approved
ketotifen mast cell activation syndrome, mastocytosis, anaphylaxis, conjunctivitis, monoclonal, rhinitis Approved
ketotifen mast cell activation syndrome, mastocytosis, anaphylaxis, conjunctivitis, monoclonal, rhinitis Approved renewal
ketotifen multiple food allergies, poor weight gain Approved
klean-prep chronic constipation, restricted diet due to food allergies Approved renewal
lamivudine aplastic anaemia, Agranulocytosis, HBV Approved
lamivudine diffuse large B-cell lymphoma, hepatitis B core antigen positive Approved
lamivudine donor core positive for hepatitis B, Congenital biliary atresia, post liver transplant Approved
lamivudine Hepatitis B Approved
lamivudine Hepatitis B Approved renewal
lamivudine hepatitis B core antibody positive, awaiting stem cell transplant, Multiple Myeloma Approved
lamivudine Hepatitis B prophylaxis prior to CHOP chemotherapy, acute myeloid leukaemia, hepatits C virus, liver fibrosis Approved
lamivudine Hepatitis B, follicular lymphoma Approved
lamivudine HIV, congestive heart failure, end-stage renal failure Approved renewal
l-arginine hyperammonaemia, urea cycle disorder Approved
l-arginine MELAS Approved
l-arginine MELAS Approved
l-arginine MELAS Approved
l-arginine MELAS Approved renewal
l-arginine MELAS, Cardiomyopathy, Seizures Approved
l-arginine MELAS, stroke-like episodes, epilepsy, obsessive-complusive disorder features, sensorineural hearing loss Approved
l-arginine MELAS, stroke-like episodes, epilepsy, obsessive-complusive disorder features, sensorineural hearing loss Approved renewal
l-arginine MELAS, Wolff-Parkinson-White syndrome Approved
l-arginine mitochondrial DNA deletion, stroke-like episodes, MELAS Approved
l-arginine non-syndromic mitochondrial disease, basal ganglia calcification, intermittent psychiatric disturbance Approved
l-arginine Pyridoxine responsive seizures, Down's syndrome Approved
l-arginine Pyridoxine responsive seizures, Down's syndrome Approved renewal
laronidase hurler's syndrome, dysostosis multiplex, Hydrocephalus, lumbar gibbus, obstructive sleep apnoea Approved
laronidase hurler's syndrome, peri- BMT Approved
l-carnitine Brown-Vialetto-Van Laere Syndrome Approved
l-carnitine bulbar palsy, carnitine deficiency, global development delay, Incontinence, refractory epilepsy, respiratory infection Approved
l-carnitine carnitine deficiency, glut-1 deficiency Approved
l-carnitine carnitine deficiency, glut-1 deficiency Approved renewal
l-carnitine carnitine deficiency, Undiagnosed neurological problem, gastrostomy feeding, global development delay, medically refractory seizures Approved
l-carnitine carnitine uptake disorder Approved
l-carnitine carnitine uptake disorder Approved
l-carnitine carnitine uptake disorder Approved
l-carnitine carnitine uptake disorder Approved
l-carnitine carnitine uptake disorder Approved renewal
l-carnitine carnitine uptake disorder Approved renewal
l-carnitine carnitine uptake disorder Approved renewal
l-carnitine carnitine uptake disorder Approved renewal
l-carnitine carnitine-acylcarnitine translocase deficiency Approved
l-carnitine carnitine-acylcarnitine translocase deficiency Approved renewal
l-carnitine carnitine-acylcarnitine translocase deficiency Approved renewal
l-carnitine glutaric aciduria type 1 Approved
l-carnitine glutaric aciduria type 1 Approved renewal
l-carnitine holocarboxylase synthetase deficiency Approved
l-carnitine holocarboxylase synthetase deficiency Approved
l-carnitine holocarboxylase synthetase deficiency Approved renewal
l-carnitine holocarboxylase synthetase deficiency Approved renewal
l-carnitine holocarboxylase synthetase deficiency Approved renewal
l-carnitine holocarboxylase synthetase deficiency Approved renewal
l-carnitine low L- carnatine secondary to ketogenic diet, doose syndrome, epileptic encephalopathy Approved
l-carnitine methylmalonic acidemia Approved
l-carnitine methylmalonic acidemia, brain injury, hyperammonaemia Approved
l-carnitine methylmalonic acidemia, brain injury, hyperammonaemia Approved
l-carnitine methylmalonic acidemia, brain injury, hyperammonaemia Approved renewal
l-carnitine multiple acyl-coenzyme A dehydrogenase deficiency Approved
l-carnitine possible carnitine uptake disorder, abnormal result on newborn screening test Approved
l-carnitine Propionic Acidaemia Approved
lenalidomide IgA multiple myeloma, bilateral diaphramatic paralysis secondary to bortezomib Approved
lenalidomide Multiple Myeloma Declined
lenalidomide myelodysplastic syndrome with 5q deletion Approved
lenalidomide myelodysplastic syndrome with 5q deletion, anaemia, JAK-2 positive, myeloproliferative neoplasms Approved
lenalidomide Myeloma, cervical spondylosis, chronic inflammatory demyelinating polyneuropathy, lumbar spondylosis Declined
lenalidomide plasma cell myeloma, muscle wasting, severe peripheral neuropathy Approved
lenalidomide plasma cell myeloma, muscle wasting, severe peripheral neuropathy Approved renewal
lenalidomide plasma cell myeloma, Painful peripheral Neuropathy Approved
lenalidomide plasma cell myeloma, Painful peripheral Neuropathy Approved renewal
lenalidomide refractory multiple myeloma, hyperlipidaemia, hypertension, neuropathic pain Declined
lenalidomide relapsed chronic lymphocytic leukaemia Declined
leuprorelin metastatic prostate cancer, Haemophilia A Approved
levamisole steroid dependent nephrotic syndrome, frequent flare-ups Approved
levetiracetam temporal lobe epilepsy, Dysembryoplastic neuroepithelial tumor Approved
levocetirizine chronic urticaria Approved
levofloxacin drug reaction, MDR tuberculosis Approved renewal
levonorgestrel dysmenorrhea, heavy menstrual bleeding, chronic vaginal discharge, Didelphic uterus Approved
levonorgestrel heavy menstrual bleeding, on warfarin, Post Liver Transplant, pulmonary hypertension Approved
levonorgestrel menorrhagia Approved
levonorgestrel menorrhagia Approved
levonorgestrel menorrhagia, endometriosis, frozen pelvis Approved
levonorgestrel (Mirena) allergy to alternatives, menorrhagia Approved
levonorgestrel (Mirena) contraception, Morbid Obesity Approved
levonorgestrel (Mirena) dysfunctional uterine bleeding, menorrhagia, contraception, Morbid Obesity Approved
levonorgestrel (Mirena) dysmenorrhea Approved
levonorgestrel (Mirena) dysmenorrhea, menorrhagia, previous bowel surgery Approved
levonorgestrel (Mirena) heavy menstrual bleeding, adenomyosis, hypertension, pelvic pain, very high BMI Approved
levonorgestrel (Mirena) irregular menstrual bleeding, menorrhagia Approved
levonorgestrel (Mirena) menorrhagia Approved
levonorgestrel (Mirena) menorrhagia, Morbid Obesity Approved
levonorgestrel (Mirena) menorrhagia, pelvic pain, endometriosis Approved
levonorgestrel (Mirena) menorrhagia, pelvic pain, Severe endometriosis Approved
levothyroxine Hashimoto's thyroiditis, Hypothyroidism Approved
lignocaine 2% Epidermolysis Bullosa, ulceration of anal canal Approved
lignocaine hydrochloride pain, acromegaly, Calciphylaxis, end-stage renal failure, severe ulceration Approved
linezolid adverse reaction to daptomycin, allergy to vancomycin, Staphylococcus epidermidis infection Approved
linezolid complex congenital heart disease, mediastinitis MRSA, respiratory infection, tracheobronchomalacia Approved
linezolid corynebacterium infection, GORD, hypertension, infected hip joint replacement Approved
linezolid corynebacterium infection, Infected Knee Joint, multi antibiotic resistance Approved
linezolid corynebacterium infection, resistant microorganisms Approved
linezolid enterococcus faecalis infection, multidrug resistant staph infection Approved
linezolid infected hip joint replacement, Klebsiella infection Approved
linezolid MDR Cellulitis, Renal Impairment Approved
linezolid MDR tuberculosis Approved
linezolid MDR tuberculosis Approved
linezolid MDR tuberculosis, hearing loss, psoas abscess, Spinal Abscess Approved
linezolid MDR tuberculosis, pulmonary tuberculosis Approved
linezolid multidrug-resistant TB Approved
linezolid multidrug-resistant tuberculosis Approved
linezolid multidrug-resistant tuberculosis Approved
linezolid multidrug-resistant tuberculosis Approved renewal
linezolid mycobacterium infection Approved
liothyronine dependent T3 replacement Approved
liothyronine dependent T3 replacement Approved renewal
liothyronine Hypothyroidism, post thyroidectomy, radioiodine ineffective Approved
liothyronine Hypothyroidism, post thyroidectomy, radioiodine ineffective Approved renewal
lipistart Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency, excessive weight gain, low zinc and iron, rhabdomyolysis Approved
liposomal doxorubicin kaposi's sarcoma, AIDS Approved
lorazepam medically refractory seizures Approved
lorenzo's oil adrenoleukodystrophy Approved
l-ornithine l aspartate hepatic encephalopathy, end stage liver disease Approved
l-ornithine l aspartate hepatic encephalopathy, end stage liver disease Approved renewal
l-ornithine l aspartate hepatic encephalopathy, Hepatitis C, liver cirrhosis Approved
l-ornithine l aspartate hepatic encephalopathy, refractory to other treatments Approved
l-ornithine l aspartate hepatic encephalopathy, refractory to other treatments Approved renewal
low protein baking mix methylmalonic acidemia Approved
low protein pasta methylmalonic acidemia Approved
macrogol anxiety, Central sensitisation syndrome, chronic abdominal pain, Chronic Nausea, Chronic severe constipation, Gastrooesophageal reflux, gastrostomy feeding, Past history of rheumatic fever Approved
magnesium chloride Gitelman's syndrome, hypokalaemia, hypomagnesaemia Approved renewal
magnesium chloride short bowel syndome, allergy to sulphur, endometriosis complications Approved
magnesium oxide renal wasting of magnesium, cycling vomiting, hypertension, low magnesium, menieres disease Approved
mannitol Cystic fibrosis, CF related diabetes, depression, steroid-induced osteopenia Approved
mannitol Cystic fibrosis, CF related diabetes, depression, steroid-induced osteopenia Approved renewal
mct peptide Langerhans cell histiocytosis, enteropathy, poor growth, probable lymphangiectasia Approved
mechlorethamine mycosis fungoides Approved
melatonin Insomnia, delerium, Long term wean from ventilator following pseudomonas bronchopneumonia Approved
mepacrine cutaneous systemic lupus erythematosus Approved
mepacrine discoid lupus erythematosis, systemic lupus erythematosus Approved
mepacrine discoid lupus erythematosis, systemic lupus erythematosus Approved renewal
mepacrine Refractory giardiasis Approved
mepacrine Refractory giardiasis Approved
mepacrine SLE, Arthritis, hepatosteatosis Approved
mepacrine systemic lupus erythematosus, arthralgia, glomerulonephritis, multiple fractures, myalgia, osteoporosis, pericarditis Approved
mepacrine systemic lupus erythematosus, arthralgia, glomerulonephritis, multiple fractures, myalgia, osteoporosis, pericarditis Approved renewal
metformin with sitagliptin diabetes type 2 Declined
methylphenidate extended release (Ritalin LA) narcolepsy Approved
methylphenidate sr hypotension, tetraplegia Approved
metoclopramide intractable vomiting, chronic fatigue syndrome, short bowel Approved
metronidazole bacterial infection, necrotic pelvic tumour, stage IV sigmoid adenocarcinoma Approved
metronidazole deep tissue infection, Invasive squamous cell carcinoma Approved
mexiletine annular tear Approved
mexiletine asthma, pelvic athropathy in pregnancy Approved
mexiletine cardiac arrhythmias, Hypertrophic cardiomyopathy Approved
mexiletine Chest Pain, neuropathic pain in pregnancy, SLE Approved
mexiletine endometriosis, pelvic pain Approved
mexiletine myotonia congenita, Thomsen's condition Approved
mexiletine neuropathic pain in pregnancy, lumbar disc prolapse Approved
mexiletine pain, painful arthropathy, pregnancy Approved
micronised progesterone cervical incompetence Approved
micronised progesterone pregnancy, cervical incompetence Approved
mifepristone relapsed meningioma Approved
milrinone severe dilated cardiomyopathy of unknown aetology, heart failure, severe left ventricular impairment Approved
minims prednisolone conjunctivitis sicca, dry eyes, keratitis Approved
mitotane adrenal cortical carcinoma Approved
mitotane adrenal cortical carcinoma Approved
mitotane adrenal cortical carcinoma Approved
mitotane adrenal cortical carcinoma, metastatic disease Approved
mitotane adrenal cortical carcinoma, metastatic disease Approved renewal
mitotane adrenocortical carcinoma Approved
mitotane adrenocortical carcinoma Approved
mitotane adrenocortical carcinoma Approved
mitotane adrenocortical carcinoma Approved
mitotane adrenocortical carcinoma Approved
mitotane adrenocortical carcinoma Approved renewal
mitotane adrenocortical carcinoma, Atrial fibrillation, cushing's syndrome, severe hypertension Approved
mitotane adrenocortical carcinoma, cushing's syndrome Approved
mitotane adrenocortical carcinoma, liver metastases, pituitary dependent Cushings syndrome, seizures Approved
mitotane carcinoma of adrenal gland, liver metastases Approved
mitotane grade 4, metastatic adrenocortical carcinoma, unresectable Approved
mitotane lung metastases, metastatic adenocarcinoma Approved
mitotane metastatic adrenocortical carcinoma Approved
mitotane metastatic adrenocortical carcinoma Approved
mitotane metastatic adrenocortical carcinoma Approved
mitotane metastatic adrenocortical carcinoma, cushing's syndrome Approved
mitotane metastatic adrenocortical carcinoma, history of, oesophageal cancer Approved
mitotane metastatic adrenocortical carcinoma, obesity, obstructive sleep apnoea Approved
montelukast angioneurotic oedema Approved
montelukast asthma, Asperger's syndrome, atopy, autism spectrum disorder Declined
montelukast asthma, atopic eczema, gastro-oesophageal reflux disease Declined
montelukast asthma, Hypothyroidism, ischaemic heart disease Approved
montelukast bronchiolitis obliterans syndrome, Graft Versus Host Disease Approved
montelukast bronchiolitis obliterans, acute myeloid leukaemia, chronic graft versus host disease Approved
montelukast cold urticaria, Anaphylaxis Approved
montelukast diabetes type 2, multiple drug allergies, multiple food allergies, Samter's triad, severe asthma Approved
montelukast Graft versus host disease of lungs, GvHD post allogeneic transplant, relapsed AML Approved
montelukast Graft versus host disease of lungs, GvHD post allogeneic transplant, relapsed AML Approved renewal
montelukast Graft versus host disease of lungs, history allogeneic stem cell transplant, history of acute lymphoblastic leukemia Approved
montelukast systemic mastocytosis Approved
montelukast systemic mastocytosis Approved
montelukast systemic mastocytosis Approved
montelukast systemic mastocytosis Approved renewal
morphine/bupivicaine/clonidine bowel cancer, uncontrolled pain Approved
morphine/bupivicaine/clonidine metastatic colon cancer, metastatic disease, severe pain Approved
moxifloxacin asbestosis, MDR pneumococcal bacteraemia Approved
moxifloxacin bacteraemia, enterococcus faecalis infection Approved
moxifloxacin bronchiectasis, Chronic back pain, chronic renal impairment, clostridium infection, severe COPD Approved
moxifloxacin bronchiectasis, multi drug resistant streptococcus pneumoniae infection Approved
moxifloxacin cellulitis Approved
moxifloxacin cellulitis, ulceration Approved
moxifloxacin cerebellar brain abscess, nocardia farcinica infection Approved
moxifloxacin community acquired pneumonia Approved
moxifloxacin deep soft tissue infection Approved
moxifloxacin Discitis Approved
moxifloxacin fungal empyema, Streptococcus pneumoniae infection Approved
moxifloxacin Genital mycoplasma infection Approved
moxifloxacin Infection due to Mycobacterium abscessus Approved
moxifloxacin Infection due to Mycobacterium abscessus Approved renewal
moxifloxacin lower respiratory tract infection, adenocarcinoma of the oesophagus Approved
moxifloxacin meningitis Approved
moxifloxacin multi antibiotic resistant streptococcus pneumoniae chest infection Approved
moxifloxacin multi antibiotic resistant streptococcus pneumoniae chest infection, Bilateral chronic bronchiectasis Approved
moxifloxacin multi drug resistant streptococcus pneumoniae infection, severe COPD Approved
moxifloxacin multi resistant staphylococcus epidermidis, prosthetic joint infection Approved
moxifloxacin multidrug-resistant streptococcus pneumoniae infection, COPD, infective exacerbation Approved
moxifloxacin multidrug-resistant streptococcus pneumoniae infection, eye infection Approved
moxifloxacin multidrug-resistant streptococcus pneumoniae infection, eye infection Approved renewal
moxifloxacin multidrug-resistant streptococcus pneumoniae pneumonia Approved
moxifloxacin multidrug-resistant streptococcus pneumoniae pneumonia, community acquired pneumonia Approved
moxifloxacin Mycobacterium Avium Intracellulare infection, bronchiectasis, Cystic fibrosis Approved
moxifloxacin Mycobacterium fortuitum infection, Osteomyelitis Approved
moxifloxacin mycobacterium marinum infection, GORD, SVT Approved
moxifloxacin mycobacterium xenopi infection Approved
moxifloxacin mycoplasma genitalium infection Approved
moxifloxacin mycoplasma genitalium infection Approved
moxifloxacin mycoplasma genitalium infection Approved
moxifloxacin mycoplasma genitalium infection Approved
moxifloxacin mycoplasma genitalium infection, bacterial vaginosis Approved
moxifloxacin mycoplasma genitalium infection, persistant non gonococcal urethritis Approved
moxifloxacin mycoplasma genitalium infection, unresponsive to azithromycin Approved
moxifloxacin Mycoplasmal pelvic inflammatory disease Approved
moxifloxacin pneumococcal meningitis, mastoiditis, Otitis Media Approved
moxifloxacin pneumonia, Underlying CLL Approved
moxifloxacin presumed tuberculous meningitis Approved
moxifloxacin presumed tuberculous meningitis Approved
moxifloxacin Staphylococcus epidermidis infection, Prosthetic Knee Joint Infection Approved
moxifloxacin Streptococcal pneumonia, fungal empyema Approved
moxifloxacin Streptococcus pneumoniae infection, COPD Approved
moxifloxacin Tuberculous meningitis Approved
moxifloxacin Tuberculous meningitis Approved
moxifloxacin wound infection, mediastinitis, Staphylococcus epidermidis infection Approved
moxifloxacin (Avelox) Genital mycoplasma infection Approved
moxifloxacin iv discitis Approved
msud amino 5 Maple syrup urine disease Approved
multivitamins Epidermolysis Bullosa, inadequate nutrition, recurrent mouth ulceration Approved
mycophenolate Batten's disease Approved
mycophenolate systemic sclerosis, Rapidly progressing Approved
mycophenolate mofetil autoimmune hepatitis Approved
mycophenolate mofetil autoimmune lymphoproliferative syndrome Approved
mycophenolate mofetil systemic lupus erythematosus, lupus nephritis class IIIa Approved renewal
mycophenolic acid lupus nephritis, end stage renal failure, post renal transplant Approved renewal
naloxone hydrochloride Chait tube, G tube, ileostomy, J tube, morphine related itch, progressive gut failure, TPN dependent Approved
naltrexone progressive familial intrahepatic cholestasis, pruritus, awaiting liver transplant Approved
nanovm powder (4-8 years) myoclonic astatic epilepsy, Intractable Epilepsy Approved
nanovm powder (4-8 years) myoclonic astatic epilepsy, Intractable Epilepsy Approved renewal
naproxen/esomeprazole Gastric reflux, Osteoarthritis Declined
nasal spray bottle plus consumables fentanyl nasal spray delivery Approved
natalizumab Multiple Sclerosis Declined
natalizumab relapsing remitting Multiple Sclerosis Declined
natalizumab relapsing remitting Multiple Sclerosis, intolerance to funded alternative Declined
natamycin fungal keratitis Approved
neomycin short bowel syndome, multiple central line infections, small bowel bacterial overgrowth Approved
nicorandil refractory angina Approved
nicorandil refractory angina, ischaemic heart disease Approved
nilotinib Chronic Myeloid Leukaemia Approved
nilotinib Chronic Myeloid Leukaemia Approved
nilotinib Chronic Myeloid Leukaemia Approved renewal
nilotinib Chronic Myeloid Leukaemia Approved renewal
nilotinib Chronic Myeloid Leukaemia Approved renewal
nilotinib Chronic Myeloid Leukaemia, Ca Thyroid currently in remission Approved
nilotinib Chronic Myeloid Leukaemia, chronic phase, interstitial lung disease, Unable to tolerate funded medicaton Approved
nilotinib Chronic Myeloid Leukaemia, imatinib and dasatinib refractory Approved
nilotinib Chronic Myeloid Leukaemia, imatinib refractory, intolerant to dasatinib Approved
nilotinib Chronic Myeloid Leukaemia, intolerance to imatinib/dasatinib Approved
nilotinib Chronic Myeloid Leukaemia, intolerance to imatinib/dasatinib Approved
nilotinib Chronic Myeloid Leukaemia, post burn scarring, PTSD Approved
nilotinib CML, intolerant to dasatinib, resistant to imatinib Approved
nilotinib CML, intolerant to dasatinib, resistant to imatinib Approved renewal
nimodipine reversible cerebral vasoconstriction syndrome Approved
nimodipine reversible cerebral vasoconstriction syndrome Approved
nitazoxanide cryptosporidium Approved
nitazoxanide Giardiasis Approved
nitazoxanide metronidazole resistant recurrent giardiasis Approved
nitazoxanide refractory giardiasis Approved
nitazoxanide refractory giardiasis Approved renewal
nivolumab metastatic melanoma Approved
obinutuzumab 17p deleted chronic lymphocytic leukaemia, hepatitis B reactivation, shingles Declined
octreotide Complex muscular disease, GIT pseudo-obstruction Approved
octreotide high output ileostomy Approved
octreotide metastatic endometrial cancer, profound diarrhoea post radiotherapy Approved
octreotide Pancreatic neuroendocrine tumor, deafness, speech difficulties Approved
octreotide Pleural Effusion, advanced adenocarcinoma of the lung Approved
octreotide post pancreatectomy for cancer Approved
octreotide progressive gut failure, Chait tube, G tube, j tube, palliative care, severe abdominal pain, TPN dependent Approved
octreotide lar gastrointestinal failure, Chronic Nausea, diaphragmatic hernia, gastric dysmotility, lung hypoplasia, possible mitochondrial disorder, total parenteral nutrition dependent, Vomiting Approved
octreotide lar protein losing enteropathy, congenital heart disease, hypoalbuminaemia, hypogammaglobulinaemia Approved
octreotide lar recurrent meningioma, somatostatin receptor expression Approved
octreotide short acting dumping syndrome Approved
oestradiol Hypopituitarism, Septo-optic dysplasia Approved
olanzapine bipolar affective disorder, psychotic symptoms Approved
olanzapine Schizophrenia Approved
olanzapine Schizophrenia Approved renewal
olanzapine (Zyprexa) psychotic disorder, drug reaction, papular urticaria Approved
olanzapine inj bipolar affective disorder type 1 Approved
omalizumab anaphylactic reaction to bee venom, Anaphylaxis, failed bee venom immunotherapy Approved renewal
omalizumab chronic severe asthma Approved
omalizumab chronic urticaria Declined
omalizumab chronic urticaria, hypertension, intolerance to cyclosporin, osteoporosis, Steroid dependent Declined
optifast Morbid Obesity, charcot's neuroarthropathy, diabetes type 2, Immobile Declined
oral elemental feed 1kcal/ml Food sensitivities, Ehlers danlos syndrome, Jejunostomy Approved
oral feed 1.5kcal/ml (Fortisip) inadequate nutrition, primary biliary cirrhosis Approved
oxaliplatin Adenocarcinoma of the stomach, chronic renal impairment Approved
oxaliplatin gastroesophageal junction carcinoma Approved
oxaliplatin metastatic small bowel adenocarcinoma Approved
oxaliplatin Stage  II (T4bNOMO) adenocarcinoma of  bowel invading liver (completely resected) Approved
oxandrolone bone marrow failure, Fanconi Anaemia Approved
oxandrolone bone marrow failure, Fanconi Anaemia Approved renewal
oxcarbazepine epilepsy Approved
oxcarbazepine epilepsy Approved renewal
oxcarbazepine epilepsy Approved renewal
oxcarbazepine Intractable epilepsy, mild hemipharesis, neuronal migration defect, previous surgery Approved
oxybutynin neurogenic bladder, Spina Bifida Approved
palivizumab chronic neonatal lung disease, Cytomegalovirus Hepatitis, Premature birth, previous intraventricular haemorrhage, sepsis Approved
palivizumab neonatal chronic lung disease Approved
palivizumab prophylaxis of RSV, congenital heart block, neonatal chronic lung disease, very premature birth Declined
pancreatin (Pancrex V) Cystic fibrosis, pancreatic insufficiency Approved
papillomavirus vaccine prevention of human papilloma virus Approved
papillomavirus vaccine recurrent respiratory papillomatosis Approved
papillomavirus vaccine recurrent respiratory papillomatosis Approved
papillomavirus vaccine recurrent respiratory papillomatosis Approved
papillomavirus vaccine recurrent respiratory papillomatosis Approved
papillomavirus vaccine recurrent respiratory papillomatosis Approved
papillomavirus vaccine recurrent respiratory papillomatosis Approved
papillomavirus vaccine recurrent respiratory papillomatosis, HPV virus Approved
papillomavirus vaccine respiratory papillomatosis, Down's syndrome Approved
para-amino salicylic acid MDR tuberculosis Approved
para-amino salicylic acid multidrug-resistant TB Approved
para-amino salicylic acid multidrug-resistant tuberculosis Approved
paracetamol pain, Chronic Nausea, chronic vomiting, gastrointestinal failure, IV nutrition dependent, possible mitochondrial disorder Approved
paracetamol severe headaches, terminal bowel cancer Approved
paracetamol (Perfalgan) intestinal dysmotility, tracheo-oesophageal fistula Approved
paraffin (Duoleum Ointment) Nethertons Syndrome, lack of skin integrity Approved
paraffin liquid 50%/white soft paraffin 50% atopic dermatitis, atopic eczema Approved
paraffin liquid 50%/white soft paraffin 50% atopic eczema Approved
paraffin liquid and soft white paraffin eczema Approved renewal
paraffin liquid and white soft paraffin congenital ichthyosis, preterm Approved
paraffin liquid/soft white paraffin (Duoleum) severe eczema, diarrhoea, failure to thrive Approved
paraffin liquid/white soft ointment 50% congenital bullous ichthyosiform erythroderma Approved
paromomycin entamoeba histolytica intestinal colonisation Approved
paromomycin entamoeba histolytica intestinal colonisation Approved
paromomycin entamoeba histolytica intestinal colonisation Approved
paromomycin metronidazole resistant recurrent giardiasis Approved
paromomycin metronidazole resistant recurrent giardiasis Approved
paromomycin Resistant trichomoniasis, Depression Approved
paromomycin Resistant trichomoniasis, funded is contraindicated, peripheral neuropathy from funded alternative Approved
pasireotide acromegaly, diabetes type 2, hypertension, Hypopituitarism Declined
pazopanib acute pancreatitis secondary to sunitinib Approved
pazopanib bilateral non-pigmented retinal tumours, Pancreatic neuroendocrine tumor, renal cell carcinoma Approved renewal
pazopanib desmoplastic small round cell tumour Declined
pazopanib follicular carcinoma of thyroid, bone metastases, liver metastases Approved
pazopanib metastatic sarcoma, soft tissue sarcoma Declined
pazopanib thyroid carcinoma Approved
pediasure failure to thrive, gastrostomy feeding, Growth hormone deficiency, nausea, nephropathic cystinosis, renal fanconi syndrome, Vomiting Approved
pegasparaginase Acute Lymphoblastic Leukaemia Declined
pegasparaginase Acute Lymphoblastic Leukaemia Declined
pegasparaginase Lymphoblastic T-cell lymphoma Declined
pegvisomant pituitary adenoma, pituitary gigantism Approved
pegvisomant pituitary adenoma, pituitary gigantism Approved renewal
pegylated inteferon Chronic Myeloid Leukaemia, pregnancy Approved
pegylated interferon essential thrombocythaemia Approved
pegylated interferon essential thrombocythaemia Approved renewal
pegylated interferon essential thrombocythaemia Approved renewal
pegylated interferon alfa essential thrombocythaemia, CALR mutation positive Approved
pegylated interferon alpha-2a Chronic Myeloid Leukaemia, intolerance to alternatives Approved
pembrolizumab adenocarcinoma of the bladder, metastatic adenocarcinoma Declined
pembrolizumab Hodgkin's lymphoma, Allogeneic stem cell transplant, bridge to transplant, refractory disease, relapsed lymphoma Declined
pembrolizumab metastatic vaginal melanoma, aortic stenosis, history of hodgkins disease, low grade B-cell non-hodgkin's lymphoma, low grade bronchogenic neoplasm of the lung Declined
pemetrexed malignant epithelioid peritoneal mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed Malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved
pemetrexed malignant mesothelioma Approved renewal
pemetrexed malignant mesothelioma, Atrial fibrillation, hypertension, impaired glucose tolerance, polymyalgia rheumatica, severe COPD Approved
pemetrexed malignant mesothelioma, hypertension, not eligible for ACC Approved
pemetrexed malignant mesothelioma, not eligible for ACC Approved
pemetrexed malignant mesothelioma, peritoneal mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma Approved
pemetrexed malignant pleural mesothelioma, asthma, diabetes type 2, hypertension Approved
pemetrexed malignant pleural mesothelioma, asthma, diabetes type 2, hypertension Approved renewal
pemetrexed malignant pleural mesothelioma, previous asbestos exposure Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved
pemetrexed mesothelioma Approved renewal
pemetrexed mesothelioma, breast cancer Approved
pemetrexed mesothelioma, neuropathy Approved
pemetrexed mesothelioma, not eligible for ACC Approved
pemetrexed mesothelioma, not eligible for ACC, previous asbestos exposure Approved
pemetrexed mesothelioma, previous asbestos exposure Approved
pemetrexed mesothelioma, Prostate cancer, renal cancer Approved
pemetrexed mesothelioma, Rheumatoid Arthritis Approved
pemetrexed mesothelioma, Sarcomatoid pleural tumour Approved
pemetrexed peritoneal mesothelioma Approved
pemetrexed peritoneal mesothelioma Approved
pemetrexed peritoneal mesothelioma Approved
pemetrexed peritoneal mesothelioma Approved
pemetrexed peritoneal mesothelioma Approved renewal
pemetrexed peritoneal mesothelioma, breast cancer in remission Approved
pemetrexed pleural mesothelioma Approved
pemetrexed pleural mesothelioma Approved
pemetrexed pleural mesothelioma Approved
pemetrexed pleural pulmonary mesothelioma Approved
pemetrexed pleural pulmonary mesothelioma, autosomal dominant polycystic kidney disease Approved
pemetrexed sarcomatous mesothelioma, infiltrating ductal carcinoma Approved
peptide based oral feed short gut syndrome, abnormal liver function, Premature birth Approved
peptide based oral feed short gut syndrome, abnormal liver function, Premature birth Approved renewal
phosphate ions osteopaenia Approved
pimecrolimus atopic dermatitis, food allergies, rickets Approved
pimecrolimus severe eczema, intra ocular pressure, unacceptable long term effects of steroids Approved
pimecrolimus severe psoriasis Approved
pipobroman adverse reaction to hydroxyurea, essential thrombocythaemia Approved
pipobroman adverse reaction to hydroxyurea, essential thrombocythaemia Approved renewal
pipobroman adverse reaction to hydroxyurea, essential thrombocytosis, JAK-2 positive Approved
pipobroman diabetes, essential thrombocythaemia, severe vascular ulceration Approved
pipobroman diabetes, essential thrombocythaemia, severe vascular ulceration Approved renewal
pipobroman diabetes, essential thrombocythaemia, severe vascular ulceration Approved renewal
pipobroman diabetes, essential thrombocythaemia, severe vascular ulceration Approved renewal
pipobroman essential thrombocythaemia Approved
pipobroman essential thrombocythaemia Approved
pipobroman essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis Approved
pipobroman essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis Approved renewal
pipobroman essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis Approved renewal
pipobroman essential thrombocythaemia, angina, bilateral pulmonary emboli, myelofibrosis Approved renewal
pipobroman essential thrombocythaemia, asthma, hypertension, ischaemic heart disease, JAK-2 positive, MGUS, osteoarthritis Approved
pipobroman essential thrombocythaemia, asthma, hypertension, ischaemic heart disease, JAK-2 positive, MGUS, osteoarthritis Approved renewal
pipobroman essential thrombocythaemia, Heart failure on anagrelide, Non-responsive to anagrelide, Skin ulcers on hydroxyurea Approved
pipobroman essential thrombocythaemia, polycythaemia vera Approved
pipobroman essential thrombocythaemia, polycythaemia vera Approved renewal
pipobroman essential thrombocythaemia, polycythaemia vera Approved renewal
pipobroman essential thrombocythaemia, polycythaemia vera Approved renewal
pipobroman essential thrombocythaemia, previous TIAs Approved
pipobroman essential thrombocythaemia, previous TIAs Approved renewal
pipobroman essential thrombocythaemia, previous TIAs Approved renewal
pipobroman essential thrombocytosis, JAK-2 positive, diverticulosis, Emphysema, hypertension, primary hypogonadism, secondary pancreatitis to azathioprine, Ulcerative Colitis Approved
pipobroman essential thrombocytosis, JAK-2 positive, diverticulosis, Emphysema, hypertension, primary hypogonadism, secondary pancreatitis to azathioprine, Ulcerative Colitis Approved renewal
pipobroman essential thrombocytosis, polycythaemia rubra vera Approved
pipobroman essential thrombocytosis, polycythaemia rubra vera Approved renewal
pipobroman polycythaemia rubra vera Approved
pipobroman polycythaemia rubra vera Approved
pipobroman polycythaemia rubra vera Approved
pipobroman polycythaemia rubra vera Approved renewal
pipobroman polycythaemia vera Approved
pipobroman polycythaemia vera, ventricular arrhythmias Approved
pipobroman polycythaemia vera, ventricular arrhythmias Approved renewal
pipobroman Primary Thrombocythaemia Approved
pirfenidone dyskeratosis congenita, Kartagener's syndrome, progressive lung fibrosis Approved
pirfenidone idiopathic pulmonary fibrosis Declined
pirfenidone idiopathic pulmonary fibrosis Declined
pirfenidone idiopathic pulmonary fibrosis, hypogonadism, Hypothyroidism Approved
plerixafor autologous stem cell transplant Approved
plerixafor autologous stem cell transplant, failed stem cell mobilisation, Multiple Myeloma Approved
plerixafor autologous stem cell transplant, stem cell harvest Approved
plerixafor diffuse B cell lymphoma, for stem cell mobilisation Approved
plerixafor failed stem cell mobilisation Approved
plerixafor failed stem cell mobilisation Approved
plerixafor failed stem cell mobilisation Approved
plerixafor failed stem cell mobilisation, autologous stem cell transplant Approved
plerixafor failed stem cell mobilisation, autologous stem cell transplant, Multiple Myeloma Approved
plerixafor failed stem cell mobilisation, awaiting stem cell transplant, T-cell lymphoma Approved
plerixafor failed stem cell mobilisation, diffuse large b-cell lymphoma Approved
plerixafor failed stem cell mobilisation, diffuse large b-cell lymphoma Approved
plerixafor failed stem cell mobilisation, diffuse large b-cell lymphoma, peripheral stem cell harvesting Approved
plerixafor failed stem cell mobilisation, follicular lymphoma Approved
plerixafor failed stem cell mobilisation, for stem cell mobilisation Approved
plerixafor failed stem cell mobilisation, for stem cell mobilisation, diffuse large b-cell lymphoma Approved
plerixafor failed stem cell mobilisation, for stem cell mobilisation, Myeloma Approved
plerixafor failed stem cell mobilisation, for stem cell mobilisation, Myeloma Approved
plerixafor failed stem cell mobilisation, lymphoma Approved
plerixafor failed stem cell mobilisation, Multiple Myeloma Approved
plerixafor failed stem cell mobilisation, Multiple Myeloma Approved
plerixafor failed stem cell mobilisation, Multiple Myeloma Approved
plerixafor failed stem cell mobilisation, Multiple Myeloma Approved
plerixafor failed stem cell mobilisation, Multiple Myeloma Approved
plerixafor failed stem cell mobilisation, Myeloma for stem cell transplant Approved
plerixafor failed stem cell mobilisation, Non-hodgkin's lymphoma Approved
plerixafor failed stem cell mobilisation, relapsed folicular lymphoma Approved
plerixafor for stem cell mobilisation Approved
plerixafor for stem cell mobilisation Approved
plerixafor for stem cell mobilisation Approved
plerixafor for stem cell mobilisation, diffuse large b-cell lymphoma Approved
plerixafor for stem cell mobilisation, failed stem cell mobilisation, relapsed Hodgkin's lymphoma Approved
plerixafor for stem cell mobilisation, Hodgkin's lymphoma Approved
plerixafor for stem cell mobilisation, mantle cell lymphoma Approved
plerixafor for stem cell mobilisation, mantle cell lymphoma Approved
plerixafor for stem cell mobilisation, Multiple Myeloma Approved
plerixafor for stem cell mobilisation, Multiple Myeloma Approved
plerixafor for stem cell mobilisation, Testicular cancer, failed stem cell mobilisation Approved
plerixafor relapsed Hodgkin's lymphoma Approved
plerixafor Stem Cell Transplant, relapsed multiple myeloma Approved
plerixafor triple hit lymphoma, failed stem cell mobilisation Approved
pneumococcal conjugate vaccine (pcv13) acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient Approved
pneumococcal conjugate vaccine (pcv13) awaiting cochlear implant, prophylaxis to prevent infection, sensorineural hearing loss Approved
pneumococcal conjugate vaccine (pcv13) high risk of infection, pneumococcus infection, Rheumatic Heart Disease Approved
pneumococcal conjugate vaccine (pcv13) high risk of re-infection, prophylaxis to prevent infection, COPD, Severe pneumonia, strep pneumonia septicaemia Approved
pneumococcal conjugate vaccine (pcv13) immunisation, pneumococcal bacteraemia Approved
pneumococcal conjugate vaccine (pcv13) pneumococcal meningitis, prophylaxis to prevent infection Approved
pneumococcal conjugate vaccine (pcv13) pneumococcus infection, bacteraemia, intensive care admissions, prophylaxis to prevent infection Approved
pneumococcal conjugate vaccine (pcv13) post splenectomy, prophylaxis to prevent infection, adenocarcinoma, Emphysema, severe COPD Approved
pneumococcal conjugate vaccine (pcv13) post transplant reimmunisation, Acute Myeloid Leukaemia, post allo-transplant Approved
pneumococcal conjugate vaccine (pcv13) preventing infection of immunocompromised patient, awaiting  renal transplant, renal failure Approved
pneumococcal conjugate vaccine (pcv13) prophylaxis to prevent infection Approved
pneumococcal conjugate vaccine (pcv13) recent ICU for pneumonia, complex effusion/ empyema Approved
pneumococcal conjugate vaccine (pcv13) splenectomy Approved
pneumococcal conjugate vaccine (pcv13) Streptococcus pneumoniae infection, meningitis, monoclonal gammopathy, Septic arthritis, smouldering myeloma Approved
pneumococcal polysaccaride vaccine acute leukamia post bone marrow transplant, preventing infection of immunocompromised patient Approved
pneumococcal polysaccaride vaccine pneumococcal meningitis, prophylaxis to prevent infection Approved
pneumococcal polysaccaride vaccine pneumococcus infection, bacteraemia, intensive care admissions, prophylaxis to prevent infection Approved
pneumococcal polysaccaride vaccine post allogeneic stem cell transplant Approved
pneumococcal polysaccaride vaccine post allogeneic stem cell transplant Approved
pneumococcal polysaccaride vaccine preventing infection of immunocompromised patient, awaiting  renal transplant, renal failure Approved
pneumococcal polysaccharide conjugate vaccine 13 post allogeneic stem cell transplant Approved
pneumococcal polysaccharide vaccine 13 (Prevenar 13) compound skull fracture, prophylaxis Approved
pneumococcal polysaccharide vaccine 23 (Pneumovax 23) prophylaxis, compound skull fracture Approved
poly(hexamethylenebiguanide) hydrochloride acanthamoeba keratitis Approved
poly(hexamethylenebiguanide) hydrochloride acanthamoeba keratitis Approved
poly(hexamethylenebiguanide) hydrochloride acanthamoeba keratitis Approved
poly(hexamethylenebiguanide) hydrochloride acanthamoeba keratitis Approved
poly(hexamethylenebiguanide) hydrochloride acanthamoeba keratitis, pellucid marginal degeneration Approved
polyethylene glycol chronic constipation, restricted diet due to food allergies Approved
polyethylene glycol chronic constipation, restricted diet due to food allergies Approved renewal
polyethylene glycol chronic constipation, restricted diet due to food allergies Approved renewal
polyethylene glycol corneal ulcers, brain stem schwanoma, facial nerve palsy Approved
pomalidomide Myeloma, epilepsy Declined
ponatinib Chronic Myeloid Leukaemia, T315l mutation, asbestosis, Pleural Effusion Declined
ponatinib Philadelphia positive acute lymphoblastic leukemia, T315l mutation Declined
ponatinib Philidelphia positive ALL, T315l mutation Declined
posaconazole adverse reaction to voriconazole, Pulmonary Aspergillosis, chronic lymphocytic leukaemia Approved
posaconazole Altenaria sp. infection, adverse reaction to alternatives, post renal transplant Approved
posaconazole aspergillus bronchitis, Cystic fibrosis Approved
posaconazole bronchopulmonary aspergillosis, Unable to tolerate funded medicaton Approved renewal
posaconazole BSLT for sarcoidosis, aspergillus in lung Approved
posaconazole BSLT for sarcoidosis, aspergillus in lung Approved renewal
posaconazole fungal prophylaxis, Graft Versus Host Disease, Stem Cell Transplant Approved
posaconazole fungal prophylaxis, Graft Versus Host Disease, Stem Cell Transplant Approved renewal
posaconazole high risk of infection, adverse reaction to voriconazole, Invasive Aspergillus infection, post lung transplant, stent surgery planned Approved
posaconazole Invasive Aspergillosis, intolerance to alternatives, post lung transplant Approved
posaconazole invasive fungal infection, severe pulmonary haemorrhage Approved
posaconazole invasive rhino-cerebral mucormycosis, Rhizopus oryzae infection, acute kidney injury, adverse reaction to alternatives, hepato-renal syndrome Approved
posaconazole mucormycosis, acute kidney injury Approved
posaconazole paecilomyces lung infection Approved
posaconazole prophylaxis antifungal, Post Liver Transplant, Severe Aplastic Anaemia Approved
posaconazole Pulmonary Aspergillosis, Acute Lymphoblastic Leukaemia, immunosuppressed secondary to chemotherapy Approved
posaconazole pulmonary mucomycosis, leukaemia Approved
posaconazole recurrent aspergillus infection, adverse reaction to voriconazole, chronic lung allograft dysfunction (CLAD), Cystic Fibrosis Approved
potassium chloride Bartter syndrome, Gitelman's syndrome Approved
potassium chloride brainstem infarct, Cardiomyopathy, gastrostomy, locked-in syndrome, PEG feeding Approved
potassium chloride cystinosis, hypokalaemia, renal fanconi syndrome, failure to thrive, global development delay Approved
potassium chloride cystinosis, hypokalaemia, renal fanconi syndrome, failure to thrive, global development delay Approved renewal
potassium chloride Gitelman's syndrome, pregnancy Approved
potassium chloride Gitelman's syndrome, pregnancy Approved renewal
potassium chloride hypokalaemia , enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation Approved
potassium chloride hypokalaemia, atrial fibrillation, CHF, gout, hypertension, previous CVA, temporal arteritis Approved
potassium chloride hypokalaemia, chronic peritoneal dialysis, end-stage renal failure, hypoxic ischemic injury Approved
potassium chloride hypokalaemia, enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation Approved
potassium chloride hypokalaemia, ileostomy, Total Colectomy Approved
potassium chloride hypokalaemia, J tube feeding requires dispersible tab, PEG tube drainage Approved
potassium chloride hypokalaemia, Kearns Sayres, mitochondrial disorder, renal disease Approved renewal
potassium citrate cystinuria Approved
potassium citrate cystinuria Approved
potassium citrate distal renal tubular acidosis, severe hypokalaemia, renal stones, sjogrens syndrome Approved
potassium citrate distal renal tubular acidosis, severe hypokalaemia, renal stones, sjogrens syndrome Approved renewal
potassium citrate electrolyte imbalance, chronic kidney disease, Cystinosis, Growth Failure Approved renewal
potassium citrate electrolyte imbalance, chronic kidney disease, Growth Failure, nephropathic cystinosis Approved renewal
potassium citrate hypercalciuria, Hyperoxaluria, recurrent nephrolithiasis Approved
potassium citrate hypocalcaemia, hypocitraturia, Ankylosing spondylitis, chronic kidney disease, dyslipidaemia, hypertension, nephrolithiasis, Ulcerative Colitis Approved
potassium citrate hypocitraturia, nephrolithiasis, Alagille's syndrome, chronic kidney disease, Chronic Liver Disease, hypersplenism Approved
potassium citrate hypocitraturia, recurrent nephrolithiasis Approved
potassium citrate hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives Approved
potassium citrate hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives Approved renewal
potassium citrate hypocitraturia, recurrent nephrolithiasis, dyslipidaemia, hypertension, intolerance to alternatives Approved renewal
potassium citrate kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia Approved
potassium citrate kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia Approved
potassium citrate kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia Approved renewal
potassium citrate kidney stone, hypercalciuria, Hyperoxaluria, hypocitraturia Approved renewal
potassium citrate nephrocalcinosis, developmental delay, Genetic testing re undiagnosed syndrome, hearing loss, hypercalciuria presumed idiopathic, short stature Approved
potassium citrate Proximal tubular acidosis, arthrogryposis renal dysfunction cholestasis syndrome Approved
potassium citrate recurrent nephrolithiasis, Dent's disease Approved
potassium citrate renal dysplasia Approved
potassium citrate renal dysplasia Approved renewal
potassium citrate renal dysplasia Approved renewal
potassium citrate uric acid renal stone Approved
potassium dihydrogen phosphate osteopaenia of prematurity Approved
potassium dihydrogen phosphate osteopenia of prematurity Approved
potassium perchlorate amiodarone induced thyrotoxicosis, paroxysmal af Approved
prasugrel cerebral aneurysm, clopidogrel resistance, stent implant Approved
prasugrel clopidogrel resistance, inracranial aneurysm requiring stent, breast carcinoma Approved
prasugrel clopidogrel resistance, inracranial aneurysm requiring stent, breast carcinoma Approved renewal
prasugrel clopidogrel resistance, intracranial stent Approved
prasugrel intracranial stent thrombosis Approved
prednisolone atypical CNS inflammatory disorder, polymyalgia rheumatica, diabetes type 2, previous DVT Approved renewal
prednisolone decompensating corneal graft, epitheliopathy, previous graft rejection Approved
prednisolone decompensating corneal graft, epitheliopathy, previous graft rejection Approved renewal
prednisolone eczema, epilepsy, florrid dermatitis, intellectual disability Approved
prednisolone mucous build up, eosinophilic oesophagitis, PEG feeding Approved
prednisolone nephrotic syndrome, Cornelia de Lange syndrome, gastrostomy feeding, Severe cerebral palsy, unable to swallow, wheelchair bound Approved
prednisolone nephrotic syndrome, Cornelia de Lange syndrome, gastrostomy feeding, Severe cerebral palsy, unable to swallow, wheelchair bound Approved renewal
prednisolone oesophageal cancer, Hypothyroidism, palliative care Approved
prednisolone polymyalgia rheumatica, Crohn's diease, ileostomy Approved
prednisolone polymyalgia rheumatica, diabetes type 2, previous DVT Approved
prednisolone polymyalgia rheumatica, diabetes type 2, previous DVT Approved renewal
prednisolone rectal bleeding, developmental delay, severe crohn's disease, Total Colectomy Approved
prednisolone eye drops chronic keratinisation of lid margins, common variable immunodeficiency, keratopathy, vernal blepharoconjunctivitis Approved
prednisolone eye drops linear IgA dermatosis, cicatricial conjunctivitis Approved
prednisolone minims chronic blepharo kerato conjuntivitis Approved renewal
prednisolone minims chronic blepharo kerato conjuntivitis Approved renewal
prednisolone minims corneal decompensation, ocular inflammation, glaucoma Approved renewal
prednisolone minims keratitis Approved
prednisolone sodium phosphate allergic eye disease, corneal ulcers, Herpes Simplex Keratitis Approved
prednisolone sodium phosphate allergic eye disease, corneal ulcers, Herpes Simplex Keratitis Approved renewal
prednisolone sodium phosphate atopic keratoconjunctivitis Approved
prednisolone sodium phosphate atopic keratoconjunctivitis Approved renewal
prednisolone sodium phosphate chronic blepharo kerato conjuntivitis Approved
prednisolone sodium phosphate chronic blepharo kerato conjuntivitis Approved
prednisolone sodium phosphate corneal decompensation, ocular inflammation, glaucoma Approved
prednisolone sodium phosphate ocular surface inflammatory disease, Failed corneal transplant Approved
prednisolone sodium phosphate Penetrating keratoplasty, topical preservative sensitivity Approved
prednisolone sodium phosphate Ulcerative Colitis, ileostomy bag, Nephrotic Syndrome Approved renewal
pregabalin chronic neuropathic pain, chronic musculoskeletal pain, intermittant visceral pain, pompe disease, respiratory failure Approved
pregabalin chronic pain syndrome Approved
pregabalin generalised pain, mucolipidosis type 3, Neuropathic pain Declined
pregabalin low grade malignant nerve sheath tumour, neuropathic pain Approved
pregabalin Neuropathic pain, bronchiectasis, dystonia, global development delay, kernicterus, scoliosis, spasticity Approved
pregabalin pain, schwannomatosis Approved
premature birth formula (S-26 LBW Gold  RTF) Premature birth Approved
primaquine malaria Approved
primidone epilepsy, asthma, hypertension, osteoporosis, post polio exhaustion Approved renewal
pristinamycin Methicillin-resistant Staphylococcus aureus Approved
pristinamycin Methicillin-resistant Staphylococcus aureus Approved renewal
pristinamycin multidrug-resistant organism, mycoplasma genitalium infection Approved
pristinamycin mycoplasma genitalium infection Approved
pristinamycin mycoplasma genitalium infection Approved
pristinamycin mycoplasma genitalium infection Approved
progesterone cervical incompetence Approved
progesterone cervical incompetence, risk of pre-term labour Approved
progesterone history of preterm labour Approved
progesterone history of preterm labour, pregnant, Previous LLETZ Approved
progesterone Prevent miscarriage, twin pregnancy Approved
progesterone prevention of preterm labour, allergy to alternatives Approved
progesterone recurrent previous miscarraige Approved
progesterone risk of pre-term labour Approved
progesterone risk of pre-term labour Approved
progesterone risk of pre-term labour Approved
progesterone risk of pre-term labour, cervical incompetence, short cervix Approved
progesterone risk of pre-term labour, pregnant, previous miscarraige, short cervix Approved
progesterone short cervix Approved
progesterone short cervix, risk of pre-term labour Approved
progesterone threatened premature labour Approved
progesterone threatened premature labour, Bicornuate Uterus, Two Cervices Approved
progesterone threatened premature labour, history of preterm labour, pregnant Approved
progesterone threatened premature labour, history of preterm labour, pregnant Approved
progesterone threatened premature labour, history of preterm labour, previous still birth Approved
progesterone threatened premature labour, pregnant, short cervix Approved
progesterone (Utrogestan) cervical incompetence Approved
progesterone (Utrogestan) risk of pre-term labour, short cervix Approved
progesterone (Utrogestan) threatened premature labour, cervical incompetence, history of preterm labour Approved
progesterone pessary cancer of cervix, history of preterm labour Approved
progesterone pessary history of preterm labour Approved
progesterone pessary history of preterm labour Approved
progesterone pessary history of preterm labour Approved
progesterone pessary recurrent previous miscarraige Approved
progesterone pessary risk of pre-term labour Approved
progesterone pessary risk of pre-term labour Approved
progesterone pessary risk of pre-term labour Approved
progesterone pessary risk of pre-term labour Approved
progesterone pessary risk of pre-term labour, cervical incompetence Approved
progesterone pessary risk of pre-term labour, cervical incompetence, short cervix Approved
progesterone pessary risk of pre-term labour, history of preterm labour, short cervix Approved
progesterone pessary risk of pre-term labour, ovarian torsion Approved
progesterone pessary risk of pre-term labour, short cervix Approved
progesterone pessary short cervix Approved
progesterone pessary twin pregnancy, history of preterm labour, short cervix Approved
propranolol atrial flutter, Cardiomyopathy Approved
propranolol cardiac arrhythmias, Hypertrophic cardiomyopathy Approved
propranolol Cardiomyopathy, arrhythmia Approved
propranolol congenital cardiac condition, Premature birth, tetralogy of fallot Approved
propranolol haemangioma Approved
propranolol haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma Approved
propranolol infantile haemangioma, laryngomaiacia Approved
propranolol infantile haemangioma, rectal bleeding Approved
propranolol long QT syndrome Approved
propranolol paroxysmal supraventricular tachycardia Approved
propranolol Recurrent SVT Approved
propranolol subglottic haemangioma Approved
propranolol SVT Approved
propranolol tetralogy of fallot Approved
propranolol       atrial tachycardias, supraventricular tachycardia Approved
propranolol       congenital cardiac condition, Premature birth, tetralogy of fallot Approved
propranolol       infantile haemangioma Approved
propranolol       infantile haemangioma Approved
propranolol       infantile haemangioma, skin ulceration Approved
propranolol                           infantile haemangioma Approved
prothionamide MDR tuberculosis Approved
prothionamide multidrug-resistant tuberculosis Approved
pseudoephedrine hydrochloride severe postural hypotension, autonomic dysreflexia, tetraplegia Approved renewal
pseudoephidrine hydrochloride severe postural hypotension, autonomic dysreflexia, tetraplegia Approved
pyridoxal 5 phosphate epileptic encephalopathy, infantile spasms Approved
pyridoxal 5-phosphate brain malformation, epilepsy, Epileptic encephalopathy, global development delay, medically refractory seizures Approved
pyridoxal 5-phosphate Epileptic encephalopathy, cognitive delay, refractory epilepsy Approved
pyridoxal 5-phosphate Epileptic encephalopathy, epilepsy, global development delay Approved
pyridoxal 5-phosphate Epileptic encephalopathy, epilepsy, global development delay Approved
pyridoxal 5-phosphate Epileptic encephalopathy, epilepsy, global development delay Approved renewal
pyridoxal 5-phosphate Epileptic encephalopathy, epilepsy, global development delay Approved renewal
pyridoxal 5-phosphate epileptic encephalopathy, possible PNPO deficiency, nasogastric tube Approved
pyridoxal 5-phosphate global development delay, Intractable Epilepsy, visual impairment Approved
pyridoxal 5-phosphate infantile spasms, global development delay, refractory seizures Approved
pyridoxal 5-phosphate refractory epilepsy, global development delay Approved
pyridoxal 5-phosphate refractory epilepsy, global development delay, severe movement disorder Approved
pyrimethamine acute lymphoblastic leukemia post unrelated transplant, toxoplasmosis prophylaxis Approved
pyrimethamine acute ocular toxoplasmosis Approved
pyrimethamine AML, Graft Versus Host Disease, neutropenia Approved
pyrimethamine cerebral toxoplasmosis, bone marrow transplant, Congenital Immune Deficiency, immunocompromised Approved
pyrimethamine Cerebral toxoplasmosis, Glioblastoma Multiforme Approved
pyrimethamine Cerebral toxoplasmosis, Glioblastoma Multiforme Approved renewal
pyrimethamine cerebral toxoplasmosis, Ocular Toxoplasmosis, immunocompetent Approved
pyrimethamine prophylaxis of toxoplasmosis, graft vs host disease post bone marrow transplant Approved
pyrimethamine toxoplasmosis prophylaxis, abnormal liver function tests, chronic graft versus host disease, graft vs host disease, matched unrelated donor transplant, post stem cell transplant, Thrombocytopaenia Approved
quinacrine refractory giardiasis Approved
quinacrine SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash Approved renewal
quinacrine SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash Approved renewal
quinacrine systemic lupus erythematosus, epilepsy, steroid sparing agent Approved
quinacrine systemic lupus erythematosus, epilepsy, steroid sparing agent Approved renewal
quinacrine systemic lupus erythematosus, epilepsy, steroid sparing agent Approved renewal
quinacrine treatment resistant recurrent giardiasis Approved
quinacrine (aka mepacrine) SLE, Arthritis, Hashimoto's thyroiditis, Severe photosensitive rash Approved
quinidine brugada syndrome, inflammatory bowel disease Approved
quinidine early repolarisation syndrome, ventricular arrhythmias, cardiac arrest Approved
quinidine implantable cardioverter defribrillator (ICD), ventricular fibrillation Approved
quinidine ventricular arrhythmias, brugada syndrome, implantable cardioverter defribrillator (ICD) Approved
quinidine ventricular arrhythmias, brugada syndrome, implantable cardioverter defribrillator (ICD) Approved renewal
quinidine ventricular fibrillation, brugada syndrome Approved
quinidine ventricular fibrillation, coronary disease, implanted cardiac defibrillator, prolonged QT Approved
raltitrexed 5FU/Capecitabine induced angina, adenocarcinoma of the colon, ischaemic heart disease Approved
raltitrexed 5FU/Capecitabine induced angina, metastatic rectal cancer Approved
raltitrexed 5FU/Capecitabine induced angina, metastatic rectal cancer Approved
raltitrexed 5FU/Capecitabine induced angina, metastatic rectal cancer Approved renewal
raltitrexed adenocarcinoma of the colon Approved
raltitrexed Metastatic colon cancer with widespread peritoneal disease Approved
raltitrexed rectal adenocarcinoma, cardiotoxicity with capecitabine, stage IV Approved
raltitrexed rectal cancer, 5FU/Capecitabine induced angina Approved
ranibizumab diabetic macular oedema Approved
ranibizumab diabetic macular oedema Approved renewal
ranibizumab diabetic macular oedema Approved renewal
reboxetine ADHD, Borderline Personality disorder, Depressive disorder Approved
regorafenib GIST, gastrointestinal stromal tumour, metastatic tumours Declined
ribavirin acquired via infected blood, chronic hepatitis C Approved
ribavirin cHCV Approved
ribavirin chronic hepatitis C Approved
ribavirin chronic hepatitis C Approved
ribavirin chronic hepatitis C Approved
ribavirin chronic hepatitis C Approved
ribavirin chronic hepatitis C Approved renewal
ribavirin Chronic hepatitis C decompensated  cirrhosis (Genotype 1) Approved
ribavirin chronic Hepatitis C genotype 3 Approved
ribavirin chronic Hepatitis C genotype 3, cirrhosis Approved
ribavirin chronic Hepatitis C genotype 3, liver cirrhosis Approved
ribavirin chronic Hepatitis C genotype 3, liver cirrhosis Approved renewal
ribavirin chronic Hepatitis C genotype 3A, cirrhosis, mood instability, post-traumatic epilepsy Approved
ribavirin chronic Hepatitis C genotype 3A, oesophageal varices Approved
ribavirin chronic Hepatitis C genotype 3A, oesophageal varices Approved renewal
ribavirin chronic hepatitis C, chronic pain, Depression, oesophageal varices Approved
ribavirin chronic hepatitis C, cirrhosis Approved
ribavirin chronic hepatitis C, cirrhosis Approved
ribavirin chronic hepatitis C, cirrhosis, biliary anastomic leak, hepatic artery stenosis, Post Liver Transplant Approved
ribavirin chronic hepatitis C, cryoglobulinaemia Approved
ribavirin chronic hepatitis C, cryoglobulinaemia, renal impairment Approved
ribavirin chronic hepatitis C, decompensated liver cirrhosis Approved
ribavirin chronic hepatitis C, decompensated liver cirrhosis, genotyoe 1 Approved
ribavirin chronic hepatitis C, decompensated liver cirrhosis, HCC Approved
ribavirin chronic hepatitis C, decompensated liver function, hepatic encephalopathy, Recent septic right hip due to osteoarthritis Approved
ribavirin chronic hepatitis C, decompensated liver function, hepatic encephalopathy, Recent septic right hip due to osteoarthritis Approved renewal
ribavirin chronic hepatitis C, Depressive disorder Approved
ribavirin chronic hepatitis C, genotype 1 Approved
ribavirin chronic hepatitis C, genotype 1 Approved
ribavirin chronic hepatitis C, genotype 1 Approved renewal
ribavirin chronic hepatitis C, hepatic encephalopathy, variceal bleeding Approved
ribavirin chronic hepatitis C, Hepatitis B, hypertension, post liver transplant diabetes, Ulcerative Colitis Approved
ribavirin chronic hepatitis C, Post Liver Transplant, renal dysfunction Approved
ribavirin chronic norovirus infection, chronic diarrhoea, Weight Loss Approved
ribavirin decompensated HCV cirrhosis Approved
ribavirin genotype 1 hepatitis C, liver cirrhosis Approved
ribavirin Hepatitis C Approved
ribavirin Hepatitis C Approved
ribavirin Hepatitis C Approved
ribavirin Hepatitis C Approved
ribavirin Hepatitis C Approved
ribavirin Hepatitis C Approved
ribavirin hepatitis C virus cirrhosis Approved
ribavirin hepatitis C virus cirrhosis, cryoglobulinaemia Approved
ribavirin hepatitis C virus cirrhosis, HIV infection Approved
ribavirin Hepatitis C, cirrhosis, liver transplant Approved
ribavirin Hepatitis C, cryoglobulinaemia, MGUS, rheumatoid arthritis Approved
ribavirin recurrent hepatitis C virus Approved
ribavirin recurrent hepatitis C virus, liver transplant Approved
ribavirin recurrent hepatitis C virus, liver transplant Approved
ribavirin recurrent hepatitis C virus, Post Liver Transplant Approved
riboflavin Brown-Vialetto-Van Laere Syndrome Approved
riboflavin Brown-Vialetto-Van Laere Syndrome, auditory neuropathy, cerebellar disturbance, ophthalmoplegia Approved
riboflavin Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy Approved
riboflavin Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy Approved renewal
riboflavin Complex 1 deficiency secondary to NUBPL gene mutations, mitochondrial cytopathy Approved renewal
riboflavin MELAS Approved
riboflavin MELAS Approved renewal
riboflavin multiple acyl-coenzyme A dehydrogenase deficiency Approved
riboflavin multiple acyl-coenzyme A dehydrogenase deficiency Approved
riboflavin multiple acyl-coenzyme A dehydrogenase deficiency Approved renewal
riboflavin multiple acyl-coenzyme A dehydrogenase deficiency Approved renewal
riboflavin multiple acyl-coenzyme A dehydrogenase deficiency, severe developmental delay Approved
riboflavin multiple acyl-coenzyme A dehydrogenase deficiency, severe developmental delay Approved renewal
riboflavin possible mitochondrial disorder Approved renewal
riboflavin riboflavin transporter deficiency Approved
riboflavin riboflavin transporter deficiency Approved
riboflavin vitamin b2 ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome Approved
riboflavin vitamin b2 ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome Approved renewal
riboflavin vitamin b2 ataxia, epilepsy, fatigue, MELAS, mitochondrial cytopathy, Wolff-Parkinson-White syndrome Approved renewal
rifaximin bacterial infection, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent Approved
rifaximin bacterial infection, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent Approved renewal
rifaximin Cholangiocarcinoma, hepatic encephalopathy, post-operative biliary stricture Approved
rifaximin Chronic Bacterial Colonisation, gastroschisis, intestinal failure, multiple episodes line sepsis Approved
rifaximin chronic encepholapathy, awaiting liver transplant, cryptogenic cirrhosis Approved
rifaximin chronic hepatic encepholapathy, decompensated liver cirrhosis, hypertension, osteoporosis Approved
rifaximin chronic hepatic encepholapathy, liver failure due to hepatitis C virus cirrhosis Approved
rifaximin cirrhosis, hepatic encephalopathy Approved
rifaximin cirrhosis, hepatic encephalopathy Approved
rifaximin Clostridium Difficile Diarrhoea, bronchiolitis obliterans, diabetes mellitus, Graft vs Host Disease, IgA myeloma, Severe pneumonia Approved
rifaximin end stage liver failure, alcohol abuse, hepatitis C Approved
rifaximin hepatic encephalopathy Approved
rifaximin hepatic encephalopathy Approved
rifaximin hepatic encephalopathy Approved
rifaximin hepatic encephalopathy Approved
rifaximin hepatic encephalopathy Approved
rifaximin hepatic encephalopathy Approved
rifaximin hepatic encephalopathy Approved
rifaximin hepatic encephalopathy Approved renewal
rifaximin hepatic encephalopathy, adenocarcinoma, IVC tear Approved
rifaximin hepatic encephalopathy, alcohol abuse, chronic end stage liver disease, hepatitis C Approved
rifaximin hepatic encephalopathy, alcohol abuse, chronic end stage liver disease, hepatitis C Approved renewal
rifaximin hepatic encephalopathy, alcoholic hepatitis Approved
rifaximin hepatic encephalopathy, alcoholic liver disease Approved
rifaximin hepatic encephalopathy, alcoholic liver disease Approved renewal
rifaximin hepatic encephalopathy, alcoholic liver disease, chronic hepatitis B virus cirrhosis Approved
rifaximin hepatic encephalopathy, alcoholic liver disease, copd, oesophageal varices Approved
rifaximin hepatic encephalopathy, alcoholic liver disease, gastric bypass, gastric ulcer Approved
rifaximin hepatic encephalopathy, alcoholic liver disease, liver cirrhosis Approved
rifaximin hepatic encephalopathy, ALD, cirrhosis Approved
rifaximin hepatic encephalopathy, ALD, diabetes mellitus, HCC, hyperlididaemia, Hypothyroidism Approved
rifaximin hepatic encephalopathy, ascites, liver cirrhosis, Portal Hypertension Approved
rifaximin hepatic encephalopathy, asthma, Cirrhosis, dyslipidaemia, hypertension, ischaemic heart disease, Myasthenia Gravis Approved
rifaximin hepatic encephalopathy, augmentin induced liver injury Approved
rifaximin hepatic encephalopathy, autism spectrum disorder, down's syndrome, end stage liver disease secondary to Hepatitis C Approved
rifaximin hepatic encephalopathy, autism spectrum disorder, down's syndrome, end stage liver disease secondary to Hepatitis C Approved renewal
rifaximin hepatic encephalopathy, autoimmune hepatitis, Cirrhosis Approved
rifaximin hepatic encephalopathy, autoimmune liver disease, autoimmune thyroid disease, Portal Hypertension Approved
rifaximin hepatic encephalopathy, autoimmune liver disease, autoimmune thyroid disease, Portal Hypertension Approved
rifaximin hepatic encephalopathy, autosomal dominant polycystic kidney disease, congenital hepatic fibrosis, Portal Hypertension Approved
rifaximin hepatic encephalopathy, Budd Chiari Syndrome, polycystic kidney disease Approved
rifaximin hepatic encephalopathy, cardiac dysrhythmia, chronic abdominal pain, chronic diarrhoea, diabetes type 2, diabetic retinopathy, diuretic resistant ascites, gout, microalbuminuria, neuropathy, primary myelofibrosis, splenomegaly Approved
rifaximin hepatic encephalopathy, chronic hepatitis C Approved
rifaximin hepatic encephalopathy, chronic renal impairment, HCV cirrhosis, previous CVA Approved
rifaximin hepatic encephalopathy, cirrhosis, hepatitis C, Portal Hypertension, Thrombocytopaenia Approved
rifaximin hepatic encephalopathy, cirrhosis, Portal Hypertension, transplant planned Approved
rifaximin hepatic encephalopathy, cryptogenic cirrhosis Approved
rifaximin hepatic encephalopathy, cryptogenic cirrhosis with diuretic resistant ascites Approved
rifaximin hepatic encephalopathy, decompensated liver cirrhosis, hepatitis C Approved
rifaximin hepatic encephalopathy, decompensated liver cirrhosis, hepatitis C Approved renewal
rifaximin hepatic encephalopathy, diabetes type 2, Hepatitis B, ischa cardio, liver cirrhosis, Non-alcoholic steatohepatitis, renal failure Approved
rifaximin hepatic encephalopathy, diabetes type 2, hernia Approved
rifaximin hepatic encephalopathy, diabetes type 2, hernia Approved renewal
rifaximin hepatic encephalopathy, diuretic resistant ascites, liver cirrhosis, primary biliary cirrhosis, TIPSS Approved
rifaximin hepatic encephalopathy, encephalopathy, GI bleed, Hepatitis B, liver cirrhosis, TIPSS Approved
rifaximin hepatic encephalopathy, end stage liver disease Approved
rifaximin hepatic encephalopathy, end stage liver disease Approved
rifaximin hepatic encephalopathy, end stage liver disease Approved
rifaximin hepatic encephalopathy, end stage liver disease secondary to Hepatitis C Approved
rifaximin hepatic encephalopathy, end stage liver disease secondary to Hepatitis C Approved renewal
rifaximin hepatic encephalopathy, end stage liver disease secondary to Hepatitis C Approved renewal
rifaximin hepatic encephalopathy, end stage liver disease, NASH Approved
rifaximin hepatic encephalopathy, hepatic venous outflow obstruction, post liver transplant, TIPSS Approved
rifaximin hepatic encephalopathy, hepatic venous outflow obstruction, post liver transplant, TIPSS Approved renewal
rifaximin hepatic encephalopathy, hernia, hyponatraemia Approved
rifaximin hepatic encephalopathy, IHD, Liver disease Approved
rifaximin hepatic encephalopathy, liver cirrhosis Approved
rifaximin hepatic encephalopathy, liver cirrhosis Approved
rifaximin hepatic encephalopathy, liver cirrhosis Approved
rifaximin hepatic encephalopathy, liver cirrhosis, multifocal hepatocellular carcinoma Approved
rifaximin hepatic encephalopathy, liver cirrhosis, NASH Approved
rifaximin hepatic encephalopathy, liver cirrhosis, Portal Hypertension Approved
rifaximin hepatic encephalopathy, liver cirrhosis, Portal Hypertension Approved renewal
rifaximin hepatic encephalopathy, liver cirrhosis, TIPSS Approved
rifaximin hepatic encephalopathy, liver failure due to hepatitis C virus cirrhosis Approved
rifaximin hepatic encephalopathy, Liver Failure, post liver transplant Approved
rifaximin hepatic encephalopathy, Portal Hypertension Approved
rifaximin hepatits C virus cirrhosis, Liver Failure Approved
rifaximin hepatits C virus cirrhosis, Liver Failure Approved renewal
rifaximin recurrent clostidium difficile infection, bronchiectasis, cerebral palsy, gastro tube fed, gastro-oesophageal reflux disease, spastic quadriplegia Approved
rifaximin recurrent severe hepatic encephalopathy, hepatitis C, Liver Transplant Approved
rifaximin small intestinal bacterial overgrowth Approved
rifaximin small intestinal bacterial overgrowth, gastroschisis, micronutrient deficiency, Short Gut Syndrome, TPN dependent Approved renewal
rituximab acute neuromyelitis optica Approved
rituximab amegakaryocytic thrombocytopaenia, diabetes, hyperlipidaemia, hypertension, retinopathy Approved
rituximab ANCA negative, pauci immune crescentic glomerulonephritis Approved
rituximab ANCA positive vasculitis, bronchiectasis, squamous cell skin cancer Approved
rituximab ANCA positive vasculitis, granulomatous polyangiitis, Wegener's Granulomatosis Approved
rituximab ANCA positive vasculitis, PR3-positive, Autoimmune hypothyroidism, diabetes type 1, focal glomerulonephritis, recurrent pulmonary haemorrhage, relapse on mycophenolate Approved
rituximab Anti Hu associated paraneoplastic encephalitis, sensory neuropathy, ovarian carcinoma Approved
rituximab antibody mediated, lung transplant rejection Approved
rituximab anti-nmda receptor encephalitis Approved
rituximab anti-nmda receptor encephalitis Approved
rituximab antisynthetase syndrome, asthma, hypertension, multiple PE Approved renewal
rituximab antisynthetase syndrome, dermatomyositis, interstitial lung disease Approved
rituximab antisynthetase syndrome, respiratory involvement Approved
rituximab autoimmune encephalomyelitis, Neuroblastoma, sensory neuropathy Approved
rituximab autoimmune haemolytic anaemia Approved
rituximab autoimmune haemolytic anaemia, Atrial fibrillation, Renal Impairment Approved
rituximab autoimmune haemolytic anaemia, chronic leg ulcers Approved
rituximab autoimmune haemolytic anaemia, Chronic Liver Disease, jaundice, Portal Hypertension Approved
rituximab autoimmune haemolytic anaemia, chronic lympocytic leukaemia Approved
rituximab autoimmune haemolytic anaemia, diabetes, NHL Approved
rituximab autoimmune haemolytic anaemia, evans syndrome, Refractory ITP Approved
rituximab autoimmune haemolytic anaemia, Pancytopenia, relapsed hairy cell leukaemia Approved
rituximab autoimmune haemolytic anaemia, previous CLL Approved
rituximab autoimmune hepatitis, systemic lupus erythematosus Approved
rituximab autoimmune limbic encephalitis, GABA-B receptor antibody mediated Approved
rituximab autoimmune neutropaenia, ITP Approved
rituximab autoimmune pancreatitis, IgG4 related disease, myocarditis, diabetes type 2, hepatosteatosis, HLA B27 uveitis Approved
rituximab autoimmune retinopathy Approved
rituximab autoimmune retinopathy, punctate inner choroidopathy Approved
rituximab CANOMAD: Chronic Ataxic Neuropathy Ophthalmoplegia IgM paraprotein cold Agglutinins Disialosyl antibodies Approved renewal
rituximab cerebral vasculitis Approved
rituximab chronic graft versus host disease, Sclerodermoid chronic graft-versus-host disease, AML, matched unrelated stem cell transplant, Scleroderma Approved
rituximab chronic immune mediated thrombocytopaenia, diabetes type 2, Leiomyosarcoma, thymoma Approved
rituximab chronic inflammatory demyelinating polyneuropathy Approved
rituximab chronic inflammatory demyelinating polyneuropathy Approved
rituximab chronic lymphocytic leukaemia, autoimmune haemolytic anaemia Approved
rituximab cicatricial pemphigoid Approved
rituximab cicatricial pemphigoid Approved renewal
rituximab cicatricial pemphigoid, severe ocular cicatricial Approved
rituximab cicatricial pemphigoid, severe ocular cicatricial, ulceration of mouth Approved
rituximab cold agglutinin disease requiring regular transfusions Approved
rituximab cold haemagglutinin disease Approved
rituximab cold haemagglutinin disease Approved
rituximab cold haemagglutinin disease, congestive heart failure Approved
rituximab cryoglobulinaemic vasculitis, Hepatitis C Approved
rituximab diffuse scleroderma, Severe Polyarticular Arthritis, interstitial lung disease, intolerence to Humira Approved
rituximab fibrillary glomerulonephritis, diabetes type 2, dyslipidaemia, hypertension, paroxysmal af Approved
rituximab Focal Segmental Glomerulosclerosis, post kidney transplant, immunosuppression post transplant, intolerance to funded alternative, proteinuria Approved
rituximab Follicular bronchiolitis, polynesian castlemans disease, idiopathic plasmacytic lymphadenopathy Approved
rituximab follicular non-hodgkin's lymphoma, lymphoma, relapsed lymphoma Approved
rituximab glomerulonephritis, JAK-2 positive, Myeloproliferative disorder Approved
rituximab granulomatous angiitis of CNS, primary cerebral vasculitis Approved
rituximab granulomatous angiitis of CNS, primary cerebral vasculitis Approved renewal
rituximab granulomatous polyangiitis, GORD, hypertension, renal impairment Approved
rituximab granulomatous polyangiitis, neutropenia, subglottic stenosis Approved
rituximab Graves' thyrotoxicosis, thyroid-related orbitopathy, thyroidectomy Approved
rituximab GvHD, acute lymphoblastic leukaemia, membranous nephropathy, post stem cell transplant, pulmonary fibrosis Approved
rituximab GvHD, fasciitis, steroid refractory, synovitis, T cell lymphoma Approved
rituximab GvHD, fasciitis, steroid refractory, synovitis, T cell lymphoma Approved renewal
rituximab haemophagocytic lymphocytosis, high epstein�Barr virus load, Hodgkin's lymphoma Approved
rituximab Hodgkin's lymphoma Approved
rituximab Hyper IgG4 disease Approved
rituximab idiopathic thrombocytopaenic purpura, SLE Approved
rituximab IgG4 related disease Approved
rituximab immune thrombocytopaenia, renal impairment Approved
rituximab immune thrombocytopaenic purpura Approved
rituximab immune thrombocytopaenic purpura, anaemia of chronic renal disease, cognitive impairment, hyperuricaemia, Myocardial Infarction Approved
rituximab immune thrombocytopaenic purpura, diabetes type 2, dyslipidaemia, hypertension, steatohepatitis Approved
rituximab immune thrombocytopaenic purpura, osteopenia Approved
rituximab ITP Approved
rituximab ITP, bleeding problems Approved
rituximab membranoproliferative glomerulonephritis, recurrent disease, ESRF, post kidney transplant, steroid resistance Approved
rituximab membranous glomerulonephritis, Nephrotic Syndrome Approved renewal
rituximab mucous membrane pemphigoid Approved
rituximab multicentric castlemans disease Approved
rituximab multicentric castlemans disease Approved renewal
rituximab Myasthenia Gravis Approved
rituximab Myasthenia Gravis Approved
rituximab Myasthenia gravis Approved
rituximab Myasthenia gravis Approved renewal
rituximab NEMO immune deficiency, chronic GvH post BMT, EBV encephalitis, EBV viremia Approved
rituximab nephrotic syndrome, Focal Segmental Glomerulosclerosis, post renal transplant Approved
rituximab nephrotic syndrome, severe recurrent membranous nephropathy, Second renal transplant Approved
rituximab nephrotic syndrome, steroid resistance Approved
rituximab neuromyelitis optica Approved
rituximab neuromyelitis optica Approved
rituximab neuromyelitis optica Approved
rituximab neuromyelitis optica Approved
rituximab neuromyelitis optica Approved renewal
rituximab neuromyelitis optica, aquarporin-4 antibody positive Approved
rituximab Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord Approved
rituximab Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord Approved renewal
rituximab Neurosarcoidosis, Cauda Equina syndrome, Gadolinium enhancement of the lower spinal cord Approved renewal
rituximab neurosarcoidosis, pancytopaenia, paraparesis Approved
rituximab nmda receptor encephalitis Approved
rituximab nmda receptor encephalitis Approved
rituximab nmda receptor encephalitis Approved
rituximab nmda receptor encephalitis Approved
rituximab opsoclonus myoclonus syndrome Approved
rituximab orbital disease, sinus IgG4 related disease Approved
rituximab orbital disease, sinus IgG4 related disease Approved renewal
rituximab pemphigus vulgaris Approved
rituximab Pemphigus Vulgaris Approved
rituximab pemphigus vulgaris, diabetes type 2, hypertension, Morbid Obesity, previous hepatitis B Approved
rituximab post transplant GvHD, Sclerodermoid chronic graft-versus-host disease Approved
rituximab primary cerebral vasculitis, coeliac disease Approved
rituximab pulmonary rheumatoid nodules, risk of further lung collapse Approved
rituximab pulmonary rheumatoid nodules, risk of further lung collapse Approved renewal
rituximab pure red cell aplasia secondary to chronic lymphocytic leukaemia Approved
rituximab pure red cell aplasia secondary to chronic lymphocytic leukaemia Approved
rituximab Rasmussen's encephalitis, focal seizures Approved
rituximab Rasmussen's encephalitis, focal seizures Approved renewal
rituximab recurrent severe GVHD Approved
rituximab Refractory ITP, obesity, SLE Approved
rituximab refractory myasthenia gravis Approved
rituximab refractory myasthenia gravis Approved renewal
rituximab relapsed chronic lymphocytic leukaemia, febrile Approved
rituximab relapsed hairy cell leukaemia, legionella pneumonia Approved
rituximab relapsing remitting Multiple Sclerosis Declined
rituximab Rheumatoid Arthritis, felty's syndrome, latent cmv infection, Pancytopenia Approved
rituximab rheumatoid vasculitis, Painful Leg Ulcers, peripheral ulcerative keratitis Approved
rituximab scleroderma related interstitial lung disease Approved
rituximab Sclerodermatous graft versus host disease post allogeneic stem cell transplant failing multiple lines of immunosuppression, Burkitt lymphoma, diabetes, EBV reactivation, myelodysplasia therapy related Approved
rituximab Sclerodermoid chronic graft-versus-host disease, diabetes type 2, dyslipidaemia, hypertension, ineffective alternatives Approved
rituximab Sclerodermoid chronic graft-versus-host disease, MDS, pneumocystis jiroveci pneumonia, reactivation of CMV Approved
rituximab seropositive rhuematoid vasculitis, osteoporosis Approved
rituximab seropositive rhuematoid vasculitis, osteoporosis Approved renewal
rituximab severe bullous pemphigoid Approved
rituximab severe bullous pemphigoid, steriod induced macular eye disease Approved
rituximab Severe Polyarticular Arthritis Approved
rituximab Severe thrombocytopaenia Approved
rituximab SLE, amputation of arm, amputation of leg, avascular necrosis of hips, Chronic Bronchitis, Coronary Artery Disease, previous DVT and PE Approved
rituximab SLE, nephritis Approved
rituximab steroid dependent nephrotic syndrome Approved
rituximab Steroid Resistant Nephrotic Syndrome Approved
rituximab Steroid Resistant Nephrotic Syndrome Approved renewal
rituximab sub-glottic stenosis, Wegener's Granulomatosis Approved
rituximab systemic lupus erythematosus, severe neuropsychiatric complications Approved
rituximab Thrombotic thrombocytopaenic purpura Approved
rituximab warm autoimmune haemolytic anaemia Approved
rituximab warm autoimmune haemolytic anaemia, Cerebrovascular accident, pancreatitis Approved
rituximab warm autoimmune haemolytic anaemia, history of, ITP, lower extremety DVT, splenectomy, steroid induced diabetes mellitus Approved
rituximab Wegener's Granulomatosis Approved
rituximab Wegener's Granulomatosis, sub-glottic stenosis Approved
rituxumab neuromyelitis optica Approved
ropivacaine severe pain unresponsive to alternates, Advanced Metastatic Breast cancer, Infected Knee Joint, pain secondary to femur fracture Approved
rose bengal metastatic melanoma Approved
rose bengal metastatic melanoma Approved
rufinamide atypical absence seizures, medically refractory seizures, myoclonic seizures, epileptic encephalopathy Approved
rufinamide atypical absence seizures, medically refractory seizures, myoclonic seizures, epileptic encephalopathy Approved renewal
rufinamide epilepsy, frontal lobe seizures Approved renewal
rufinamide epilepsy, frontal lobe seizures Approved renewal
rufinamide Epileptic encephalopathy, global development delay, severe drop seizures Approved
rufinamide Epileptic encephalopathy, Intractable Epilepsy Approved
rufinamide Epileptic encephalopathy, Intractable Epilepsy Approved renewal
rufinamide epileptic encephalopathy, medically refractory seizures, autism spectrum disorder Approved
rufinamide epileptic encephalopathy, medically refractory seizures, developmental regression, HLAB1502 allele positive Approved
rufinamide epileptic encephalopathy, medically refractory seizures, developmental regression, HLAB1502 allele positive Approved renewal
rufinamide epileptic encephalopathy, refractory seizures, autism spectrum disorder, severe drop seizures Approved
rufinamide Intractable epilepsy, autism spectrum disorder, Hypomelanosis of Ito, intellectual disability Approved
rufinamide Intractable epilepsy, autism, Lennox-Gastaut syndrome Approved
rufinamide Intractable epilepsy, autism, Lennox-Gastaut syndrome Approved renewal
rufinamide Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy Approved
rufinamide Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy Approved renewal
rufinamide Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy Approved renewal
rufinamide Intractable Epilepsy, Cognitive deficit, epilepsy secondary to neonatal meningitis, intellectual disability, partial epilepsy Approved renewal
rufinamide Intractable epilepsy, cognitive impairment, Hydrocephalus Approved
rufinamide Intractable epilepsy, GORD, neutropenia, osteoporosis, severe developmental delay Approved
rufinamide Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy Approved
rufinamide Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy Approved renewal
rufinamide Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy Approved renewal
rufinamide Lennox�Gastaut syndrome, Chromosomal abnormality, epilepsy Approved renewal
rufinamide Lennox-Gastaut syndrome Approved
rufinamide Lennox-Gastaut syndrome, Chromosomal abnormality, epilepsy Approved renewal
rufinamide Lennox-Gastaut syndrome, learning difficulties Approved
rufinamide Lennox-Gastaut syndrome, learning difficulties Approved renewal
rufinamide Lennox-Gastaut syndrome, learning difficulties Approved renewal
rufinamide Lennox-Gastaut syndrome, learning difficulties Approved renewal
rufinamide Lennox-Gastaut syndrome, nonconvulsive status epilepticus, refractory epilepsy, Astrocytoma Grade 2, atonic attacks, drop attacks, frequent cyanotic spells Approved
rufinamide Lennox-Gastaut syndrome, nonconvulsive status epilepticus, refractory epilepsy, Astrocytoma Grade 2, atonic attacks, drop attacks, frequent cyanotic spells Approved renewal
rufinamide Lennox-Gastaut syndrome, refractory epilepsy Approved
rufinamide Lennox-Gastaut syndrome, refractory epilepsy Approved
rufinamide Lennox-Gastaut syndrome, refractory seizures, autism, intellectual disability Approved
rufinamide medically refractory seizures, intellectual disability Approved
rufinamide myoclonic astatic epilepsy, refractory epilepsy Approved
rufinamide myoclonic astatic epilepsy, refractory epilepsy Approved renewal
rufinamide refractory epilepsy Approved
rufinamide refractory epilepsy Approved renewal
rufinamide refractory epilepsy Approved renewal
rufinamide refractory epilepsy, Lennox-Gastaut syndrome Approved
rufinamide refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism Approved
rufinamide refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism Approved renewal
rufinamide refractory epilepsy, severe drop seizures, tonic seizures, Lennox-Gastaut syndrome, severe autism Approved renewal
rufinamide Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability Approved
rufinamide Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability Approved renewal
rufinamide Refractory seizure disorder, severe drop seizures, subcortical band heterotopia, challenging behaviour, intellectual disability Approved renewal
sevalamer end-stage renal disease, hyperphosphataemia, secondary hyperparathyroidism Approved
sevelamer end stage renal disease, Steroid Resistant Nephrotic Syndrome Approved
sevelamer end stage renal disease, Steroid Resistant Nephrotic Syndrome Approved renewal
sevelamer end stage renal failure, hyperphosphataemia, hypoplastic kidney, Unable to tolerate funded medicaton, diabetes type 2, diabetic neuropathy, gout, hypercalcaemia, hypertension, Hypothyroidism Approved
sevelamer end stage renal failure, hyperphosphataemia, hypoplastic kidney, Unable to tolerate funded medicaton, diabetes type 2, diabetic neuropathy, gout, hypercalcaemia, hypertension, Hypothyroidism Approved renewal
sevelamer hyperphosphataemia, ANCA positive vasculitis, chronic peritoneal dialysis, Chronic Renal Failure Approved
sevelamer hyperphosphataemia, ANCA positive vasculitis, chronic peritoneal dialysis, Chronic Renal Failure Approved renewal
sevelamer painful dystrophic calcification, tertiary hyperparathyroidism, tumoural calcinosis, CF related diabetes, Cystic fibrosis, end stage kidney disease, liver transplant, surgery contraindicated Approved renewal
sevelamer secondary hyperparathyroidism, end-stage renal disease, hyperphosphataemia Approved
sevelamer severe hyperparathyroidism, ineffective alternatives, surgery contraindicated Approved
sildenafil bridge to transplant, Chronic Renal Failure Approved renewal
sildenafil bridge to transplant, Chronic Renal Failure Approved renewal
sildenafil bridge to transplant, PAH secondary to lung disease, interstitial lung disease Approved
sildenafil bridge to transplant, PAH secondary to lung disease, interstitial lung disease Approved renewal
sildenafil bridge to transplant, PAH secondary to lung disease, interstitial lung disease Approved renewal
sildenafil constrictive pericarditis, pulmonary hypertension, left heart disease, pericardiectomy, Right Heart Failure Approved
sildenafil CREST syndrome, raynauds phenomenon Approved
sildenafil CREST syndrome, raynauds phenomenon Approved renewal
sildenafil diffuse cutaneous systemic sclerosis, Scleroderma, ulceration Approved
sildenafil end stage heart failure, pulmonary hypertension Approved
sildenafil end stage left heart disease, on transplant list, Severe dilated cardiomyopathy, left ventricular impairment, LV thrombus, Renal Impairment Approved
sildenafil familial dilated cardiomyopathy, left heart disease Approved
sildenafil haemangioma, lymphangioma of tongue Approved
sildenafil pulmonary arterial hypertension, congenital systemic pulmonary shunts Approved
sildenafil pulmonary hypertension, Cardiac Transplant, Severe dilated cardiomyopathy Approved
sildenafil pulmonary hypertension, lung transplant candidate, pulmonary fibrosis Approved
sildenafil raynauds phenomenon Approved
sildenafil raynauds phenomenon Approved
sildenafil raynaud's syndrome Approved
sildenafil raynaud's syndrome, critical ischaemia left foot, discoid lupus, Peripheral Vascular disease, secondary non-healing ulcer Approved
sildenafil reactive pulmonary hypertension, congenital diaphragmatic hernia Approved
sildenafil Scleroderma, digital ischaemia Approved
sildenafil (Avigra) PAH, complex congenital heart disease, cyanosis Approved
sirolimus adenoma sebaceum, tuberous sclerosis Approved
sirolimus adenoma sebaceum, tuberous sclerosis Approved renewal
sirolimus CNS lesions, renal angiomyolipoma, arteriovenous malformations, intractable seizures, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas Approved
sirolimus facial angiofibromas, ADHD, epilepsy, tuberous sclerosis Approved
sirolimus facial angiofibromas, epilepsy, tuberous sclerosis Approved
sirolimus facial angiofibromas, renal angiomyolipoma, subependymal giant cell astrocytomas, tuberous sclerosis Approved
sirolimus facial angiofibromas, renal angiomyolipoma, subependymal giant cell astrocytomas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, subungual angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved
sirolimus facial angiofibromas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, tuberous sclerosis Approved renewal
sirolimus facial angiofibromas, tuberous sclerosis, attention deficit hyperactivity disorder, epilepsy, Mild to Moderate Intellectual Impairment Approved
sirolimus facial angiofibromas, tuberous sclerosis, epilepsy, mental handicap Approved
sirolimus facial angiofibromas, tuberous sclerosis, epilepsy, mental handicap Approved renewal
sirolimus gastrointestinal bleeding, Blue Rubber Bleb Naevus Syndrome (BRBNS) Approved
sirolimus gastrointestinal bleeding, Blue Rubber Bleb Naevus Syndrome (BRBNS) Approved
sirolimus Gorham-Stout disease Approved
sirolimus hyperinsulinemic hypoglycaemia, hyperinsulinism in infant Approved
sirolimus hyperinsulinemic hypoglycaemia, hyperinsulinism in infant Approved
sirolimus hyperinsulinemic hypoglycaemia, hyperinsulinism in infant Approved
sirolimus hyperinsulinemic hypoglycaemia, hyperinsulinism in infant Approved
sirolimus lymphovascular malformation Approved
sirolimus lymphovascular malformation Approved renewal
sirolimus metastatic uterine perivascular epithelioid cell tumour Approved
sirolimus PASLI-R1 syndrome Approved
sirolimus PASLI-R1 syndrome Approved renewal
sirolimus perivascular epithelioid cell tumour Approved
sirolimus perivascular epithelioid cell tumour Approved renewal
sirolimus PIK3CA-related segmental overgrowth, Klippel-Trenaunay Syndrome Approved
sirolimus pulmonary lymphangioleiomyomatosis Approved
sirolimus renal angiomyolipoma, risk of haemorrhage, tuberous sclerosis, intellectual disability, rash Approved
sirolimus renal angiomyolipoma, severe tuberous sclerosis Approved
sirolimus renal angiomyolipoma, severe tuberous sclerosis Approved renewal
sirolimus renal angiomyolipoma, severe tuberous sclerosis, arteriovenous malformations, nephrectomy, risk of haemorrhage Approved
sirolimus renal angiomyolipoma, tuberous sclerosis Approved
sirolimus renal angiomyolipoma, tuberous sclerosis, Extensive skin disease Approved
sirolimus renal angiomyolipoma, tuberous sclerosis, Extensive skin disease Approved renewal
sirolimus tuberous sclerosis Approved
sirolimus tuberous sclerosis Approved
sirolimus tuberous sclerosis Approved
sirolimus tuberous sclerosis Approved renewal
sirolimus tuberous sclerosis, renal angiomyolipoma Approved
sirolimus ointment facial angiofibromas, tuberous sclerosis Approved
sirolimus ointment facial angiofibromas, tuberous sclerosis Approved
sitagliptin allergy to insulin, diabetes type 2, hypertension Approved
slow sodium hyponatraemia secondary to SIADH Approved
sodium benzoate Citrullinaemia type 1 Approved renewal
sodium benzoate hyperammonaemia Approved
sodium benzoate hyperammonaemia, urea cycle disorder Approved
sodium benzoate non-ketotic hyperglycinaemia Approved
sodium benzoate OTC Deficiency, urea cycle disorder Approved
sodium benzoate Propionic Acidaemia Approved
sodium benzoate secondary hyperammonaemia, Portal Hypertension, portal vein thrombosis, Portosystemic connections, tetralogy of fallot repair Approved
sodium chloride appendectomy, hyponatraemia, partial cystectomy, post right hemicolectomy, post thyroidectomy, right uretic JJ stent, severe COPD, stroke, tonsillectomy Approved
sodium chloride Congestive Heart Failure, restrictive cardiomyopathy, hyponatraemia Approved
sodium chloride corneal oedema Approved
sodium chloride Crohns Disease, bowel resection Approved
sodium chloride Crohns Disease, bowel resection Approved renewal
sodium chloride Crohn's disease, bowel resection Approved renewal
sodium chloride hyponatraemia, enlarged left kidney, pulmonary hypoplasia, renal dysplasia right kidney, severe pelvicalyceal dilatation Approved
sodium chloride hyponatraemia, Schizophrenia, small bowel fistula Approved
sodium chloride SIADH, Small Cell lung Cancer Approved
sodium chloride (Muro 128) decompensating corneal graft Approved
sodium chloride (Slow Sodium) hyponatraemia, Pancreatic neuroendocrine tumor, SIADH Approved
sodium chloride (Slow Sodium) low sodium levels, Crohn's diease, Hodgkin's lymphoma Approved
sodium chloride (Slow Sodium)   Approved
sodium chloride solution Cystic fibrosis, meconium ileus at birth Approved
sodium citrate metabolic acidosis, reflux nephropathy Approved
sodium dihydrogen phosphate metabolic bone disease of the neonate, Premature birth Approved
sodium dl 3 hydroxybutyrate glut-1 deficiency, Behavioural problems, epilepsy, intellectual disability Approved
sodium phenylbutyrate carnitine-acylcarnitine translocase deficiency, PEG feeding Approved
sodium phenylbutyrate hyperammonia, multiple oesophageal varices, portal hypertension, portal vein thrombosis, Portosystemic connections Approved
sodium phenylbutyrate hyperammonia, multiple oesophageal varices, portal hypertension, portal vein thrombosis, Portosystemic connections Approved renewal
sodium phenylbutyrate OTC Deficiency, urea cycle disorder Approved
sodium picosulfate chronic constipation, epilepsy, malone's appendicostomy for antegrade continence enema Approved renewal
sodium picosulfate Chronic severe constipation, anxiety, developmental delay, epilepsy, Paediatric autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) Approved
sodium picosulfate familial mitochondrial myopathy, idiopathic intestinal pseudo obstruction Approved
sodium picosulfate slow transit constipation, appendicostomy Approved
sodium picosulfate magnesium oxide citric acid constipation, Hirschsprung's disease Approved
sofosbuvir chronic Hepatitis C genotype 3A, Diabetes Mellitus Declined
sofosbuvir HCV cirrhosis, Hepatocellular carcinoma, HIV infection, Kaposi's sarcoma Declined
sofosbuvir plus ledipasvir chronic Hepatitis C genotype 3A, hepatits C virus cirrhosis, acquired via infected blood products, haemophilia, hepatocellular carcinoma, Post Liver Transplant Declined
sofosbuvir plus ledipasvir chronic hepatitis C, hepatic fibrosis, acquired via infected blood products, von Willebrand disease Declined
sofosbuvir plus ledipasvir chronic hepatitis C, liver cirrhosis, methadone maintenance, prior depression Declined
sofosbuvir plus ledipasvir chronic hepatitis C, liver fibrosis, acquired via infected blood products, haemophilia, Head Injury, secondary epilepsy Declined
sofosbuvir plus ledipasvir decompensated HCV cirrhosis, Head Injury, hepatocellular carcinoma, hypertension Declined
sofosbuvir plus ledipasvir genotype 1 hepatitis C, acquired via infected blood products, liver fibrosis Declined
sofosbuvir plus ledipasvir genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood Declined
sofosbuvir plus ledipasvir genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood Declined
sofosbuvir plus ledipasvir genotype 1 hepatitis C, hepatitis C virus cirrhosis, acquired via infected blood products Declined
sofosbuvir plus ledipasvir genotype 1 hepatitis C, liver fibrosis, acquired via infected blood Declined
sofosbuvir plus ledipasvir genotype 1 hepatitis C, liver fibrosis, acquired via infected blood Declined
sofosbuvir plus ledipasvir genotype 1 hepatitis C, liver fibrosis, acquired via infected blood products Declined
sofosbuvir plus ledipasvir hepatitis C virus cirrhosis, acquired via infected blood products, chronic Hepatitis C genotype 3A, haemophilia, Post Liver Transplant Declined
sofosbuvir plus ledipasvir hepatitis C virus cirrhosis, acquired via infected blood products, chronic kidney disease Declined
somatropin GH deficiency, adverse reaction to alternatives, hypoglycaemia, Panhypopituitarism Approved
sorafenib aggressive fibromatosis, desmoid tumour Approved
sorafenib aggressive fibromatosis, desmoid tumour Approved renewal
sorafenib follicular carcinoma of thyroid, hurthle cell carcinoma of the thyroid Declined
sorafenib follicular carcinoma of thyroid, refractory thyroid cancer, metastatic to lungs Declined
sorafenib Metastatic Thyroid cancer, papillary carcinoma of the thyroid, refractory to radiotherapy Declined
sorafenib papillary carcinoma of the thyroid Declined
spiramycin foetal toxoplasmosis infection, maternal toxoplasmosis Approved
spiramycin foetal toxoplasmosis infection, maternal toxoplasmosis Approved
spiramycin maternal toxoplasmosis Approved
spiramycin toxoplasmosis in pregnancy Approved
spiramycin toxoplasmosis in pregnancy Approved
stanozolol hereditary angioedema Approved renewal
stanozolol hereditary angioedema, intolerance to alternatives Approved
stiripentol dravet's syndrome, severe myoclonic epilepsy of infancy, learing impairment Approved
streptozocin duodenal tumour, neuroendocrine tumour, unresectable, diabetes type 2, gout Approved
streptozocin duodenal tumour, neuroendocrine tumour, unresectable, diabetes type 2, gout Approved renewal
streptozocin hypoglycaemia due to insulinoma, metastatic pancreatic neuroendocrine tumour, liver metastases Approved
streptozocin metastatic atypical carcinoid, neuroendocrine tumour Approved
streptozocin metastatic neuroendocrine tumour Approved
streptozocin metastatic neuroendocrine tumour Declined
streptozocin metastatic pancreatic carinoma, hypoglycaemia Approved
streptozocin metastatic pancreatic neuroendocrine tumour Declined
streptozocin Pancreatic neuroendocrine tumor Approved
sulfadiazine cerebral toxoplasmosis, Ocular Toxoplasmosis, immunocompetent Approved
sulindac desmoid fibromatosis Approved
sulindac desmoid fibromatosis Approved
sulindac desmoid fibromatosis Approved
sulphadiazine Cerebral toxoplasmosis, Glioblastoma Multiforme Approved
sulphadiazine Cerebral toxoplasmosis, Glioblastoma Multiforme Approved renewal
sulthiame continuous spike wave in slow wave sleeep, Epileptic encephalopathy, Landau-Kleffner Syndrome Approved renewal
sulthiame electrical status epilepticus in slow wave sleep, epileptic encephalopathy Approved
sulthiame electrical status epilepticus in slow wave sleep, epileptic encephalopathy Approved renewal
sulthiame epilepsy aphasia disorder, epileptic encephalopathy Approved
sulthiame Intractable Epilepsy, cerebral palsy, dystonia, Excessive drooling, Insomnia, intellectual handicap, scoliosis Approved
sulthiame Lennox-Gastaut syndrome, drop attacks, Intellectual Handicap, mild cerebral palsy, myoclonic seizures, tonic clonic seizures Approved
sunitinib angiosarcoma of the pericardium Approved
sunitinib ascites, GIST relapse, imatinib refractory, peritoneal metastases Approved
sunitinib extraskeletal myxoid chondrosarcoma Approved
sunitinib imatinib refractory GIST Approved
sunitinib imatinib refractory, nilotinib resistance, GIST relapse Approved
sunitinib metastatic translocation renal variant renal tumour, extensive nodal disease Approved
sunitinib progressive metastatic gastrointestinal stromal tumour Approved
sunitinib refractory to chemotherapy, thymic carcinoma Declined
tacrolimus angio immunoblastic T cell lymphoma, aplastic anaemia Approved
tacrolimus angio immunoblastic T cell lymphoma, aplastic anaemia Approved renewal
tacrolimus aplastic anaemia Approved
tacrolimus aplastic anaemia Approved
tacrolimus aplastic anaemia Approved renewal
tacrolimus Corneal stem cell failure, possible graft versus host disease, Stevens-Johnson Syndrome Approved
tacrolimus Crohn's disease Approved
tacrolimus Crohns Disease, coeliac disease, refractory to other treatments, refractory to standard treatments Approved
tacrolimus Crohn's disease, coeliac disease, refractory to other treatments, refractory to standard treatments Approved renewal
tacrolimus Crohn's disease, coeliac disease, refractory to other treatments, refractory to standard treatments Approved renewal
tacrolimus Crohn's disease, poor growth Approved
tacrolimus Crohn's disease, poor growth Approved renewal
tacrolimus Crohns Disease, sclerosing cholangitis Approved
tacrolimus dermatitis of the vulva/external genitalia, Staphylococcus aureus infection, velocardiofacial (DiGeorge) syndrome Approved renewal
tacrolimus dermatitis of thh vulva/external genitalia, Staphylococcus aureus infection Approved
tacrolimus Erythoderma psoriasis Approved
tacrolimus Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor Approved
tacrolimus Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor Approved renewal
tacrolimus Focal Segmental Glomerulosclerosis, cyclosporin dependent, gingival hyperplania, Nephrotic Syndrome, short stature, steroid dependent, tremor Approved renewal
tacrolimus Focal Segmental Glomerulosclerosis, cyclosporin ineffective, renal dysfunction Approved
tacrolimus Focal Segmental Glomerulosclerosis, Nephrotic Syndrome Approved renewal
tacrolimus Focal Segmental Glomerulosclerosis, Nephrotic Syndrome Approved renewal
tacrolimus Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome Approved
tacrolimus Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome Approved
tacrolimus Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment Approved
tacrolimus Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment Approved renewal
tacrolimus Ig A nephropathy Approved
tacrolimus Ig A nephropathy Approved renewal
tacrolimus Ig A nephropathy Approved renewal
tacrolimus immunosuppression secondary to liver transplant, Refractory rejection Approved
tacrolimus liver transplant, Cognitive deficit, previous graft rejection Approved renewal
tacrolimus metastatic Crohn's disease of skin Approved
tacrolimus minimal change nephrotic syndrome, steroid dependent nephrotic syndrome, asthma, cerebral palsy, Chronic lung disease, developmental delay Approved
tacrolimus Nephrotic Syndrome Approved
tacrolimus Nephrotic Syndrome Approved
tacrolimus nephrotic syndrome Approved
tacrolimus Nephrotic Syndrome Approved renewal
tacrolimus Pure Red Cell Aplasia Approved
tacrolimus pyoderma gangrenosum, Crohn's disease, post surgery Approved
tacrolimus Renal Impairment, Severe Aplastic Anaemia Approved renewal
tacrolimus Renal Impairment, Severe Aplastic Anaemia Approved renewal
tacrolimus severe acquired aplastic anaemia Approved
tacrolimus Severe Aplastic Anaemia Approved
tacrolimus Severe Aplastic Anaemia Approved
tacrolimus Severe Aplastic Anaemia, anaemia, Thrombocytopaenia Approved
tacrolimus Severe Aplastic Anaemia, liver impairment Approved
tacrolimus severe atopic dermatitis Approved
tacrolimus steroid dependent minimal change glomerulonephritis Approved
tacrolimus steroid dependent minimal change glomerulonephritis, frequently relapsing, possible follicular carcinoma of thyroid Approved
tacrolimus steroid dependent nephrotic syndrome Approved
tacrolimus steroid dependent nephrotic syndrome Approved
tacrolimus steroid dependent nephrotic syndrome Approved
tacrolimus steroid dependent nephrotic syndrome Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome Approved
tacrolimus Steroid Resistant Nephrotic Syndrome Approved
tacrolimus Steroid Resistant Nephrotic Syndrome Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome, cyclophosphamide toxicity, cyclosporin unsuitable Approved
tacrolimus Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis Approved
tacrolimus Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis Approved
tacrolimus Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome, Focal Segmental Glomerulosclerosis Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome, gum hypertrophy, hirsutism, renal impairment Approved
tacrolimus Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment Approved
tacrolimus Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome, hypertension, renal impairment Approved renewal
tacrolimus Steroid Resistant Nephrotic Syndrome, hypoalbuminaemia, minimal change nephrotic syndrome Approved
tacrolimus Steroid Resistant Nephrotic Syndrome, hypoalbuminaemia, minimal change nephrotic syndrome Approved renewal
tacrolimus ulcerative proctitis Approved
tacrolimus ulcerative proctitis Approved renewal
tacrolimus ointment hypertrophic conjunctival spring catarrh, glaucoma Approved
tacrolimus ointment metastatic Crohn's disease of skin Approved renewal
tacrolimus ointment metastatic Crohn's disease of skin Approved renewal
tacrolimus ointment non-healing wound, post surgery, protectomy, severe crohn's disease Approved
tacrolimus ointment Refractory to steroids, vulval crohn's disease Approved
taurolidine recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent Approved
taurolidine recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent Approved renewal
taurolidine recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent Approved renewal
taurolidine recurrent line sepsis, gastric dysmotility, Hirschsprung's disease, TPN dependent Approved renewal
taurolidine recurrent port infections, haemophilia Approved
telaprevir hepatitis C Approved
temozolomide anaplastic astrocytoma Approved
temozolomide anaplastic ependymoma, Spinal Metastases Approved
temozolomide duodenal gastrinoma, metastatic neuroendocrine tumour, unresectable, zollinger-ellison syndrome Approved
temozolomide Ewings sarcoma Approved
temozolomide ewings sarcoma, metastatic Approved
temozolomide insulinoma, metastatic pancreatic neuroendocrine tumour Approved
temozolomide intermediate grade NET, hypertension Approved
temozolomide intermediate grade NET, liver metastases Approved
temozolomide liver metastases, lung cancer, neuroendocrine tumour Approved
temozolomide liver metastases, lung cancer, neuroendocrine tumour Approved renewal
temozolomide meningioma Approved
temozolomide metastatic carcinoid tumour, hepatomegaly, liver metastases Approved
temozolomide metastatic ewings sarcoma Approved
temozolomide metastatic ewings sarcoma Approved
temozolomide metastatic ewings sarcoma Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour Approved renewal
temozolomide metastatic neuroendocrine tumour, carcinoid syndrome Approved
temozolomide metastatic neuroendocrine tumour, carcinoid syndrome Approved
temozolomide metastatic neuroendocrine tumour, carcinoid syndrome Approved
temozolomide metastatic neuroendocrine tumour, cushing's syndrome Approved
temozolomide metastatic neuroendocrine tumour, Hypercalcaemia of Malignancy Approved
temozolomide metastatic neuroendocrine tumour, hypercholesterolaemia Approved
temozolomide metastatic neuroendocrine tumour, hypercholesterolaemia, hypertension, ischaemic heart disease Approved
temozolomide metastatic neuroendocrine tumour, hypertension Approved
temozolomide metastatic neuroendocrine tumour, hypertension, pernicious anaemia Approved
temozolomide metastatic neuroendocrine tumour, hypertension, pernicious anaemia Approved renewal
temozolomide metastatic neuroendocrine tumour, hypertension, pernicious anaemia Approved renewal
temozolomide metastatic neuroendocrine tumour, intermediate grade NET Approved
temozolomide metastatic neuroendocrine tumour, liver metastases, peritoneum metastases, small bowel metastases Approved
temozolomide metastatic neuroendocrine tumour, Lung Metastases, relapse following chemotherapy, tracheal compression Approved
temozolomide metastatic neuroendocrine tumour, neuroendocrine tumour Approved
temozolomide metastatic neuroendocrine tumour, neuroendocrine tumour, intermediate grade NET Approved
temozolomide metastatic neuroendocrine tumour, neuroendocrine tumour, intermediate grade NET Approved renewal
temozolomide metastatic neuroendocrine tumour, stage IV, hypertension Approved
temozolomide metastatic neuroendocrine tumour, widespread metastases Approved
temozolomide metastatic neuroendocrine tumour, widespread metastases Approved renewal
temozolomide metastatic neuroendocrine tumour, widespread metastases Approved renewal
temozolomide metastatic pancreatic neuroendocrine tumour Approved
temozolomide metastatic pancreatic neuroendocrine tumour Approved
temozolomide metastatic pancreatic neuroendocrine tumour Approved
temozolomide metastatic pancreatic neuroendocrine tumour Approved
temozolomide metastatic pancreatic neuroendocrine tumour Approved
temozolomide metastatic pancreatic neuroendocrine tumour, atrial fibrillation, dyslipidaemia, hyperkalaemia, hypertension, previous st jude mitral replacement Approved
temozolomide metastatic paraganglioma, metastatic neuroendocrine tumour Approved
temozolomide metastatic small cell neuroendocrine carcinoma of anorectal junction Approved
temozolomide neuroendocrine cancer Approved
temozolomide neuroendocrine cancer Approved renewal
temozolomide neuroendocrine cancer, Hypothyroidism Approved
temozolomide neuroendocrine cancer, liver metastases Approved
temozolomide neuroendocrine tumour Approved
temozolomide neuroendocrine tumour, intermediate grade NET Approved
temozolomide Pancreatic neuroendocrine tumor Approved
temozolomide Pancreatic neuroendocrine tumor Approved
temozolomide Pancreatic neuroendocrine tumor Approved
temozolomide Pancreatic neuroendocrine tumor Approved
temozolomide Pancreatic neuroendocrine tumor Approved
temozolomide Pancreatic neuroendocrine tumor Approved
temozolomide Pancreatic neuroendocrine tumor Approved renewal
temozolomide Pancreatic neuroendocrine tumor Approved renewal
temozolomide Pancreatic neuroendocrine tumor Approved renewal
temozolomide Pancreatic neuroendocrine tumor, Angina, liver metastases, pacemaker, renal cell carcinoma Approved
temozolomide Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy Approved
temozolomide Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy Approved renewal
temozolomide Pancreatic neuroendocrine tumor, Insulin-Dependent Diabetes Mellitus, pancreatectomy Approved renewal
temozolomide Pancreatic neuroendocrine tumor, liver metastases Approved
temozolomide Pancreatic neuroendocrine tumor, non insulin-dependent diabetes mellitus Approved
temozolomide Pancreatic neuroendocrine tumor, Portal Hypertension, portal vein thrombosis, splenomegaly Approved
temozolomide pituitary macroadenoma Approved
temozolomide primary CNS lymphoma Approved
temozolomide primary CNS lymphoma, relapsed lymphoma Approved
temozolomide pulmonary neuroendocrine tumour Approved
temozolomide recurrent medulloblastoma Approved
temozolomide recurrent medulloblastoma Approved
temozolomide recurrent pancreatic neuroendocrine tumour, insulinoma, liver metastases Approved
temozolomide relapsed CNS lymphoma Approved
temozolomide relapsed Ewings sarcoma Approved
temozolomide relapsed Ewings sarcoma Approved
temozolomide relapsed Ewings sarcoma Approved
temozolomide relapsed Ewings sarcoma Approved
temozolomide relapsed Ewings sarcoma Approved
temozolomide relapsed Ewings sarcoma Approved
temozolomide relapsed neuroblastoma, metastatic neuroblastoma Approved
temozolomide rhabdomyosarcoma Approved
teniposide IgA multiple myeloma, plasmacytoma, Thrombocytopaenia Approved
teniposide IgG multiple myeloma, acute renal failure, hyperkalaemia Approved
teniposide Lymphoblastic T-cell lymphoma Approved
teniposide lytic bone lesions, Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved
teniposide Multiple Myeloma Approved renewal
teniposide Multiple Myeloma Approved renewal
teniposide Multiple Myeloma Approved renewal
teniposide Multiple Myeloma, anaemia, renal impairment Approved
teniposide Multiple Myeloma, bone disease Approved
teniposide Multiple Myeloma, bone disease Approved
teniposide Multiple Myeloma, bone disease Approved
teniposide Multiple Myeloma, bone disease, Moderate renal impairment Approved
teniposide Multiple Myeloma, bone disease, Moderate renal impairment Approved renewal
teniposide Multiple Myeloma, bone disease, renal impairment Approved
teniposide Multiple Myeloma, Bone disease, with incipient cord compression Approved
teniposide Multiple Myeloma, bone metastases Approved
teniposide Multiple Myeloma, Crohn's diease Approved
teniposide Multiple Myeloma, hypertension, renal impairment, spinal stenosis Approved
teniposide Multiple Myeloma, intermittent AF Approved
teniposide Multiple Myeloma, lytic bone lesions Approved
teniposide Multiple Myeloma, mds, refractory anaemia with ringed sideroblasts (RARS), secondary to lenalidomide Approved
teniposide Multiple Myeloma, mitral valve prolapse Approved
teniposide Multiple Myeloma, non insulin-dependent diabetes mellitus, osteoarthritis of the spine Approved
teniposide Multiple Myeloma, plasma cell leukaemia Approved
teniposide Multiple Myeloma, plasma cell leukaemia, end-stage renal failure on dialysis Approved
teniposide Multiple Myeloma, renal impairment Approved
teniposide Myeloma Approved
teniposide Myeloma, cast nephropathy Approved
teniposide Myeloma, thoracic compression fracture Approved
teniposide plasma cell myeloma, back pain, haemochromatosis Approved
teniposide plasma cell myeloma, deep vein thrombosis, squamous cell skin cancer Approved
teniposide primary central nervous system lymphoma Approved
teniposide primary central nervous system lymphoma Approved
teniposide primary CNS lymphoma Approved
teniposide primary CNS lymphoma Approved
teniposide primary CNS lymphoma, chronic active hepatitis Approved
teniposide refractory multiple myeloma Approved
teniposide refractory multiple myeloma Approved
teniposide refractory multiple myeloma, Pancytopenia, renal impairment Approved
teniposide relapsed multiple myeloma Approved
teniposide relapsed multiple myeloma Approved
teniposide relapsed multiple myeloma Approved
teniposide relapsed multiple myeloma Approved
teniposide relapsed multiple myeloma Approved
teniposide relapsed multiple myeloma Approved
teniposide relapsed multiple myeloma, hypercalcaemia Approved
teniposide relapsed multiple myeloma, hypercalcaemia Approved
teniposide relapsed multiple myeloma, Renal Impairment Approved
teniposide relapsed myeloma, bone disease, Diabetes Mellitus Approved
teniposide relapsed plasma cell myeloma, hypertension Approved
teniposide T cell acute lymphoblastic leukemia Approved
teniposide T cell acute lymphoblastic leukemia Approved
teriparatide bisphosphonate related osteonecrosis of the jaw, stage III Approved
teriparatide bisphosphonate related osteoradionecrosis of the jaw Approved
teriparatide osteogenesis imperfecta Approved
testosterone hypogonadism, fibromuscular dysplasia, migraines Approved
testosterone gel Congenital hypopituitarism, funded alternative unsuitable Approved
thalidomide angioimmunoblastic T cell lymphoma Approved
thalidomide arteriovenous malformations, refractory intestinal bleeding Approved
thalidomide Behcet's disease, duodenal carcinoma, fungal pneumonia, pulmonary embolism, renal calculus Approved
thalidomide Behcet's disease, duodenal carcinoma, fungal pneumonia, pulmonary embolism, renal calculus Approved renewal
thalidomide chromosomal translocation t(11;14)(q13;q32) and nuclear cyclin D1 overexpression, relapsed mantle cell lymphoma Approved
thalidomide chronic anaemia, Hereditary hemorrhagic telangiectasia Approved
thalidomide chronic anaemia, Hereditary hemorrhagic telangiectasia Approved renewal
thalidomide chronic pruritus, nodular prurigo Approved
thalidomide chronic recurrent gastric vascular ectasia, syncope with bleeding events, cerebrovascular disease, CREST syndrome, history of stroke, primary biliary cirrhosis Approved
thalidomide Erythema Nodosum Leprosum Approved
thalidomide gastrointestinal bleeding, myelodysplasia, small bowel angiodysplasia Approved
thalidomide GI bleeds, cerebrovascular disease, Peripheral Vascular disease, polymyalgia, small bowel vascular ectasia, subclavian steal syndrome Approved renewal
thalidomide multibacillary leprosy, relapsed erythema nodosum leprosum Approved
thalidomide multibacillary leprosy, relapsed erythema nodosum leprosum, foot ulcer Approved
thalidomide recurrent GI bleeding, severe crohn's disease Approved renewal
thalidomide recurrent GI bleeding, severe crohn's disease Approved renewal
thalidomide recurrent GI bleeding, small bowel angioectasia Approved
thalidomide recurrent GI bleeding, small bowel angioectasia Approved renewal
thalidomide recurrent GI bleeding, small bowel angioectasia Approved renewal
thalidomide recurrent GI bleeding, small bowel angioectasia Approved renewal
thalidomide refractory small bowel bleeding Approved
thalidomide Refractory small intestinal bleeding Approved
thalidomide Refractory small intestinal bleeding Approved renewal
thalidomide severe crohn's disease Approved
thiothixene paranoid schizophrenia Approved
ticagrelor antiphospholipid syndrome, ischaemic heart disease, VF cardiac arrest Approved
ticagrelor Coronary Artery Disease, dyslipidaemia, post stenting Approved
ticagrelor coronary artery disease, multiple allergies, STEMI Approved
ticagrelor coronary artery disease, multiple allergies, STEMI Approved renewal
ticagrelor post stenting, intolerance to funded alternative Approved
timolol and travaprost glaucoma, allergy to preservative Approved
timolol and travaprost glaucoma, allergy to preservative Approved renewal
timolol maleate eye drops essential iris atrophy left eye, glaucoma Approved
timolol minims glaucoma, allergy to preservative Approved
tinidazole Resistant trichomoniasis Approved
tinidazole Resistant trichomoniasis, Depression Approved
tizanidine dystonia, Dopamine-2-receptor antibody encephalitis, spasticity Approved
tobramycin bronchiectasis, chronic colinisiation, developmental delay, hypogammaglobulinaemia, seizures Approved
tobramycin bronchiectasis, macrophage activation syndrome, systemic onset juvenile idiopathic arthritis Approved
tobramycin respiratory syncytial virus, severe chronic lung disease, bronchiolitis, possible cystic fibrosis, pseudomonas aeruginosa Approved
tocilizumab adult onset Stills disease, folliculis, hepatosplenomegaly, myocarditis, pericarditis Approved
tocilizumab castleman's disease Declined
tocilizumab castleman's disease Declined
tocilizumab juvenile idiopathic arthritis, uveitis, glaucoma, juvenile idiopathic uveitis, ocular inflammation, Positive ANA Approved
tocilizumab multicentric castlemans disease Declined
tocilizumab multicentric castlemans disease, aspiration pneumonia, Congestive Heart Failure, meningococcal septicaemia, mitral regurgitation, nephrectomy, Past history of rheumatic fever Declined
tocilizumab polyarticular juvenile idiopathic arthritis, Anaphylaxis to rituxumab, refractory to standard treatments, unacceptable side effects of high dose steroid treatment Approved
tocilizumab polyarticular juvenile idiopathic arthritis, Anaphylaxis to rituxumab, refractory to standard treatments, unacceptable side effects of high dose steroid treatment Approved renewal
tocilizumab polymyalgic syndrome, refractory to other treatments, obstructive sleep apnoea Approved renewal
tocilizumab systemic onset juvenile idiopathic arthritis, early macrophage activation syndrome Approved
tolvaptan SIADH, hypertension, ischaemic heart disease, post operative knee surgery, post surgery Approved
tolvaptan SIADH, hypertension, ischaemic heart disease, post operative knee surgery, post surgery Approved renewal
topotecan neuroblastoma stage 4 Approved
topotecan neuroblastoma stage 4 Approved
topotecan neuroblastoma stage 4 Approved renewal
topotecan wilm's tumour, liver metastases Approved
tramadol pain, hydrocephalus with shunt, Spina Bifida, swallowing dysfunction Declined
tramadol sr pain management, Spina Bifida Approved
tramadol sr pain management, Spina Bifida Approved renewal
tranexamic acid fungating left breast primary, metastatic breast cancer, pulmonary embolism Approved
trastuzumab breast cancer, Her2 positive, controlled intracranial metastases, No systemic progression Approved
trastuzumab breast cancer, Her2 positive, locally advanced breast cancer Approved
trastuzumab breast cancer, Her2 positive, locally advanced breast cancer Approved renewal
travoprost bak-free glaucoma Approved
travoprost bak-free glaucoma Approved renewal
travoprost bak-free glaucoma, allergy to preservative Approved
travoprost bak-free glaucoma, allergy to preservative Approved renewal
travoprost bak-free glaucoma, allergy to preservative Approved renewal
travoprost bak-free glaucoma, asthma, multiple allergies Approved renewal
travoprost bak-free glaucoma, asthma, multiple allergies Approved renewal
travoprost bak-free primary open glaucoma, meibomian gland dysfunction Approved renewal
travoprost bak-free primary open glaucoma, meibomian gland dysfunction Approved renewal
treosulphan conditioning for stem cell transplant, Severe combined immune deficiency Approved
treosulphan Severe combined immune deficiency, allogeneic transplant, awaiting stem cell transplant Approved
treprostinil raynaud's syndrome, severe peripheral ischaemia, risk of further amputation, skin ulceration, very poor venous access Approved
triamcinolone acetonide macular oedema, retinal vein occlusion, allergy to preservative Approved renewal
triamcinolone acetonide macular oedema, vitrectomy Approved renewal
triamcinolone hexacetonide macular oedema, retinal vein occlusion, allergy to preservative Approved
triamcinolone hexacetonide macular oedema, vitrectomy Approved
trientine Wilson's disease Approved
trientine Wilson's disease, daibetes type 1 Approved
trientine dihydrochloride Wilson's disease Approved renewal
trientine hydrochloride Wilson's disease, diabetes type 1 Approved renewal
trientine hydrochloride Wilson's disease, diabetes type 1 Approved renewal
trihexyphenidyl cerebral palsy, choreoathetoid cerebral palsy, dystonia, kernicterus Approved
trihexyphenidyl Complex Mitochondrial Disorder, choreoathetoid movements, excessive oral secretions, excessive sweating, global development delay, hyponatraemia, severe GI dysmotility Approved
trihexyphenidyl Complex Mitochondrial Disorder, choreoathetoid movements, excessive oral secretions, excessive sweating, global development delay, hyponatraemia, severe GI dysmotility Approved renewal
trihexyphenidyl dystonia Approved
trihexyphenidyl dystonia, Dopamine-2-receptor antibody encephalitis, spasticity Approved
trihexyphenidyl dystonia, hypoxic ischaemic encophalopathy, Neonatal Seizures Approved
trihexyphenidyl dystonic cerebral palsy, aspiration pneumonia, Excessive drooling, global development delay, seizures Approved
triiodothyroacetic acid Allan-Herndon-Dudley Syndrome Approved
triiodothyroacetic acid Allan-Herndon-Dudley Syndrome Approved
triiodothyroacetic acid Allan-Herndon-Dudley Syndrome, MCT8 thyroid transported defect, gastrostomy feeding, severe developmental delay, Severe GORD, sleep disturbance Approved
tyr anamix infant tyrosinaemia non-type I Approved
tyr anamix junior tyrosinaemia type I Approved
tyr anamix junior tyrosinaemia type I Approved renewal
tyr anamix junior tyrosinaemia type III Approved
tyr anamix junior tyrosinaemia type III Approved renewal
tyr anamix junior tyrosinaemia type III Approved renewal
ubiquinone Brown-Vialetto-Van Laere Syndrome Approved
ursodeoxycholic acid bile reflux, painful gastropathy Approved
ursodeoxycholic acid bile reflux, painful gastropathy Approved renewal
ursodeoxycholic acid biliary atresia, awaiting liver transplant, pruritus secondary to cholestasis, recurrent Cholangitis Approved
ursodeoxycholic acid biliary atresia, failing kasai portoenterostomy Approved
ursodeoxycholic acid biliary atresia, failing kasai portoenterostomy Approved renewal
ursodeoxycholic acid cholangiopathy, intra-hepatic stones, post liver transplant, Roux reconstruction Approved
ursodeoxycholic acid cholelithiasis, pancreatitis, surgery contraindicated Approved
ursodeoxycholic acid cholestasis, Liver disease, short bowel syndome Approved
ursodeoxycholic acid cholestatic hepatitis, cholestatic jaundice Approved
ursodeoxycholic acid chronic cholestatis, ABCB4 mutation causing premature complicated gallstone disease Approved
ursodeoxycholic acid deranged liver enzymes, GvHD post allogeneic transplant Approved
ursodeoxycholic acid intractable pruritus, Biliary Atresia, kasai procedure, liver transplant Approved
ursodeoxycholic acid intractable pruritus, cholestatic liver disease Approved
ursodeoxycholic acid intractable pruritus, primary sclerosing cholangitis, Ulcerative Colitis Approved
ursodeoxycholic acid liver graft verus host disease, acute myeloid leukaemia, hypertension, mild renal impairment Declined
ursodeoxycholic acid PBC Approved renewal
ursodeoxycholic acid primary biliary cirrhosis Approved
ursodeoxycholic acid primary biliary cirrhosis, hypertension, splenomegaly Approved
ursodeoxycholic acid primary sclerosing cholangitis Approved
ursodeoxycholic acid primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease Approved
ursodeoxycholic acid primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease Approved renewal
ursodeoxycholic acid primary sclerosing cholangitis, autoimmune hepatitis, inflammatory bowel disease Approved renewal
ursodeoxycholic acid primary sclerosing cholangitis, pancolitis Approved renewal
ursodeoxycholic acid progressive familial intrahepatic cholestasis Approved
ursodeoxycholic acid pruritus secondary to cholestasis, Liver Failure, oesophageal varices Approved
ursodeoxycholic acid recurrent choledocholithiasis, asthma, diabetes insipidus Approved
ursodeoxycholic acid recurrent intrahepatic stone disease Approved
ursodeoxycholic acid severe pruritus, cirrhosis, intrahepatic biliary strictures, primary sclerosing cholangitis, Ulcerative Colitis Approved
ursodeoxycholic acid severe pruritus, cirrhosis, intrahepatic biliary strictures, primary sclerosing cholangitis, Ulcerative Colitis Approved renewal
ustekinumab severe chronic plaque psoriasis, treatment refractory Approved
ustekinumab severe chronic plaque psoriasis, treatment refractory Approved renewal
valaciclovir disseminated varicella zoster virus infection, AML, bone marrow transplant, prophylaxis Approved
valaciclovir gingivostomatitis, immunosuppressed patient, Recurrent herpes simplex Approved
valaciclovir HSV keratitis with stromal disease, scarring and neovascularistion, eczema on mycophenolate, Herpes Simplex Keratitis Approved
valaciclovir prophylaxis to prevent infection, post bone marrow transplant, recurrent herpes zoster flares Approved
valaciclovir Recurrent herpes simplex, Herpes Simplex Keratitis, virus not controlled on Acyclovir Approved
valaciclovir shingles Approved
valganciclovir Active Hepatitis, Acute Lymphoblastic Leukaemia, Congenital Heart Disease, high EBV load Approved
valganciclovir acute leukamia post bone marrow transplant, treatment of CMV disease Approved
valganciclovir Acute Lymphoblastic Leukaemia, reactivation of CMV Approved
valganciclovir Acute Myeloid Leukaemia, CMV viraemia, post bone marrow transplant, secondary pancytopenia Approved
valganciclovir anterior uveitis, CMV, glaucoma, post LASIK surgery, reduced endothelial cell count, secondary cataract Approved
valganciclovir anterior uveitis, CMV, glaucoma, post LASIK surgery, reduced endothelial cell count, secondary cataract Approved renewal
valganciclovir cmv colitis Approved
valganciclovir CMV disease post lung transplant Approved
valganciclovir CMV disease post renal transplant Approved
valganciclovir cmv infection post allo-transplant Approved
valganciclovir CMV myocarditis, immunocompetent, pulmonary oedema Approved
valganciclovir Crohn's diease, Cytomegalovirus induced haemophagocytic lymphohistiocytosis Approved
valganciclovir cytomegalovirus infection, Epstein Barr Virus, post renal transplant Approved
valganciclovir cytomegalovirus infection, GvHD, T cell lymphoma Approved
valganciclovir cytomegalovirus infection, Hypothyroidism, idiopathic thrombocytopaenic purpura, polycystic kidney disease, post splenectomy, systemic lupus erythematosus Approved
valganciclovir high EBV replication, post renal transplant Approved
valganciclovir high EBV replication, post renal transplant Approved renewal
valganciclovir Kaposi's sarcoma associated HHV-8, castleman's disease, HIV infection Approved
valganciclovir Kidney Transplant, Prophylaxis of CMV Approved
valganciclovir post bone marrow transplant, reactivation of CMV Approved
valganciclovir post bone marrow transplant, reactivation of CMV Approved
valganciclovir Prophylaxis of CMV Approved
valganciclovir Prophylaxis of CMV, polycystic kidney disease, post kidney transplant Approved
valganciclovir reactivation of CMV Approved
valganciclovir reactivation of CMV, conditioned with cyclophosphamide, fludarabine treatment, post allogeneic stem cell transplant, received ATG treatment in hospital Approved
valganciclovir reactivation of CMV, post bone marrow transplan